0001145197-20-000037.txt : 20201105 0001145197-20-000037.hdr.sgml : 20201105 20201104180226 ACCESSION NUMBER: 0001145197-20-000037 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 201288005 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 10-Q 1 podd-20200930.htm 10-Q podd-20200930
false2020Q30001145197December 31us-gaap:AccountingStandardsUpdate201613Memberus-gaap:AccountingStandardsUpdate201613MemberP1Y00011451972020-01-012020-09-30xbrli:shares00011451972020-10-28iso4217:USD00011451972020-09-3000011451972019-12-31iso4217:USDxbrli:shares00011451972020-07-012020-09-3000011451972019-07-012019-09-3000011451972019-01-012019-09-300001145197us-gaap:CommonStockMember2020-06-300001145197us-gaap:AdditionalPaidInCapitalMember2020-06-300001145197us-gaap:RetainedEarningsMember2020-06-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-3000011451972020-06-300001145197us-gaap:CommonStockMember2020-07-012020-09-300001145197us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001145197us-gaap:RetainedEarningsMember2020-07-012020-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001145197us-gaap:CommonStockMember2020-09-300001145197us-gaap:AdditionalPaidInCapitalMember2020-09-300001145197us-gaap:RetainedEarningsMember2020-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001145197us-gaap:CommonStockMember2019-06-300001145197us-gaap:AdditionalPaidInCapitalMember2019-06-300001145197us-gaap:RetainedEarningsMember2019-06-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-3000011451972019-06-300001145197us-gaap:CommonStockMember2019-07-012019-09-300001145197us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-30xbrli:pure0001145197podd:ConvertibleSeniorNotes375Member2019-09-300001145197us-gaap:AdditionalPaidInCapitalMemberpodd:ConvertibleSeniorNotes375Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes375Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes1.25Member2019-09-300001145197us-gaap:AdditionalPaidInCapitalMemberpodd:ConvertibleSeniorNotes1.25Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes1.25Member2019-07-012019-09-300001145197us-gaap:RetainedEarningsMember2019-07-012019-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300001145197us-gaap:CommonStockMember2019-09-300001145197us-gaap:AdditionalPaidInCapitalMember2019-09-300001145197us-gaap:RetainedEarningsMember2019-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-3000011451972019-09-300001145197us-gaap:CommonStockMember2019-12-310001145197us-gaap:AdditionalPaidInCapitalMember2019-12-310001145197us-gaap:RetainedEarningsMember2019-12-310001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-3100011451972019-01-012019-12-310001145197us-gaap:CommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001145197us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001145197srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310001145197us-gaap:CommonStockMember2020-01-012020-09-300001145197us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300001145197us-gaap:RetainedEarningsMember2020-01-012020-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300001145197us-gaap:CommonStockMember2018-12-310001145197us-gaap:AdditionalPaidInCapitalMember2018-12-310001145197us-gaap:RetainedEarningsMember2018-12-310001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-3100011451972018-12-310001145197us-gaap:CommonStockMember2019-01-012019-09-300001145197us-gaap:AdditionalPaidInCapitalMember2019-01-012019-09-300001145197us-gaap:AdditionalPaidInCapitalMemberpodd:ConvertibleSeniorNotes375Member2019-01-012019-09-300001145197podd:ConvertibleSeniorNotes375Member2019-01-012019-09-300001145197us-gaap:AdditionalPaidInCapitalMemberpodd:ConvertibleSeniorNotes1.25Member2019-01-012019-09-300001145197podd:ConvertibleSeniorNotes1.25Member2019-01-012019-09-300001145197us-gaap:RetainedEarningsMember2019-01-012019-09-300001145197us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-09-300001145197us-gaap:ShippingAndHandlingMember2020-07-012020-09-300001145197us-gaap:ShippingAndHandlingMember2019-07-012019-09-300001145197us-gaap:ShippingAndHandlingMember2020-01-012020-09-300001145197us-gaap:ShippingAndHandlingMember2019-01-012019-09-300001145197us-gaap:SellingAndMarketingExpenseMember2019-07-012019-09-300001145197us-gaap:ResearchAndDevelopmentExpenseMember2019-07-012019-09-300001145197us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-09-300001145197us-gaap:SellingAndMarketingExpenseMember2019-01-012019-09-300001145197us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2019-01-012019-09-300001145197us-gaap:AccountsReceivableMember2019-01-012019-09-300001145197srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2020-06-300001145197srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2020-06-300001145197srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2019-12-310001145197podd:U.S.OmnipodMember2020-07-012020-09-300001145197podd:U.S.OmnipodMember2019-07-012019-09-300001145197podd:U.S.OmnipodMember2020-01-012020-09-300001145197podd:U.S.OmnipodMember2019-01-012019-09-300001145197podd:InternationalOmnipodMember2020-07-012020-09-300001145197podd:InternationalOmnipodMember2019-07-012019-09-300001145197podd:InternationalOmnipodMember2020-01-012020-09-300001145197podd:InternationalOmnipodMember2019-01-012019-09-300001145197podd:ProductOmnipodMember2020-07-012020-09-300001145197podd:ProductOmnipodMember2019-07-012019-09-300001145197podd:ProductOmnipodMember2020-01-012020-09-300001145197podd:ProductOmnipodMember2019-01-012019-09-300001145197podd:DrugDeliveryMember2020-07-012020-09-300001145197podd:DrugDeliveryMember2019-07-012019-09-300001145197podd:DrugDeliveryMember2020-01-012020-09-300001145197podd:DrugDeliveryMember2019-01-012019-09-300001145197us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-07-012020-09-300001145197us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-09-300001145197us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-01-012019-09-300001145197us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-07-012019-09-300001145197us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-09-300001145197us-gaap:CashMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CashMember2020-09-300001145197us-gaap:CashMemberus-gaap:FairValueInputsLevel2Member2020-09-300001145197us-gaap:CashMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CashMember2019-12-310001145197us-gaap:CashMemberus-gaap:FairValueInputsLevel2Member2019-12-310001145197us-gaap:MoneyMarketFundsMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2020-09-300001145197us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2020-09-300001145197us-gaap:MoneyMarketFundsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2019-12-310001145197us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2019-12-310001145197us-gaap:CommercialPaperMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2020-09-300001145197us-gaap:CommercialPaperMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2019-12-310001145197podd:RestrictedCashMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberpodd:RestrictedCashMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberpodd:RestrictedCashMember2020-09-300001145197podd:RestrictedCashMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberpodd:RestrictedCashMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberpodd:RestrictedCashMember2019-12-310001145197us-gaap:FairValueInputsLevel1Member2020-09-300001145197us-gaap:FairValueInputsLevel2Member2020-09-300001145197us-gaap:FairValueInputsLevel1Member2019-12-310001145197us-gaap:FairValueInputsLevel2Member2019-12-310001145197srt:MinimumMember2020-01-012020-09-300001145197srt:MaximumMember2020-01-012020-09-300001145197us-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:ShortTermInvestmentsMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197us-gaap:ShortTermInvestmentsMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197podd:LongTermInvestmentsMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2020-09-300001145197podd:LongTermInvestmentsMember2020-09-300001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-09-300001145197us-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:ShortTermInvestmentsMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197us-gaap:CommercialPaperMemberus-gaap:ShortTermInvestmentsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMemberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:ShortTermInvestmentsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:USTreasuryAndGovernmentMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:CorporateBondSecuritiesMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2019-12-310001145197podd:LongTermInvestmentsMember2019-12-310001145197us-gaap:FairValueInputsLevel1Memberpodd:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197podd:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2019-12-310001145197us-gaap:CustomerRelationshipsMember2020-09-300001145197us-gaap:CustomerRelationshipsMember2019-12-310001145197podd:InternalUseSoftwareMember2020-09-300001145197podd:InternalUseSoftwareMember2019-12-310001145197us-gaap:IntellectualPropertyMember2020-09-300001145197us-gaap:IntellectualPropertyMember2019-12-310001145197country:US2020-01-012020-09-300001145197country:CA2020-01-012020-09-300001145197podd:ConvertibleSeniorNotes1.375Member2019-12-310001145197podd:ConvertibleSeniorNotes1.375Member2020-09-300001145197us-gaap:ConvertibleDebtMemberpodd:ConvertibleSeniorNotes1.375Member2020-09-300001145197us-gaap:ConvertibleDebtMemberpodd:ConvertibleSeniorNotes1.375Member2019-12-310001145197podd:ConvertibleSeniorNotes375Member2019-12-310001145197podd:ConvertibleSeniorNotes375Member2020-09-300001145197podd:ConvertibleSeniorNotes375Memberus-gaap:ConvertibleDebtMember2020-09-300001145197podd:ConvertibleSeniorNotes375Memberus-gaap:ConvertibleDebtMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberpodd:ConvertibleSeniorNotes1.375Member2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberpodd:ConvertibleSeniorNotes1.375Member2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberpodd:ConvertibleSeniorNotes1.375Member2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberpodd:ConvertibleSeniorNotes1.375Member2019-12-310001145197podd:ConvertibleSeniorNotes375Memberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-09-300001145197podd:ConvertibleSeniorNotes375Memberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-09-300001145197podd:ConvertibleSeniorNotes375Memberus-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001145197podd:ConvertibleSeniorNotes375Memberus-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2020-09-300001145197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2019-12-310001145197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2019-12-31podd:lawsuit00011451972015-05-052015-06-160001145197srt:MinimumMemberpodd:FeesToFormerEuropeanDistributorMember2019-09-300001145197srt:MaximumMemberpodd:FeesToFormerEuropeanDistributorMember2019-09-300001145197podd:FeesToFormerEuropeanDistributorMember2019-12-310001145197podd:FeesToFormerEuropeanDistributorMember2020-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310001145197us-gaap:AccumulatedTranslationAdjustmentMember2020-07-012020-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-07-012020-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2019-06-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-06-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310001145197us-gaap:AccumulatedTranslationAdjustmentMember2019-07-012019-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-07-012019-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-09-300001145197us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300001145197us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-300001145197us-gaap:CostOfSalesMember2020-07-012020-09-300001145197us-gaap:CostOfSalesMember2019-07-012019-09-300001145197us-gaap:CostOfSalesMember2020-01-012020-09-300001145197us-gaap:CostOfSalesMember2019-01-012019-09-300001145197us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300001145197us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300001145197us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-012020-09-300001145197us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-07-012019-09-300001145197us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300001145197us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300001145197us-gaap:EmployeeStockOptionMember2020-07-012020-09-300001145197us-gaap:EmployeeStockOptionMember2019-07-012019-09-300001145197us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001145197us-gaap:EmployeeStockOptionMember2019-01-012019-09-300001145197us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300001145197us-gaap:RestrictedStockUnitsRSUMember2019-07-012019-09-300001145197us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300001145197us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300001145197podd:ConvertibleSeniorNotes1.25Member2020-09-300001145197podd:ConvertibleSeniorNotes1.25Member2020-07-012020-09-300001145197podd:ConvertibleSeniorNotes1.25Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes1.25Member2020-01-012020-09-300001145197podd:ConvertibleSeniorNotes1.25Member2019-01-012019-09-300001145197podd:ConvertibleSeniorNotes1.375Member2019-09-300001145197podd:ConvertibleSeniorNotes1.375Member2020-07-012020-09-300001145197podd:ConvertibleSeniorNotes1.375Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes1.375Member2020-01-012020-09-300001145197podd:ConvertibleSeniorNotes1.375Member2019-01-012019-09-300001145197podd:ConvertibleSeniorNotes375Member2020-07-012020-09-300001145197podd:ConvertibleSeniorNotes375Member2019-07-012019-09-300001145197podd:ConvertibleSeniorNotes375Member2020-01-012020-09-300001145197podd:ConvertibleSeniorNotes375Member2019-01-012019-09-300001145197us-gaap:SecuredDebtMemberus-gaap:SubsequentEventMember2020-10-310001145197us-gaap:SecuredDebtMemberus-gaap:SubsequentEventMember2020-10-012020-10-31podd:numberOfTransaction0001145197srt:ScenarioForecastMemberus-gaap:SecuredDebtMember2020-10-012020-12-31podd:numberOfManufacturingLine0001145197srt:ScenarioForecastMemberus-gaap:SecuredDebtMember2020-12-310001145197srt:ScenarioForecastMemberus-gaap:SecuredDebtMemberpodd:EquipmentFinancingTransactionOneMember2020-12-310001145197srt:ScenarioForecastMemberus-gaap:SecuredDebtMemberpodd:EquipmentFinancingTransactionOneMember2020-10-012020-12-310001145197podd:EquipmentFinancingTransactionTwoMembersrt:ScenarioForecastMemberus-gaap:SecuredDebtMember2020-12-310001145197podd:EquipmentFinancingTransactionTwoMembersrt:ScenarioForecastMemberus-gaap:SecuredDebtMember2020-10-012020-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________
Form 10-Q
 _____________________________________________________
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-33462
___________________________________________________________
INSULET CORPORATION
(Exact name of Registrant as specified in its charter)
__________________________________________________________________________________________________
Delaware 04-3523891
(State or Other Jurisdiction of
Incorporation or Organization)		 (I.R.S. Employer
Identification No.)
100 Nagog ParkActonMassachusetts 01720
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: (978) 600-7000
________________________________________________________________________________________________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒     No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par Value Per SharePODDThe NASDAQ Stock Market, LLC

As of October 28, 2020, the registrant had 65,927,871 shares of common stock outstanding.



TABLE OF CONTENTS
 
Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2020 and December 31, 2019
Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2020 and 2019
Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2020 and 2019
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) for the three and nine months ended September 30, 2020 and 2019
Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2020 and 2019

PART I - FINANCIAL INFORMATION
Item 1.
Condensed Consolidated Financial Statements (Unaudited)
INSULET CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in millions, except share and per share data)September 30, 2020December 31, 2019
ASSETS
Current Assets
Cash and cash equivalents$838.1 $213.7 
Short-term investments58.6 162.4 
Accounts receivable trade, less allowance for credit losses of $3.6 and $3.8
85.4 69.3 
Inventories124.9 101.0 
Prepaid expenses and other current assets53.4 44.6 
Total current assets1,160.4 591.0 
Long-term investments0.5 58.4 
Property, plant and equipment, net449.2 399.4 
Other intangible assets, net10.4 13.2 
Goodwill39.7 39.8 
Other assets50.4 41.1 
Total assets$1,710.6 $1,142.9 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable$57.0 $54.5 
Accrued expenses and other current liabilities118.2 103.2 
Total current liabilities175.2 157.7 
Convertible debt, net921.5 887.9 
Other liabilities18.9 21.4 
Total liabilities1,115.6 1,067.0 
Commitments and contingencies (Note 9)
Stockholders’ Equity
Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding
— — 
Common stock, $.001 par value, 100,000,000 authorized; 65,871,736 and 62,685,492 issued and outstanding
0.1 0.1 
Additional paid-in capital1,244.7 749.0 
Accumulated deficit(649.2)(672.0)
Accumulated other comprehensive loss(0.6)(1.2)
Total stockholders’ equity595.0 75.9 
Total liabilities and stockholders’ equity$1,710.6 $1,142.9 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
INSULET CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
 Three Months Ended September 30,Nine Months Ended September 30,
(in millions, except share and per share data)2020201920202019
Revenue$234.0 $192.1 $658.3 $528.8 
Cost of revenue82.2 69.0 237.1 182.6 
Gross profit151.8 123.1 421.2 346.2 
Research and development expenses38.8 31.3 108.5 96.8 
Selling, general and administrative expenses89.2 74.8 253.9 217.5 
Operating income23.8 17.0 58.8 31.9 
Interest expense, net(11.4)(7.7)(32.6)(18.3)
Loss on extinguishment of debt— (6.4)— (6.4)
Other income (expense), net1.0 (1.8)2.0 0.5 
Income before income taxes13.4 1.1 28.2 7.7 
Income tax expense(1.8)(0.3)(4.3)(1.1)
Net income$11.6 $0.8 $23.9 $6.6 
Net income per share:
Basic$0.18 $0.01 $0.37 $0.11 
Diluted$0.17 $0.01 $0.36 $0.11 
Weighted-average number of common shares outstanding:
Basic65,717,820 60,743,211 64,329,181 59,986,163 
Diluted66,827,692 62,335,679 65,598,197 61,728,018 
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
INSULET CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
 Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Net income$11.6 $0.8 $23.9 $6.6 
Other comprehensive income (loss), net of tax:
Currency translation adjustment3.3 (1.8)0.5 (3.0)
Unrealized (loss) gain on available-for-sale debt securities(0.3)— 0.1 1.3 
Total other comprehensive income (loss), net of tax3.0 (1.8)0.6 (1.7)
Comprehensive income (loss)$14.6 $(1.0)$24.5 $4.9 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
INSULET CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(UNAUDITED)

Three Months Ended September 30, 2020
 Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Accumulated Other Comprehensive LossTotal
Shareholders’
Equity
(in millions, except share data)SharesAmount
Balance at June 30, 202065,604,347 $0.1 $1,227.6 $(660.8)$(3.6)$563.3 
Exercise of options to purchase common stock264,456 — 10.6 — — 10.6 
Stock-based compensation— — 6.6 — — 6.6 
Restricted stock units vested, net of shares withheld for taxes2,933 — (0.1)— — (0.1)
Net income— — — 11.6 — 11.6 
Other comprehensive income— — — — 3.0 3.0 
Balance at September 30, 202065,871,736 $0.1 $1,244.7 $(649.2)$(0.6)$595.0 

Three Months Ended September 30, 2019
 Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Accumulated Other Comprehensive LossTotal
Shareholders’
Equity
(in millions, except share data)SharesAmount
Balance at June 30, 201960,149,926 $0.1 $930.3 $(677.8)$(2.8)$249.8 
Exercise of options to purchase common stock471,356 — 17.3 — — 17.3 
Stock-based compensation expense— — 6.6 — — 6.6 
Restricted stock units vested, net of shares withheld for taxes8,195 — (0.3)— — (0.3)
Conversion feature of 0.375% Notes, net of issuance costs
— — 207.8 — — 207.8 
Extinguishment of conversion feature on 1.25% Notes, net of issuance costs
— — (438.6)— — (438.6)
Issuance of shares for debt repayment1,157,492 — 194.4 — — 194.4 
Purchase of capped call options— — (85.4)— — (85.4)
Net income— — — 0.8 — 0.8 
Other comprehensive loss— — — — (1.8)(1.8)
Balance at September 30, 201961,786,969 $0.1 $832.1 $(677.0)$(4.6)$150.6 


The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Nine Months Ended September 30, 2020
 Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Accumulated Other Comprehensive LossTotal
Shareholders’
Equity
(in millions, except share data)SharesAmount
Balance at December 31, 201962,685,492 $0.1 $749.0 $(672.0)$(1.2)$75.9 
Adoption of ASU 2016-13 (Note 1)— — — (1.1)— (1.1)
Issuance of common stock2,369,668 — 477.5 — — 477.5 
Exercise of options to purchase common stock568,830 — 21.9 — — 21.9 
Issuance for employee stock purchase plan18,685 — 2.9 — — 2.9 
Stock-based compensation— — 20.3 — — 20.3 
Restricted stock units vested, net of shares withheld for taxes229,061 — (26.9)— — (26.9)
Net income— — — 23.9 — 23.9 
Other comprehensive income— — — — 0.6 0.6 
Balance at September 30, 202065,871,736 $0.1 $1,244.7 $(649.2)$(0.6)$595.0 

Nine Months Ended September 30, 2019
 Common StockAdditional
Paid-in
Capital		Accumulated
Deficit		Accumulated Other Comprehensive LossTotal
Shareholders’
Equity
(in millions, except share data)SharesAmount
Balance at December 31, 201859,188,758 $0.1 $898.5 $(683.6)$(2.9)$212.1 
Exercise of options to purchase common stock1,188,043 — 40.9 — — 40.9 
Issuance of shares for employee stock purchase plan27,613 — 2.0 — — 2.0 
Stock-based compensation expense— 20.7 — — 20.7 
Restricted stock units vested, net of shares withheld for taxes225,063 — (8.2)— — (8.2)
Conversion feature of 0.375% Notes, net of issuance costs
— — 207.8 — — 207.8 
Extinguishment of conversion feature on 1.25% Notes, net of issuance costs
— — (438.6)— — (438.6)
Issuance of shares for debt repayment1,157,492 — 194.4 — — 194.4 
Purchase of capped call options— — (85.4)— — (85.4)
Net income— — — 6.6 — 6.6 
Other comprehensive loss— — — — (1.7)(1.7)
Balance at September 30, 201961,786,969 $0.1 $832.1 $(677.0)$(4.6)$150.6 







The accompanying notes are an integral part of these condensed consolidated financial statements.
7

INSULET CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Nine Months Ended September 30,
(in millions)20202019
Cash flows from operating activities
Net income$23.9 $6.6 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization29.7 18.8 
Non-cash interest33.6 24.3 
Stock-based compensation20.3 20.7 
Loss on extinguishment of debt— 6.4 
Provision for credit losses3.1 2.6 
Other0.3 1.9 
Changes in operating assets and liabilities:
Accounts receivable(19.9)(6.8)
Inventories(22.9)(20.0)
Prepaid expenses and other assets(16.8)(4.0)
Accounts payable, accrued expenses and other current liabilities36.1 (1.7)
Other liabilities(2.4)2.7 
Net cash provided by operating activities85.0 51.5 
Cash flows from investing activities
Capital expenditures(88.5)(114.6)
Acquisition of intangible assets(8.3)(6.4)
Purchases of investments(37.9)(63.9)
Receipts from the maturity or sale of investments200.0 165.3 
Net cash provided by (used in) investing activities65.3 (19.6)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs477.5 — 
Proceeds from issuance of convertible notes, net of issuance costs— 780.2 
Repayment of convertible debt— (453.6)
Purchase of capped call options— (85.4)
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan24.8 42.9 
Payment of withholding taxes in connection with vesting of restricted stock units(26.9)(8.2)
Net cash provided by financing activities475.4 275.9 
Effect of exchange rate changes on cash(1.3)(1.8)
Net increase in cash, cash equivalents and restricted cash624.4 306.0 
Cash, cash equivalents and restricted cash at beginning of period213.7 113.9 
Cash, cash equivalents and restricted cash at end of period$838.1 $419.9 
Supplemental noncash information:
Purchases of property and equipment included in accounts payable and accrued expenses$4.7 $10.2 
Lease liabilities arising from obtaining right-of-use assets$2.1 $5.1 
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
INSULET CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying financial statements reflect the consolidated operations of Insulet Corporation and its subsidiaries (“Insulet” or the “Company”). The unaudited consolidated financial statements have been prepared in United States dollars, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. In management’s opinion, the unaudited consolidated financial statements contain all normal recurring adjustments necessary for a fair statement of the interim results reported. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or for any other subsequent interim period.
The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited consolidated financial statements do not include all of the annual disclosures required by GAAP; accordingly, they should be read in conjunction with the Company’s audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Accounts Receivable and Allowance for Credit Losses
Trade accounts receivable consist of amounts due from third-party payors, customers and intermediaries and are presented at amortized cost. The allowance for credit losses reflects an estimate of losses inherent in the Company’s accounts receivable portfolio determined based on historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectable.
The allowance for credit losses is measured on a collective (pool) basis when similar risk characteristics exist. The Company has identified the following portfolio segments and measures the allowance for credit losses using the following methods:
Direct Customer Receivables—The Company measures expected credit losses on direct customer receivables using an aging methodology. The risk of loss for direct customer receivables is higher than other portfolios. The Company relies on third-party payors to accept and timely process claims and on direct consumers to have the ability to pay. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Distributor Receivables—The Company measures expected credit losses on distributor receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers payment history as well as credit ratings of the distributors, in addition to current conditions and supportable forecasts.
National Healthcare System Receivables—The Company measures expected credit losses on national healthcare system receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Shipping and Handling Costs
Shipping and handling costs are included in selling, general and administrative expenses and were $3.2 million and $2.2 million for the three months ended September 30, 2020 and 2019, respectively, and were $7.0 million and $7.1 million for the nine months ended September 30, 2020 and 2019, respectively.
Fair Value Measurements
Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. To measure fair value of assets and liabilities, the Company uses the following fair value hierarchy based on three levels of inputs:
Level 1—observable inputs, such as quoted prices in active markets for identical assets or liabilities;
Level 2—significant other observable inputs that are observable either directly or indirectly; and
Level 3—significant unobservable inputs for which there are little or no market data, which require the Company to develop its own assumptions.
9
Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity. See Notes 3 and 8 for financial assets and liabilities held at carrying amount on the consolidated balance sheet and Note 4 for investments measured at fair value on a recurring basis.
Advertising Costs
The Company expenses advertising costs as they are incurred. Advertising expenses were $10.0 million and $3.4 million for the three months ended September 30, 2020 and 2019, respectively and $15.6 million and $8.6 million for the nine months ended September 30, 2020 and 2019, respectively.
Reclassification of Prior Period Amounts
Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. A portion of facility costs and certain information technology costs have been allocated from selling, general and administrative to research and development expenses based on square foot and system usage, respectively. In addition, certain quality assurance costs were reclassified from research and development expenses to selling, general and administrative expenses. The net impact of these adjustments was a $0.6 million and $1.9 million increase to research and development expenses and a corresponding decrease to selling, general and administrative expenses for the three and nine months ended September 30, 2019, respectively. There was no change to previously reported operating or net income. Further, the Company reclassified the $0.9 million change in unbilled receivables from the change in accounts and unbilled receivables to the change in prepaid expenses and other assets in the prior year statement of cash flows. This reclassification had no effect on previously reported net cash provided by operating activities.
Recently Adopted Accounting Standards
Effective January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2016-13, Credit Losses (Topic 326) (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost, such as the Company’s trade receivables and contract assets, to be presented net of expected credit losses, which may be estimated based on relevant information such as historical experience, current conditions and future expectation for each pool of similar financial assets. The new guidance also requires enhanced disclosures related to trade receivables and associated credit losses. The Company adopted ASU 2016-13 using the modified retrospective method, whereby the guidance is applied prospectively as of the date of adoption and prior periods are not restated. The cumulative effect of adopting ASU 2016-13 resulted in a $1.1 million increase to the opening balance of accumulated deficit upon adoption related to an increase in the allowance for credit losses on accounts receivable.
The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.
(in millions)Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
Credit losses at the beginning of the period$4.6 $3.8 
Effect of adoption— 1.1 
Credit losses at the beginning of the period after adoption4.6 4.9 
Provision for expected credit losses0.5 3.1 
Write-offs charged against allowance(1.6)(4.7)
Recoveries of amounts previously written-off0.1 0.3 
Credit losses at the end of the period$3.6 $3.6 
Effective January 1, 2020, the Company adopted ASU 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 requires an entity to measure the impairment of goodwill assigned to a reporting unit as the amount by which the carrying value of the assets and liabilities of the reporting unit, including goodwill, exceeds the reporting units’ fair value. The adoption of this guidance had no impact on the consolidated financial statements.
10
Note 2. Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenues:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
U.S. Omnipod$132.3 $109.4 $377.7 $293.6 
International Omnipod79.8 67.8 226.1 187.4 
Total Omnipod212.1 177.2 603.8 481.0 
Drug Delivery21.9 14.9 54.5 47.8 
Total$234.0 $192.1 $658.3 $528.8 
During the three and nine months ended September 30, 2020, the Company had one customer that represented 11% and two customers that in aggregate represented 21% of total revenue, respectively. During both the three and nine months ended September 30, 2019, the Company had one customer that represented 11% of total revenue. At September 30, 2020, the company had one customer that accounted for 12% of consolidated net accounts receivable. No customer accounted for more than 10% of consolidated net accounts receivable balance at December 31, 2019.
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2020December 31, 2019
Accrued expenses and other current liabilities$4.3 $3.2 
Other liabilities0.9 1.0 
Total deferred revenue$5.2 $4.2 
During both the three months ended September 30, 2020 and 2019, the Company recognized insignificant revenue included in deferred revenue at the beginning of 2020 and 2019, respectively. During the nine months ended September 30, 2020 and 2019, the Company recognized $1.7 million and $1.1 million of revenue included in deferred revenue at the beginning of 2020 and 2019, respectively.
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2020December 31, 2019
Prepaid expenses and other current assets$10.4 $9.5 
Other assets20.7 19.9 
Total capitalized contract acquisition costs, net$31.1 $29.4 
The Company recognized $2.7 million and $2.3 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2020 and 2019, respectively. The Company recognized $7.8 million and $6.4 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2020 and 2019, respectively.
The Company had unbilled receivables of $15.2 million and $13.5 million at September 30, 2020 and December 31, 2019, respectively.
Note 3. Cash and Cash Equivalents
The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:
September 30, 2020December 31, 2019
(in millions)TotalLevel 1Level 2TotalLevel 1
Level 2 (1)
Cash$298.4 $298.4 $— $85.3 $85.3 $— 
Money market mutual funds535.9 535.9 — 115.5 115.5 — 
Commercial paper— — — 10.0 — 10.0 
Restricted cash3.8 3.8 — 2.9 2.9 — 
Total cash and cash equivalents$838.1 $838.1 $— $213.7 $203.7 $10.0 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
11
Note 4. Investments
The Company’s short-term and long-term investments in debt securities had maturity dates that range from one to two years at September 30, 2020. Realized gains or losses for both the three and nine months ended September 30, 2020 and 2019 were insignificant.
The following table provides amortized costs, gross unrealized gains and losses, fair values and the level in the fair value hierarchy for the Company’s investments at September 30, 2020 and December 31, 2019:
(in millions)Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueLevel 1
Level 2 (1)
September 30, 2020
U.S. government and agency bonds$52.7 $0.4 $— $53.1 $53.1 $— 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total short-term investments$58.2 $0.4 $— $58.6 $53.1 $5.5 
Certificates of deposit$0.5 $— $— $0.5 $— $0.5 
Total long-term investments$0.5 $— $— $0.5 $— $0.5 
December 31, 2019
U.S. government and agency bonds$94.7 $0.3 $— $95.0 $85.0 $10.0 
Corporate bonds51.0 0.1 — 51.1 — 51.1 
Certificates of deposit6.3 — — 6.3 — 6.3 
Commercial Paper10.0 — — 10.0 — 10.0 
Total short-term investments$162.0 $0.4 $— $162.4 $85.0 $77.4 
U.S. government and agency bonds$52.9 $0.1 $(0.1)$52.9 $42.9 $10.0 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total long-term investments$58.4 $0.1 $(0.1)$58.4 $42.9 $15.5 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
Note 5. Inventories
At the end of each period, inventories were comprised of the following:
(in millions)September 30, 2020December 31, 2019
Raw materials$27.3 $23.3 
Work-in-process57.2 40.3 
Finished goods40.4 37.4 
    Total inventories$124.9 $101.0 
Note 6. Goodwill and Other Intangible Assets, Net
The change in the carrying amount of goodwill for the nine months ended September 30, 2020 was as follows:
(in millions)
Goodwill at December 31, 2019$39.8 
Foreign currency translation(0.1)
Goodwill at September 30, 2020$39.7 
12
The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:
September 30, 2020December 31, 2019
(in millions)
Gross Carrying AmountAccumulated AmortizationNet Book
Value		Gross Carrying AmountAccumulated AmortizationNet Book
Value
Customer relationships (1)
$9.8 $(3.4)$6.4 $9.9 $(2.8)$7.1 
Internal-use software11.3 (8.2)3.1 12.0 (6.8)5.2 
Intellectual property1.0 (0.1)0.9 1.0 (0.1)0.9 
Total$22.1 $(11.7)$10.4 $22.9 $(9.7)$13.2 
(1) Includes customer relationships acquired from the Company’s former European distributor. See Note 9.
Amortization expense for intangible assets was $0.7 million for both the three months ended September 30, 2020 and 2019. Amortization expense for intangible assets was $2.2 million and $1.9 million for the nine months ended September 30, 2020, and 2019, respectively. Amortization expense associated with intangible assets included on the Company’s consolidated balance sheet as of September 30, 2020 is expected to be as follows:
Years Ending December 31,
(in millions)
2020 (remaining)$0.7 
20212.2 
20221.7 
20231.2 
20241.1 
Thereafter3.5 
     Total$10.4 
Note 7. Accrued Expenses and Other Current Liabilities
The components of accrued expenses and other current liabilities were as follows:
(in millions)September 30, 2020December 31, 2019
Employee compensation and related costs$45.9 $45.8 
Accrued rebates9.8 7.5 
Supplier purchases5.4 2.4 
Value added taxes payable4.9 1.8 
Deferred revenue4.3 3.2 
Short-term lease liability4.6 3.6 
Warranty liability3.2 4.7 
Accrued interest2.3 1.7 
Other37.8 32.5 
Accrued expenses and other current liabilities$118.2 $103.2 
Product Warranty Costs
The Company provides a four-year warranty on Personal Diabetes Managers (“PDMs”) sold in the United States and Europe and a five-year warranty on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty at the time the product is shipped based on historical experience and the estimated cost to service the claims. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of operations. Cost to service the claims reflects the current product cost.
13
The following table is a summary of the activity related to the Company’s product warranty liability: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Product warranty liability at beginning of period$8.1 $6.6 $8.5 $6.4 
Warranty expense3.1 3.3 8.3 8.6 
Warranty claims settled(4.2)(3.1)(9.8)(8.2)
Product warranty liability at the end of period$7.0 $6.8 $7.0 $6.8 
Note 8. Convertible Debt, Net
The components of outstanding convertible debt consisted of the following:
(in millions)
September 30, 2020December 31, 2019
1.375% Convertible Senior Notes, due November 2024
$402.5 $402.5 
0.375% Convertible Senior Notes, due September 2026
800.0 800.0 
Unamortized debt discount(263.4)(294.8)
Debt issuance costs(17.6)(19.8)
Total convertible debt, net$921.5 $887.9 
The carrying amount and the estimated fair value of the Company’s convertible debt, which is based on the Level 2 quoted market prices, were as follows:
September 30, 2020December 31, 2019
(in millions)
Carrying Value
Estimated Fair Value (1)
Carrying Value
Estimated Fair Value (1)
1.375% Convertible Senior Notes, due November 2024
$319.5 $512.8 $306.9 $512.8 
0.375% Convertible Senior Notes, due September 2026
602.0 1,022.8 581.0 840.0 
  Total$921.5 $1,535.6 $887.9 $1,352.8 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
Note 9. Commitments and Contingencies
Legal Proceedings
Between May 5, 2015 and June 16, 2015, three class action lawsuits were filed by shareholders in the U.S. District Court, for the District of Massachusetts, against the Company and certain then current and former executives of the Company. Two suits subsequently were voluntarily dismissed. Arkansas Teacher Retirement System v. Insulet, et al., 1:15-cv-12345, (“ATRS”) alleged that the Company (and certain then current and former executives) committed violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making allegedly false and misleading statements about the Company’s business, operations and prospects. On February 8, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment was made into an escrow account for the plaintiffs and the class they purport to represent. On August 6, 2018, the Court issued an order approving the settlement, but took the plaintiffs’ motion for fees and expenses under advisement, which motion remains pending. The Company had previously accrued fees and expenses in connection with this matter for the amount of the final settlement liability that was not covered by insurance, the amount of which was not material to the Company’s consolidated financial statements.
In addition, on April 26, 2017, a derivative action (Walker v. DeSisto, et al., 1:17-cv-10738) (“Walker”) was filed, and on October 13, 2017, a second derivative action (Carnazza v. DeSisto, et al., 1:17-cv-11977) (“Carnazza”) was filed, both on behalf of the Company, each by a shareholder in the U.S. District Court for the District of Massachusetts against the Company (as a nominal defendant) and certain individual then current and former officers and directors of the Company. The allegations in the actions are substantially similar to those alleged in the securities class action. The actions seek, among other things, damages, disgorgement of certain types of compensation or profits, and attorneys’ fees and costs. On July 11, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment of attorneys’ fees and reimbursement of expenses will be paid to plaintiffs’ counsel, subject to the Court’s approval. On July 13, 2018, the plaintiffs filed a motion for preliminary approval of the settlement, which is pending. The Company expects that such fees and expenses payable to plaintiff’s counsel will be covered by the Company’s insurance.
14
In June 2020, Roche Diabetes Care, Inc. (“Roche”) filed a patent infringement lawsuit against the Company in the United States District Court for the District of Delaware alleging that the Company’s manufacture and sale of its Omnipod Insulin Management System, Omnipod Starter Kit and Omnipod 10 Pod Pack in the United States infringed Roche’s now-expired U.S. Patent 7,931,613. Roche is seeking monetary damages in the form of a reasonable royalty and attorneys’ fees and costs. Since the patent expired in 2019, Roche is not seeking injunctive relief and the lawsuit will have no impact on ongoing sales of the Company’s products. The Company believes that it has meritorious defenses to Roche’s claims and intends to vigorously defend against them. The court has set a trial date of July 25, 2022. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses, which could be material.
In July 2020, the Company filed a patent infringement claim against Roche Diabetes Care Limited (“Roche Ltd.”) in the United Kingdom alleging that Roche Ltd.’s manufacture and sale of the Accu-Chek® Solo insulin pump and its consumable components infringes European Patent No. 1 335 764 in the United Kingdom. The Company is seeking an injunction to last until expiry of the patent and monetary damages. Roche Ltd. has responded to the complaint and argues that the patent is invalid and not infringed.
The Company is, from time to time, involved in the normal course of business in various legal proceedings, including intellectual property, contract, employment and product liability suits. Other than as described above, the Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its results of operations.
Fees to Former European Distributor
Following the expiration of an agreement with a former European distributor on June 30, 2018, the Company was required to pay a quarterly per-unit fee for Omnipod sales to certain customers of the former European distributor for a one-year period through June 30, 2019. The Company recognized a liability and an associated intangible asset for this fee as qualifying sales occurred. The methodology applicable for determining the total fee under the distribution agreement is subject to an active arbitration proceeding in Switzerland. The final amount of the fee could vary significantly depending on the number of customers who count for purposes of calculating the fee under the terms of the agreement. The Company estimates that the final aggregate fee is in the range of $5 million to $55 million. As of both September 30, 2020 and December 31, 2019, the Company had $2.7 million accrued related to this matter. The associated gross intangible asset was $7.8 million at both September 30, 2020 and December 31, 2019.
Note 10. Accumulated Other Comprehensive Loss
Changes in the components of accumulated other comprehensive loss, net of tax, were as follows:
Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(4.4)$0.8 $(3.6)$(1.6)$0.4 $(1.2)
Other comprehensive income (loss)3.3 (0.3)3.0 0.5 0.1 0.6 
Balance at the end of period$(1.1)$0.5 $(0.6)$(1.1)$0.5 $(0.6)

Three Months Ended September 30, 2019Nine Months Ended September 30, 2019
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized (Loss) Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(3.4)$0.6 $(2.8)$(2.2)$(0.7)$(2.9)
Other comprehensive (loss) income(1.8)— (1.8)(3.0)1.3 (1.7)
Balance at the end of period$(5.2)$0.6 $(4.6)$(5.2)$0.6 $(4.6)
15
Note 11. Interest Expense
Interest expense, net was as follows: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Contractual coupon interest$2.1 $2.6 $6.4 $7.5 
Accretion of debt discount10.6 8.2 31.5 22.2 
Amortization of debt issuance costs0.7 0.7 2.1 2.1 
Capitalized interest(1.5)(2.1)(4.7)(8.1)
     Interest expense, net of portion capitalized11.9 9.4 35.3 23.7 
Interest income(0.5)(1.7)(2.7)(5.4)
Interest expense, net$11.4 $7.7 $32.6 $18.3 
Note 12. Stock-Based Compensation
Compensation expense related to stock-based awards was recorded as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Cost of revenue$0.1 $0.3 $0.3 $0.9 
Research and development expenses2.3 2.2 7.3 6.4 
Selling, general and administrative expenses4.2 4.1 12.7 13.4 
Total$6.6 $6.6 $20.3 $20.7 
Note 13. Income Taxes
The Company’s effective tax rate for the three and nine months ended September 30, 2020 was 13.3% and 15.3%, compared with 24.7% and 14.1% for the three and nine months ended September 30, 2019. Income tax benefits have not been recorded for losses in jurisdictions where valuation allowances exist against net deferred tax assets, primarily in the United States. As of September 30, 2020 and December 31, 2019, the Company maintained a full valuation allowance against its U.S. net deferred tax assets based on the determination that it is not more likely than not that these future benefits will be realized. The Company had no uncertain tax positions at both September 30, 2020 and December 31, 2019.
In April 2020, new interpretations of a German tax law related to intellectual property and withholding tax were released. Based on the Company's interpretation of the German tax law, there was no effect on the consolidated financial statements.
Note 14. Net Income Per Share
Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted net income per share is computed using the weighted average number of common shares outstanding and, when dilutive, common share equivalents from outstanding stock options and restricted stock units (using the treasury-stock method), and potential common shares from the Company’s convertible notes (using the if-converted method). The weighted-average number of common shares used in the computation of basic and diluted net income per share were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Weighted average number of common shares outstanding, basic65,717,820 60,743,211 64,329,181 59,986,163 
Stock options978,657 1,370,792 1,082,247 1,514,245 
Restricted stock units131,215 221,676 186,769 227,610 
Weighted average number of common shares outstanding, diluted66,827,692 62,335,679 65,598,197 61,728,018 
16
The number of common share equivalents excluded from the computation of diluted net income per share because either the effect would have been anti-dilutive, or the performance criteria related to the units had not yet been met, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
1.25% Convertible Senior Notes
— 2,055,786 — 2,055,786 
1.375% Convertible Senior Notes
4,319,429 4,319,429 4,319,429 4,319,429 
0.375% Convertible Senior Notes
3,528,400 3,528,400 3,528,400 3,528,400 
Unvested restricted stock units272,992 455,876 272,877 455,824 
Stock options65,331 7,858 56,522 136,342 
Total8,186,152 10,367,349 8,177,228 10,495,781 
Note 15. Subsequent Events
In October 2020, the Company entered into a $70 million loan secured by a mortgage of its facility located in Acton, Massachusetts. The loan has a five-year term and an interest rate of approximately 5.2%. The monthly payment is based on a 20-year amortization period with the final payment of the outstanding principal due in 2025.
In the fourth quarter of 2020, the Company entered into two equipment financing transactions secured by machinery and equipment associated with two of its highly automated manufacturing lines located in Acton, Massachusetts. The first transaction was in the amount of approximately $37 million with a term of 60 months and an interest rate of approximately 4.5%. The second transaction was in the amount of $23 million with a term of 42 months and an interest rate of approximately 5.4%.
17
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the accompanying notes included in this quarterly report. The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs and involve risks, uncertainties and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed under the headings “Risk Factors” and “Forward-Looking Statements” in both our annual report on Form 10-K for the year ended December 31, 2019 and in this quarterly report.
Overview
We are primarily engaged in the development, manufacture and sale of our proprietary Omnipod® System (“Omnipod”), an innovative, continuous insulin delivery system for people with insulin-dependent diabetes. There are two primary types of insulin therapy practiced today: multiple daily injection (“MDI”) therapy using syringes or insulin pens; and pump therapy using insulin pumps. Insulin pumps are used to perform continuous subcutaneous insulin infusion, or insulin pump therapy, and typically use a programmable device and an infusion set to administer insulin into a person’s body. Insulin pump therapy has been shown to provide people with insulin-dependent diabetes with numerous advantages relative to MDI therapy. The Omnipod System features a small, lightweight, self-adhesive disposable tubeless Omnipod device (“Pod”) that is worn on the body for up to three days at a time; and its wireless companion, the handheld Personal Diabetes Manager. The Omnipod System, which features discreet and easy-to-use devices communicates wirelessly, provides for virtually pain-free automated cannula insertion and eliminates the need for traditional MDI therapy or the use of traditional pump and tubing. We believe that the Omnipod System’s unique proprietary design and features allow people with insulin-dependent diabetes to manage their diabetes with unprecedented freedom, comfort, convenience and ease.
In addition to the diabetes market, we have partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. Most of our drug delivery revenue currently consists of sales of Pods to Amgen for use in the Neulasta® Onpro® kit, an innovative delivery system for Amgen’s white blood cell booster to help reduce the risk of infection after intense chemotherapy.
Our mission is to improve the lives of people with diabetes. To assist in achieving this mission, we are focused on the following key strategic imperatives:
•delivering consumer-focused innovation;
•ensuring the best customer experience globally;
•expanding our global footprint; and
•driving operational excellence.
Our long-term financial objective is to sustain profitable growth. To achieve this goal, we expect our efforts in 2020 to focus primarily on the development in the United States of Omnipod 5, powered by Horizon™ (“Omnipod 5”), our automated insulin delivery system. We completed the first phase of our Omnipod 5 pivotal trial in October and during the third quarter, we began enrolling pediatric patients ages two to six years old in the next phase of our Omnipod 5 pivotal study. In addition, during the third quarter, we received U.S. Food and Drug Administration (“FDA”) clearance for an Omnipod 5 feasibility study for individuals with Type 2 diabetes.
In order to support our continued growth and the expected launch of Omnipod 5 in the first half 2021, we continue to focus on adding capacity to our U.S. manufacturing plant. During the first quarter of 2020, we began producing salable product on our second highly automated manufacturing line in the U.S. and we are in the process of installing a third highly automated manufacturing line on which salable product is expected in 2021. During the third quarter, we installed two manufacturing lines at a new contract manufacturer in China.
Additionally, in 2020, we planned to further roll out our Omnipod DASHTM Insulin Management System (“Omnipod DASH”), our next generation digital mobile Omnipod platform, in Europe and Canada and enter five new countries in Western Europe and the Middle East to expand the commercial sale of Omnipod and our global footprint. In the third quarter, we began the roll out of Omnipod DASH in our international markets. We are still committed to entering new countries, although the timing for some has shifted to early 2021 primarily due to the coronavirus pandemic discussed under Recent Developments below. This change in expected timing will not have a material impact on our 2020 revenues since we did not expect these actions to have a meaningful contribution in 2020, although they are expected to contribute to our long-term growth.
Finally, we plan to continue our product development efforts and expand awareness of and access to our products. Achieving the above strategic imperatives is expected to require additional investments in certain initiatives and personnel, as well as enhancements to our supply chain operation capacity, efficiency and effectiveness.
Recent Developments
A novel strain of coronavirus (“COVID-19”) was identified in China in December 2019, and subsequently declared a pandemic by the World Health Organization in March 2020. The COVID-19 outbreak in China resulted in abnormally low production at our contract manufacturer in China during the first two months of the year, which resulted in incremental depreciation expense for under-utilized
18
plant capacity for those two months. In response to this outbreak, we took measures to ensure our ability to continue to provide product to our customers, including providing manufacturing incentives to our contract manufacturer in China and utilizing expedited, but more costly, shipping measures to transport product from China. In addition, we implemented strict screening and additional sanitation measures.
We have been able to produce at normal capacity since March. Additionally, our second highly automated manufacturing line in our U.S. manufacturing plant has provided additional manufacturing redundancy to help mitigate manufacturing risks stemming from COVID-19. Refer to Item 1A. Risk Factors for a discussion of COVID-19 risks.
Results of Operations
Three Months Ended September 30,
(dollars in millions)20202019Percent
Change		Currency
Impact
Constant
Currency (1)
Revenue:
U.S. Omnipod$132.3 $109.4 20.9 %— %20.9 %
International Omnipod79.8 67.8 17.7 %5.3 %12.4 %
Total Omnipod212.1 177.2 19.7 %2.1 %17.6 %
Drug Delivery21.9 14.9 47.0 %— %47.0 %
Total$234.0 $192.1 21.8 %1.9 %19.9 %

Nine Months Ended September 30,
(dollars in millions)20202019Percent
Change		Currency
Impact
Constant
Currency (1)
Revenue:
U.S. Omnipod$377.7 $293.6 28.6 %— %28.6 %
International Omnipod226.1 187.4 20.7 %(0.1)%20.8 %
Total Omnipod603.8 481.0 25.5 %(0.1)%25.6 %
Drug Delivery54.5 47.8 14.0 %— %14.0 %
Total$658.3 $528.8 24.5 %— %24.5 %
(1) Constant currency revenue growth is a non-GAAP financial measure which should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. See “Management’s Use of Non-GAAP Measures.”
Revenue
Total revenue for the three months ended September 30, 2020 increased $41.9 million, or 21.8%, to $234.0 million, compared with $192.1 million for the three months ended September 30, 2019. Constant currency revenue growth of 19.9% was primarily driven by higher volume and, to a lesser extent, favorable sales channel mix.
Total revenue for the nine months ended September 30, 2020 increased $129.5 million, or 24.5%, to $658.3 million, compared with $528.8 million for the nine months ended September 30, 2019. Constant currency revenue growth of 24.5% was primarily driven by higher volume and, to a lesser extent, favorable sales channel mix.
U.S. Omnipod
U.S. Omnipod revenue for the three months ended September 30, 2020 increased $22.9 million, or 20.9%, to $132.3 million, compared with $109.4 million for the three months ended September 30, 2019. This increase was primarily due to higher volumes driven by growing our customer base, and to a lesser extent, an increase due to growth through the pharmacy channel, where Pods have a higher average selling price due in part to the fact that we offer the PDM for no charge.
U.S. Omnipod revenue for the nine months ended September 30, 2020 increased $84.1 million, or 28.6%, to $377.7 million, compared with $293.6 million for the nine months ended September 30, 2019. This increase was primarily due to higher volumes driven by growing our customer base, and to a lesser extent, an increase due to growth through the pharmacy channel, where Pods have a higher average selling price due in part to the fact that we offer the PDM for no charge. For full year 2020, we expect strong Omnipod revenue growth driven by continued market penetration and volume growth of Omnipod DASH, primarily in the pharmacy channel. We expect this revenue growth to be partially offset by the impact of lower new customer starts stemming from COVID-19.
International Omnipod
International Omnipod revenue for the three months ended September 30, 2020 increased $12.0 million, or 17.7%, to $79.8 million, compared with $67.8 million for the three months ended September 30, 2019. Excluding the 5.3% favorable impact of currency
19
exchange, the remaining 12.4% increase in revenue was primarily driven by higher volumes as we continue to expand awareness and access to the Omnipod.
International Omnipod revenue for the nine months ended September 30, 2020 increased $38.7 million, or 20.7%, to $226.1 million, compared with $187.4 million for the nine months ended September 30, 2019. This increase in revenue was primarily driven by higher volumes as we continue to expand awareness and access to the Omnipod and, to a lesser extent, an increase in days-on-hand inventory at distributors due to COVID-19. Similar to in the U.S., for the full year 2020, we expect higher International Omnipod revenue due to continued volume growth and market penetration. We expect this revenue growth to be partially offset by the impact of lower new customer starts stemming from COVID-19.
Drug Delivery
Drug Delivery revenue for the three months ended September 30, 2020 increased $7.0 million, or 47.0%, to $21.9 million, compared with $14.9 million for the three months ended September 30, 2019, due to increased demand for Amgen's Neulasta® Onpro® kit which includes our pods, driven by COVID-19.
Drug Delivery revenue for the nine months ended September 30, 2020 increased $6.7 million, or 14.0%, to $54.5 million compared with $47.8 million for the nine months ended September 30, 2019, due to increased demand for Amgen's Neulasta® Onpro® kit which includes our pods, driven by COVID-19. For full year 2020, we expect Drug Delivery revenue to increase due to a higher demand forecast resulting from COVID-19.
Operating Expenses
Three Months Ended September 30,Nine Months Ended September 30,
2020201920202019
(dollars in millions)AmountPercent of RevenueAmountPercent of RevenueAmountPercent of RevenueAmountPercent of Revenue
Cost of revenue$82.2 35.1 %$69.0 35.9 %$237.1 36.0 %$182.6 34.5 %
Research and development expenses$38.8 16.6 %$31.3 16.3 %$108.5 16.5 %$96.8 18.3 %
Selling, general and administrative expenses$89.2 38.1 %$74.8 38.9 %$253.9 38.6 %$217.5 41.1 %
Cost of Revenue
Cost of revenue for the three months ended September 30, 2020 increased $13.2 million, or 19.1%, to $82.2 million, compared with $69.0 million for the three months ended September 30, 2019. Gross margin was 64.9% for the three months ended September 30, 2020, compared with 64.1% for the three months ended September 30, 2019. The 80 basis point increase in gross margin was primarily due to higher average selling price due to growth in the pharmacy channel, and to a lesser extent, product mix, partially offset by start-up costs and inefficiencies related to our new U.S. manufacturing operations.
Cost of revenue for the nine months ended September 30, 2020 increased $54.5 million, or 29.8%, to $237.1 million, compared with $182.6 million for the nine months ended September 30, 2019. Gross margin was 64.0% for the nine months ended September 30, 2020, compared with 65.5% for the nine months ended September 30, 2019. The 150 basis point decrease in gross margin was primarily due to start-up costs and inefficiencies related to our new U.S. manufacturing operations as well as two months of higher depreciation expense for under-utilized plant capacity, recruiting and screening expenses, expedited shipping costs and manufacturing incentives totaling $7.6 million associated with our contract manufacturer in China as a result of the coronavirus pandemic. This decrease was partially offset by higher average selling price due to growth in the pharmacy channel. We expect full year 2020 gross margin to be approximately 64%, which reflects an estimated $9 to $10 million of costs resulting from the coronavirus pandemic, in addition to start-up costs and inefficiencies as we continue to ramp up our U.S. manufacturing operations, partially offset by continued improvements in our global manufacturing and supply chain operations and the move into the pharmacy channel in the United States.
Research and Development Expenses
Research and development expenses for the three months ended September 30, 2020 increased $7.5 million, or 24.0%, to $38.8 million, compared with $31.3 million for the three months ended September 30, 2019. This increase was primarily due to spend related to Omnipod 5.
Research and development expenses for the nine months ended September 30, 2020 increased $11.7 million, or 12.1%, to $108.5 million, compared with $96.8 million for the nine months ended September 30, 2019. This increase was primarily due to spend related to Omnipod 5, partially offset by reduced spend on Omnipod DASH, which was launched in the prior year period. We expect research and development spending for the full year 2020 to increase compared with 2019.
20
Selling, General and Administrative Expenses
Selling general and administrative expenses for the three months ended September 30, 2020 increased $14.4 million, or 19.3%, to $89.2 million, compared with $74.8 million for the three months ended September 30, 2019. This increase was primarily attributable to year-over-year headcount additions, mainly sales and customer service personnel, as well as the pilot of our direct-to-consumer advertising campaign. These increases were partially offset by a decrease in travel and entertainment expenses due to reduced activity resulting from COVID-19.
Selling general and administrative expenses for the nine months ended September 30, 2020 increased $36.4 million, or 16.7%, to $253.9 million, compared with $217.5 million for the nine months ended September 30, 2019. This increase was primarily attributable to year-over-year headcount additions, mainly sales and customer service personnel, as well as the pilot of our direct-to-consumer advertising campaign. These increases were partially offset by a decrease in travel and entertainment expenses due to reduced activity resulting from COVID-19. We expect selling, general and administrative expenses for the full year 2020 to increase compared with 2019 due to expansion of our U.S. sales force and customer support personnel and investments in our operating structure to facilitate our continued growth, including the launch of our pilot direct-to-consumer advertising campaign.
Non-Operating Items
Interest Expense, Net
Net interest expense increased $3.7 million to $11.4 million for the three months ended September 30, 2020, compared with $7.7 million for the three months ended September 30, 2019. This increase was driven by a $2.4 million increase in non-cash interest expense, primarily associated with our 0.375% Notes issued in September 2019, a $1.2 million decrease in interest income due to lower market rates and a shift in a portion of our investment portfolio to more liquid investments and a $0.6 million decrease in capitalized interest, primarily due to the placement of our second U.S. manufacturing line into service during the first quarter of 2020.
Net interest expense increased $14.3 million to $32.6 million for the nine months ended September 30, 2020, compared with $18.3 million for the nine months ended September 30, 2019. This increase was driven by a $9.3 million increase in non-cash interest expense, primarily associated with our 0.375% Notes issued in September 2019 and a $3.4 million decrease in capitalized interest primarily due to the placement of our first and second U.S. manufacturing lines into service during the second quarter of 2019 and the first quarter of 2020, respectively, as well as a $2.7 million decrease in interest income due to lower market rates and a shift in a portion of our investment portfolio to more liquid investments.
Loss on Extinguishment of Debt
During the three and nine months ended September 30, 2019, we recognized a $6.4 million loss on extinguishment of debt related to the repurchase of $225.0 million in principal of our 1.25% Convertible Senior Notes due September 2021, the remainder of which were repurchased during the fourth quarter of 2019.
Other Income, Net
During the three months ended September 30, 2020, we had other income of $1.0 million, compared with other expense of $1.8 million for the three months ended September 30, 2019. The increase in other income was primarily driven by unrealized foreign currency gains due to the change in exchange rates.
During the nine months ended September 30, 2020, we had other income, net of $2.0 million, compared with $0.5 million for the nine months ended September 30, 2019, The increase in other income was primarily driven by unrealized foreign currency gains due to the change in exchange rates, partially offset by a $1.8 million insurance recovery for damaged inventory in excess of our cost received during the nine months ended September 30, 2019.
Income Tax Expense, Net
Income tax expense was $1.8 million and $0.3 million for the three months ended September 30, 2020 and 2019, respectively. This resulted in effective tax rates of 13.3% and 24.7% for the three months ended September 30, 2020 and 2019, respectively. The decrease in the effective tax rate was primarily driven by a shift in expected jurisdictional mix of income.
Income tax expense was $4.3 million and $1.1 million for the nine months ended September 30, 2020 and 2019, respectively. This resulted in effective tax rates of 15.3% and 14.1% for the nine months ended September 30, 2020 and 2019, respectively. The increase in the year-to-date effective tax rate was driven by a shift in expected jurisdictional mix of income.
21
Adjusted EBITDA
The table below presents reconciliations of Adjusted EBITDA, a non-GAAP financial measure, to net income, the most directly comparable financial measure prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”):
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Net income$11.6 $0.8 $23.9 $6.6 
Interest expense, net11.4 7.7 32.6 18.3 
Income tax expense1.8 0.3 4.3 1.1 
Depreciation and amortization10.9 7.8 29.7 18.8 
Stock-based compensation6.6 6.6 20.3 20.7 
Loss on extinguishment of debt— 6.4 — 6.4 
Adjusted EBITDA$42.3 $29.6 $110.8 $71.9 

Non-GAAP Financial Measures
Management uses the following non-GAAP financial measures:
Constant currency revenue growth represents the change in revenue between current and prior year periods using a constant currency, the exchange rate in effect during the applicable prior year period. We present constant currency revenue growth because we believe it provides meaningful information regarding our results on a consistent and comparable basis. Management uses this non-GAAP financial measure, in addition to financial measures in accordance with accounting principles generally accepted in the United States (“GAAP”), to evaluate our operating results. It is also one of the performance metrics that determines management incentive compensation.
Adjusted EBITDA represents net income (loss) plus net interest expense, income tax expense (benefit), depreciation and amortization, stock-based compensation and other significant unusual items, as applicable. We present Adjusted EBITDA because management uses it as a supplemental measure in assessing our operating performance, and we believe that it is helpful to investors, and other interested parties as a measure of our comparative operating performance from period to period. Adjusted EBITDA is a commonly used measure in determining business value and we use it internally to report results. It is also one of the performance metrics that determines management incentive compensation.
These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. In addition, the above definitions may differ from similarly titled measures used by others. Non-GAAP financial measures exclude the effect of items that increase or decrease our reported results of operations; accordingly, we strongly encourage investors to review our consolidated financial statements in their entirety.
Liquidity and Capital Resources
As of September 30, 2020, we had $838.1 million in cash and cash equivalents and $59.1 million of investments in marketable securities. We believe that our current liquidity will be sufficient to meet our projected operating, investing and debt service requirements for at least the next twelve months. As of September 30, 2020, we had $67.4 million in capital commitments.
In October 2020, the Company entered into a $70 million loan secured by a mortgage of its facility located in Acton, Massachusetts. The loan has a five-year term and an interest rate of approximately 5.2%. The monthly payment is based on a 20-year amortization period with the final payment of the outstanding principal due in 2025.
In the fourth quarter of 2020, the Company entered into two equipment financing transactions secured by machinery and equipment associated with two of its highly automated manufacturing lines located in Acton, Massachusetts. The first transaction was in the amount of approximately $37 million with a term of 60 months and an interest rate of approximately 4.5%. The second transaction was in the amount of $23 million with a term of 42 months and an interest rate of approximately 5.4%.
We intend to use the proceeds from the loan and equipment financing transactions for general corporate purposes.
22
Convertible Debt
To finance our operations and global expansion, we have periodically issued convertible senior notes, which are convertible into our common stock. As of September 30, 2020, the following notes were outstanding:
Issuance DateCouponPrincipal Outstanding
(in millions)		Due DateInitial Conversion Rate per Share of Common StockConversion Price per Share of Common Stock
November 20171.375%$402.5 November 202410.7315$93.18 
September 20190.375%800.0 September 20264.4105$226.73 
Total$1,202.5 
Additional information regarding our debt issuances is provided in Note 8 to the consolidated financial statements.
Summary of Cash Flows
Nine Months Ended September 30,
(in millions)20202019
Cash provided by (used in):
Operating activities$85.0 $51.5 
Investing activities65.3 (19.6)
Financing activities475.4 275.9 
Effect of exchange rate changes on cash(1.3)(1.8)
Net increase in cash and cash equivalents$624.4 $306.0 
Operating Activities
Net cash provided by operating activities of $85.0 million for the nine months ended September 30, 2020 was primarily attributable to net income, as adjusted for non-cash interest, depreciation and amortization, and stock-based compensation, partially offset by a $25.9 million working capital cash outflow driven by a $22.9 million increase in inventories, a $19.9 million increase in accounts receivable, and a $16.8 million increase in prepaid expenses and other assets, partially offset by a $36.1 million increase in accounts payable, accrued expenses and other current liabilities. The increase in inventories was driven by a planned inventory build associated with the further roll out of Omnipod DASH throughout the remaining European countries we serve. The increase in accounts receivable was primarily due to an increase in International Omnipod revenue and sales in the U.S. pharmacy channel, both of which generally have longer payment terms. The increase in prepaid expenses and other assets was driven by an increase in unbilled revenue resulting from an increase in demand for our Drug Delivery product. Finally, the increase in accounts payable, accrued expenses and other current liabilities was driven by timing of payments.
Investing Activities
Net cash provided by investing activities was $65.3 million for the nine months ended September 30, 2020, compared with net cash used in investing activities of $19.6 million for nine months ended September 30, 2019.
Capital Spending—Capital expenditures were $88.5 million for the nine months ended September 30, 2020 and primarily related to equipment to increase our manufacturing capacity. Capital expenditures of $114.6 million for the nine months ended September 30, 2019 were primarily associated with the construction of our manufacturing and corporate headquarters facility in Acton, Massachusetts. For the full year 2020, although we expect capital expenditures to be lower than 2019, we continue to expand manufacturing capacity and invest in technology to support our growth and the launch of Omnipod 5. We expect to fund our capital expenditures using a combination of existing cash and investments as well as cash generated from operations.
Purchases and Sales of Investments—Net sales of marketable securities were $162.1 million for the nine months ended September 30, 2020, compared with $101.4 million for the nine months ended September 30, 2019. The increase in net sales of marketable securities was driven by a shift in a portion of our investment portfolio to investments that are classified as cash equivalents due to the sale of certain long-term investments prior to maturity.
Financing Activities
Net cash provided by financing activities was $475.4 million for the nine months ended September 30, 2020, compared with net cash provided by financing activities of $275.9 million for nine months ended September 30, 2019.
23
Issuance of Common Stock—During the nine months ended September 30, 2020, we sold 2.4 million common shares for $478.7 million in an underwritten registered offering. Net proceeds from the offering were $477.5 million. The proceeds provide us with additional liquidity to mitigate risk and allow us to continue investing in the growth of our business and our strategic initiatives.
Option Exercises and Payment of Taxes for Restricted Stock Net Settlements—Total proceeds from option exercises were $24.8 million and $42.9 million for the nine months ended September 30, 2020 and 2019, respectively. The $18.1 million decrease in proceeds from option exercises was primarily driven by the retirement of former executives in the prior year period. Payments for taxes related to net restricted and performance stock unit settlements were $26.9 million and $8.2 million for the nine months ended September 30, 2020 and 2019, respectively. The $18.7 million increase in payments for taxes related to restricted stock net settlements was primarily due to a higher achievement percentage on performance stock units vested in the first quarter of 2020 compared to the prior year.
Commitments and Contingencies
Following the expiration of an agreement with a former European distributor on June 30, 2018, we were required to pay a quarterly per-unit fee for Omnipod sales to certain customers of the former European distributor for a one-year period through June 30, 2019. The methodology applicable for determining the total fee under the distribution agreement is subject to an active arbitration proceeding in Switzerland. The final amount of the fee could vary significantly depending on the number of customers who count for purposes of calculating the fee under the terms of the agreement. We estimate that the final aggregate fee for the applicable twelve-month period could be in the range of $5 million to $55 million, of which $5.1 million had been paid as of September 30, 2020.
Legal Proceedings
The significant estimates and judgments related to establishing litigation reserves are discussed under “Legal Proceedings” in Note 9 to the consolidated financial statements included in this Form 10-Q.
Off-Balance Sheet Arrangements
As of September 30, 2020, we had various outstanding letters of credit and bank guarantees totaling $2.8 million, none of which is individually significant. We have restricted cash that serves as collateral for these outstanding letters of credit and bank guarantees that are included in cash and cash equivalents on our consolidated balance sheet.
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to use judgment in making estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities.
We believe that our accounting policies for revenue recognition, accounts receivable and allowance for credit losses, product warranty and contingencies are based on, among other things, judgments and assumptions made by management that include inherent risks and uncertainties. There have been no significant changes to the above critical accounting policies or in the underlying accounting assumptions and estimates used in such policies from those disclosed in our annual consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019, except our accounting policy for our allowance for doubtful accounts (now termed allowance for credit losses). As of January 1, 2020, we adopted Accounting Standards Update (“ASU”) 2016-13, Credit Losses (Topic 326), as described in Note 1 to the consolidated financial statements in this Form 10-Q.
Accounting Standards Issued and Not Yet Adopted
In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 eliminates certain exceptions in the current guidance regarding the approach for intraperiod tax allocations, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This new guidance also simplifies the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies such things as the accounting for transactions that result in a step up in the tax basis of goodwill. The guidance is effective for us beginning in the first quarter of 2021 with early adoption permitted. The adoption of this guidance is not expected to have a significant impact on our consolidated financial statements.
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by eliminating certain separation models. Under ASU 2020-06, a convertible debt instrument will generally be reported as a single liability at its amortized cost with no separate accounting for embedded conversion features. Consequently, the interest rate of convertible debt instruments will be closer to the coupon interest rate. In addition, ASU 2020-06 eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. The guidance is effective for us beginning in the first quarter of 2022 with early adoption permitted. We plan to early adopt ASU 2020-06 as of January 1, 2021, which is expected to result in an approximate $330
24
million decrease in additional paid in capital from the derecognition of the bifurcated equity component, $250 million increase in debt from the derecognition of the discount associated with the bifurcated equity component and $80 million decrease to the opening balance of accumulated deficit, representing the cumulative interest expense recognized related to the amortization of the bifurcated conversion option. We expect to write-off the related deferred tax liabilities with a corresponding adjustment to the valuation allowance, resulting in no net impact to the cumulative adjustment to retained earnings. Adoption of this standard will have no impact on our diluted earnings per share as we calculate earnings per share using the if-converted method.
FORWARD-LOOKING STATEMENTS
This quarterly report on Form 10-Q contains forward-looking statements. Forward-looking statements relate to future events or our future financial performance. We generally identify forward looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. These statements are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, results of operations and financial condition.
The outcomes of the events described in these forward-looking statements are subject to risks, uncertainties and assumptions. These risks and uncertainties include, but are not limited to:
•risks associated with public health crises and pandemics, such as the COVID-19 global pandemic, including the duration of the outbreak, government actions and restrictive measures implemented in response, supply chain disruptions, delays in clinical trials, and other impacts to the business, or on our ability to execute business continuity plans;
•risks associated with our dependence on our principal product platform, the Omnipod System, and our ability to design, develop, manufacture and commercialize future products; 
•our ability to reduce production costs and increase customer orders and manufacturing volumes;
•adverse changes in general economic conditions;
•the impact of healthcare reform laws; 
•supply problems or price fluctuations with sole source or third-party suppliers on which we are dependent;
•the potential establishment of a competitive bid program for conventional insulin pumps;
•failure to retain key suppliers and/or supplier pricing discounts and achieve satisfactory gross margins;
•international business risks, including regulatory, commercial and logistics risks associated with selling our products in Europe in light of the uncertainty related to the separation of the United Kingdom from the European Union (Brexit); 
•our inability to secure and retain adequate coverage or reimbursement from third-party payors for the Omnipod System or future products and potential adverse changes in reimbursement rates or policies relating to the Omnipod System or future products;
•failure to retain key payor partners and their members;
•adverse effects resulting from competition;
•technological change and product innovation adversely affecting our business;
•changes to or termination of our license to incorporate a blood glucose meter into the Omnipod System or our inability to enter into new license or other agreements with respect to the Omnipod System’s current or future features;
•challenges to the future development of our non-insulin drug delivery product line; 
•our ability to protect our intellectual property and other proprietary rights;
•conflicts with the intellectual property of third parties, including claims that our current or future products infringe or misappropriate the proprietary rights of others;
•adverse regulatory or legal actions relating to the Omnipod System or future products;
•failure of our contract manufacturers or component suppliers to comply with the FDA’s quality system regulations;
•potential adverse impacts resulting from a recall, or discovery of serious safety issues, of the Omnipod System;
•the potential violation of the U.S. Foreign Corrupt Practices Act or any other federal, state or foreign anti-bribery/anti-corruption laws or laws prohibiting “kickbacks” or protecting the confidentiality of health information or other protected personal information, or any challenge to or investigation into our practices under these laws;
•product liability and other lawsuits that may be brought against us, including stemming from off-label use of our product;
•breaches or failures of our product or information technology systems, including by cyber-attack;
25
•reduced retention rates of our customer base;
•unfavorable results of clinical studies relating to the Omnipod System or future products, or the products of our competitors;
•future publication of articles or announcement of positions by diabetes associations or other organizations that are unfavorable to the Omnipod System;
•the concentration of our manufacturing operations and storage of our inventory in a limited number of locations; 
•our ability to attract and retain personnel; 
•our ability to scale our business to support revenue growth;
•fluctuations in quarterly results of operations;
•risks associated with potential future acquisitions or investments in new businesses; 
•our ability to generate sufficient cash to service all of our indebtedness or raise additional funds on acceptable terms or at all;
•the expansion of our distribution network; 
•the volatility of the trading price of our common stock;
•risks related to future sales of our common stock or the conversion of any of our convertible debt;
•potential limitations on our ability to use our net operating loss carryforwards; and
•anti-takeover provisions in our organizational documents.
The risk factors discussed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019 and in this Quarterly Report could cause our results to differ materially from those expressed in forward-looking statements. In addition, there may be other risks and uncertainties that we are unable to predict at this time or that we currently do not expect to have a material adverse effect on our business. Actual results could differ materially from those projected in the forward-looking statements; accordingly, you should not rely upon forward-looking statements as predictions of future events. We expressly disclaim any obligation to update these forward-looking statements other than as required by law.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Refer to “Part II. Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of our interest rate risk, market price sensitive instruments and foreign currency exchange risk.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities and Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of September 30, 2020. Based on the evaluation, our chief executive officer and chief financial officer concluded that, as of that date, our disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Information regarding our material pending legal proceedings, which is incorporated herein by reference, is provided in Note 9 to the consolidated financial statements in this Form 10-Q.
26
Item 1A. Risk Factors
Please refer to the “Risks Factors” section in our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of risks to which our business, financial condition, results of operations and cash flows are subject. Other than as set forth below, there have been no material changes to the risk factors disclosed in the aforementioned Annual Report.
Our financial condition and results of operations have been and may to continue to be adversely affected by the recent coronavirus outbreak.
A novel strain of coronavirus (COVID-19) was identified in China in December 2019, and subsequently declared a pandemic by the World Health Organization in March 2020. To date, this outbreak, which has surfaced in nearly all regions around the world, and preventative measures taken to contain or mitigate the outbreak, have caused, and are continuing to cause, business slowdown or shutdown in affected areas and disruption in the financial markets globally. This has led to a significant increase in unemployment and a loss of employee-sponsored insurance coverage for many people in the United States. As a result, consumers may reduce their spending and our customer attrition rate may increase, which could have a material adverse effect on our business, sales, financial condition and results of operations.
The COVID-19 pandemic also has the potential to significantly impact our supply chain if the manufacturing plants that produce our products or product components, the distribution centers where we manage our inventory, or the operations of our logistics and other service providers, including third parties that sterilize our products, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. Although China, where we manufacture a significant portion of our product, has experienced a recovery and we are currently producing at pre-COVID-19 levels, should China suffer a COVID-19 relapse, it could hinder our ability to produce product and have a material adverse effect on our business and results of operations.
As a result of the COVID-19 pandemic, we have taken steps to protect the health and safety of our employees and have transitioned to a remote work environment for those that can perform their job function outside of our facilities. The remote work environment has increased risks associated with our information technology systems and networks, including cyber-attacks, computer viruses, disruptions, or shutdowns that could result in a failure to protect our information technology systems and data integrity.
The further spread of COVID-19, and the requirements to take action to help limit the spread of the illness, may impact our ability to carry out our business as usual. For example, the COVID-19 pandemic may divert healthcare resources away from the conduct of clinical trials and interrupt the operations of the FDA and comparable foreign regulatory agencies, which could delay product approval timelines. Further, we could experience limitations on employee resources that would otherwise be focused on the conduct of preclinical studies and clinical trials, including because of sickness of employees or their families, the requirement for employees to avoid contact with large groups of people and the reliance on working from home. The continued spread of COVID-19 may also slow potential enrollment of clinical trials, reduce the number of eligible patients for our clinical trials and impact our ability to recruit principal investigators and site staff. As a result of the COVID-19 pandemic, including related governmental guidance or requirements, many of our employees are working from home, which may negatively impact productivity and cause other disruptions to our business. In addition, if the pandemic continues, we may experience a decline in sales activities, which may hinder new customer starts and negatively impact our revenue growth.
The extent of the impact of the COVID-19 pandemic on our business and financial performance, including our ability to execute our near-term and long-term business strategies and initiatives in the expected time frame, will depend on future developments, including the duration and severity of the pandemic, which are uncertain and cannot be predicted. In addition, the pandemic could cause an economic slowdown of potentially extended duration and lead to a global depression. Any sustained disruption in the capital markets from the COVID-19 pandemic could negatively impact our ability to raise capital. If the macro-economic disruption continues for pro-longed periods, we may need to raise additional capital and capital may not be available on acceptable terms, or at all. While we have a strong balance sheet as of September 30, 2020, in part due to the completion of a public offering of common stock in May 2020, and currently do not need to raise additional capital, should the opportunity arise to raise capital on favorable terms, we may choose to do so in order to minimize this risk. We cannot predict when the macro-economic disruption stemming from the coronavirus will ebb or when the economy will return to pre-coronavirus levels, if at all.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
27
Item 5. Other Information
None.
Item 6. Exhibits
NumberDescription
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Executive Officer.
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by Chief Financial Officer.
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, by Chief Executive Officer and Chief Financial Officer.
101
The following materials from Insulet Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 formatted in iXBRL (Inline eXtensible Business Reporting Language), as follows:
(i) Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2020 and December 31, 2019
(ii) Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended September 30, 2020 and 2019
(iii) Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the Three and Nine Months Ended September 30, 2020 and 2019
(iv) Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) for the Three and Nine Months Ended September 30, 2020 and 2019
(v) Condensed Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended September 30, 2020 and 2019
(vi) Condensed Notes (Unaudited) to Consolidated Financial Statements
*This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.
28
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INSULET CORPORATION
 
(Registrant)
Date:November 4, 2020/s/ Shacey Petrovic
Shacey Petrovic
Chief Executive Officer
(Principal Executive Officer)
 
Date:November 4, 2020/s/ Wayde McMillan
Wayde McMillan
Chief Financial Officer
(Principal Financial Officer)

29
 EX-31.1 2 podd-exx311x2020x09x30.htm EX-31.1 Document
EXHIBIT 31.1

CERTIFICATION
I, Shacey Petrovic, certify that:    
1.I have reviewed this Quarterly Report on Form 10-Q of Insulet Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ Shacey Petrovic
Shacey Petrovic
Chief Executive Officer
Date:November 4, 2020

 EX-31.2 3 podd-exx312x2020x09x30x.htm EX-31.2 Document
EXHIBIT 31.2
CERTIFICATION
I, Wayde McMillan, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Insulet Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ Wayde McMillan
Wayde McMillan
Chief Financial Officer
Date:November 4, 2020

 EX-32.1 4 podd-exx321x2020x09x30.htm EX-32.1 Document
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Insulet Corporation, a Delaware corporation (the “Company”), does hereby certify with respect to the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2020, as filed with the Securities and Exchange Commission (the “Report”) that, to their knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Shacey Petrovic
Shacey Petrovic
Chief Executive Officer
Date:November 4, 2020
/s/ Wayde McMillan
Wayde McMillan
Chief Financial Officer
Date:November 4, 2020

 EX-101.SCH 5 podd-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2105102 - Disclosure - Revenue and Contract Acquisition Costs link:presentationLink link:calculationLink link:definitionLink 2306302 - Disclosure - Revenue and Contract Acquisition Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Revenue and Contract Acquisition Costs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2111103 - Disclosure - Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 2312303 - Disclosure - Cash and Cash Equivalents (Tables) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 2114104 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 2315304 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2416407 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2417408 - Disclosure - Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2118105 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2319305 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2420409 - Disclosure - Inventories - Components of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2121106 - Disclosure - Goodwill and Other Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 2322306 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2423410 - Disclosure - Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2424411 - Disclosure - Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2425412 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2426413 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details) link:presentationLink link:calculationLink link:definitionLink 2127107 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 2328307 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2429414 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2430415 - Disclosure - Accrued Expenses and Other Current Liabilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431416 - Disclosure - Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details) link:presentationLink link:calculationLink link:definitionLink 2132108 - Disclosure - Convertible Debt, Net link:presentationLink link:calculationLink link:definitionLink 2333308 - Disclosure - Convertible Debt, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2434417 - Disclosure - Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2435418 - Disclosure - Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2136109 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2437419 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2138110 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2339309 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 2440420 - Disclosure - Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 2141111 - Disclosure - Interest Expense link:presentationLink link:calculationLink link:definitionLink 2342310 - Disclosure - Interest Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 2443421 - Disclosure - Interest Expense - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2144112 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2345311 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2446422 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details) link:presentationLink link:calculationLink link:definitionLink 2147113 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2448423 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2149114 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 2350312 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2451424 - Disclosure - Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2452425 - Disclosure - Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2153115 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2454426 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 podd-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 podd-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 podd-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Other income (expense), net Other Nonoperating Income (Expense) Schedule of Reconciliation of Changes in Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accretion of debt discount Amortization of Debt Discount (Premium) Payables and Accruals [Abstract] Payables and Accruals [Abstract] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Value added taxes payable Value Added Taxes Payable, Current Value Added Taxes Payable, Current Schedule of Accumulated Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Security Exchange Name Security Exchange Name Capitalized interest Interest Costs Capitalized Adjustment Warranty liability Standard Product Warranty Accrual, Current Proceeds from issuance of convertible notes, net of issuance costs Proceeds from Convertible Debt Accounts receivable Increase (Decrease) In Accounts Receivable And Unbilled Revenue Increase (Decrease) In Accounts Receivable And Unbilled Revenue Selling, general and administrative expenses Selling and Marketing Expense [Member] Operating income Operating Income (Loss) Total current liabilities Liabilities, Current Fees To Former European Distributor Fees To Former European Distributor [Member] Fees To Former European Distributor [Member] Commitment due in next twelve months Other Commitment, to be Paid, Year One Summary of Deferred Revenue Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Commitments and contingencies (Note 9) Commitments and Contingencies ASSETS Assets [Abstract] Accounting Policies [Abstract] Accounting Policies [Abstract] Entity Address, State or Province Entity Address, State or Province Accounts payable Accounts Payable, Current Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accumulated deficit Retained Earnings (Accumulated Deficit) Total Omnipod Product, Omnipod [Member] Product, Omnipod [Member] Short-term Investments [Abstract] Short-term Investments [Abstract] Unamortized debt discount Debt Instrument, Unamortized Discount Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Other assets Deferred Costs and Other Assets CANADA CANADA 1.25% Convertible Senior Notes 1.25% Convertible Senior Notes Convertible Senior Notes, 1.25% [Member] Convertible Senior Notes, 1.25% [Member] Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding Preferred Stock, Value, Issued U.S. government and agency bonds US Treasury and Government [Member] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Other liabilities Other Liabilities, Noncurrent Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition U.S. Omnipod U.S. Omnipod [Member] U.S. Omnipod [Member] Unbilled receivable Unbilled Receivables, Current Cumulative Effect, Period of Adoption, Adjusted Balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Inventories Total inventories Inventory, Net Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Measurement Frequency [Domain] Measurement Frequency [Domain] Advertising expense Advertising Expense Concentration risk, percentage Concentration Risk, Percentage Geographical [Domain] Geographical [Domain] Amortization of capitalized commission costs Capitalized Contract Cost, Amortization Summary of Carrying Amount and Estimated Fair Value of Convertible Debt Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block] Statement [Line Items] Statement [Line Items] Schedule of Potential Common Share Equivalents Excluded from Computation of Diluted Net Income (Loss) per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Forecast Forecast [Member] Net income per share: Earnings Per Share, Basic and Diluted [Abstract] Debt instrument, term Debt Instrument, Term Statement [Table] Statement [Table] Write-offs charged against allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Product Warranty Costs Standard Product Warranty, Policy [Policy Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Financial instrument value Debt Instrument, Fair Value Disclosure Preferred stock, issued (in shares) Preferred Stock, Shares Issued Effective tax rate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Conversion feature, net of issuance costs Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Entity Small Business Entity Small Business Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Convertible Debt, Net Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Proceeds from issuance of common stock, net of issuance costs Proceeds from Issuance of Common Stock Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Interest income Interest and Dividend Income, Operating Goodwill [Roll Forward] Goodwill [Roll Forward] Amendment Flag Amendment Flag Schedule of Computation of Basic and Diluted Net Income (Loss) per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Weighted-average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Other Other Accrued Liabilities, Current Product Warranty Liability [Line Items] Product Warranty Liability [Line Items] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Measurement Frequency [Axis] Measurement Frequency [Axis] Short-term investments Debt Securities, Available-for-sale, Current Accounts Receivable and Allowance for Credit Losses Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Schedule of Components of Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Purchases of property and equipment included in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Geographical [Axis] Geographical [Axis] Subsequent Events Subsequent Events [Text Block] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Statement of Cash Flows Statement of Cash Flows [Abstract] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Income Statement Location [Axis] Income Statement Location [Axis] Allowance for doubtful accounts Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss, Current Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Cash Cash [Member] Income Statement Location [Domain] Income Statement Location [Domain] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Restricted stock units vested, net of shares withheld for taxes (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Amortization of other intangible assets Amortization of Intangible Assets Issuance of common stock Stock Issued During Period, Value, New Issues Total cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total assets Assets International Omnipod International Omnipod [Member] International Omnipod [Member] Scenario [Axis] Scenario [Axis] Title of 12(b) Security Title of 12(b) Security Schedule of Components of Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Other intangible assets, net Net Book Value Finite-Lived Intangible Assets, Net Subsequent Event Type [Axis] Subsequent Event Type [Axis] Reclassification [Line Items] Reclassification [Line Items] Unrealized (loss) gain on available-for-sale debt securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Antidilutive Securities [Axis] Antidilutive Securities [Axis] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Cost of revenue Cost of Sales [Member] Interest expense, net of portion capitalized Interest Expense Accrued interest Interest Payable Equipment financing transaction two Equipment Financing Transaction Two [Member] Equipment Financing Transaction Two Depreciation and amortization Depreciation, Depletion and Amortization Short-term investments Short-term Investments [Member] Accrued liabilities Accrued Liabilities Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Accrued rebates Accrued Exchange Fee Rebate Revenue recognized Contract with Customer, Liability, Revenue Recognized Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Internal-use software Internal Use Software [Member] Internal Use Software [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Inventories Increase (Decrease) in Inventories Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Debt Instrument [Axis] Debt Instrument [Axis] Additional Paid-in Capital Additional Paid-in Capital [Member] Interest expense, net Interest expense, net Interest Income (Expense), Net Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Other Other Operating Activities, Cash Flow Statement Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] 1.375% Convertible Senior Notes 1.375% Convertible Senior Notes Convertible Senior Notes, 1.375% [Member] Convertible Senior Notes, 1.375% [Member] Research and development expenses Research and Development Expense Number of equipment financing transactions Debt instrument, Number Of Equipment Financing Transactions Debt instrument, Number Of Equipment Financing Transactions Subsequent event Subsequent Event [Member] Reclassification of Prior Period Amounts Reclassification, Comparability Adjustment [Policy Text Block] Common stock, authorized (in shares) Common Stock, Shares Authorized Concentration Risk Type [Axis] Concentration Risk Type [Axis] Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan Proceeds from Stock Options Exercised Contractual coupon interest Interest Expense, Debt, Excluding Amortization Estimated Fair Value Estimate of Fair Value Measurement [Member] Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Summary of Interest and Other Expense Schedule Of Interest And Other Expense On Debt [Table Text Block] Schedule of Interest Expense on Debt 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Current Assets Assets, Current [Abstract] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Total capitalized contract acquisition costs, net Capitalized Contract Cost, Net Scenario [Domain] Scenario [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Purchase of capped call options Adjustments To Additional Paid in Capital Capped Call Options Adjustments To Additional Paid in Capital Capped Call Options Document Period End Date Document Period End Date Summary of Revenue from Contracts with Customers Disaggregation of Revenue [Table Text Block] Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Components of Inventories Schedule of Inventory, Current [Table Text Block] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation Share-based Payment Arrangement, Noncash Expense Number of class actions dismissed (in legal matters) Loss Contingency, Claims Dismissed, Number Payment of withholding taxes in connection with vesting of restricted stock units Payment, Tax Withholding, Share-based Payment Arrangement Restricted stock units vested, net of shares withheld for taxes Restricted Stock, Value, Shares Issued Net of Tax Withholdings Cover [Abstract] Cover [Abstract] Goodwill and Other Intangible Assets, Net Intangible Assets Disclosure [Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Derivative maturity date range Derivative, Average Remaining Maturity Customer relationships Customer Relationships [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Cost of revenue Cost of Goods and Services Sold Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Fair Value Debt Securities, Available-for-sale Equity Components [Axis] Equity Components [Axis] Warranty claims settled Standard and Extended Product Warranty Accrual, Decrease for Payments Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Schedule of Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Short-term lease liability Operating Lease, Liability, Current Product warranty liability at beginning of period Product warranty liability at the end of period Standard and Extended Product Warranty Accrual Employee compensation and related costs Accrued Salaries, Current Entity Interactive Data Current Entity Interactive Data Current United States UNITED STATES Corporate bonds Corporate Bond Securities [Member] Summary of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Summary of Share-Based Compensation Expense Share-based Payment Arrangement, Option, Activity [Table Text Block] Accounts and unbilled receivables Accounts Receivable Accounts Receivable [Member] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] 2020 (remaining) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other liabilities Increase (Decrease) in Other Operating Liabilities Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Advertising Costs Advertising Cost [Policy Text Block] Debt issuance costs Debt Issuance Costs, Net Shipping and Handling Shipping and Handling [Member] Warranty expense Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Research and development expenses Research and Development Expense [Member] Issuance of shares for debt repayment Stock Issued During Period, Value, Conversion of Convertible Securities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Accounts receivable trade, less allowance for credit losses of $3.6 and $3.8 Accounts Receivable, after Allowance for Credit Loss, Current Finished goods Inventory, Finished Goods, Gross Summary of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Entity Address, Postal Zip Code Entity Address, Postal Zip Code Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Goodwill Goodwill at December 31, 2019 Goodwill at September 30, 2020 Goodwill Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Total other comprehensive income (loss), net of tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Document Transition Report Document Transition Report Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Level 2 Fair Value, Inputs, Level 2 [Member] 0.375% Convertible Senior Notes 0.375% Convertible Senior Notes Convertible Senior Notes .375% [Member] Convertible Senior Notes .375% [Member] Document Quarterly Report Document Quarterly Report Summary of Changes in Carrying Amounts of Goodwill Schedule of Goodwill [Table Text Block] Equity [Abstract] Equity [Abstract] Purchase of capped call options Payments for Derivative Instrument, Financing Activities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Accrued expenses and other current liabilities Deferred revenue Contract with Customer, Liability, Current Subsequent Event [Line Items] Subsequent Event [Line Items] Supplier purchases Accounts Payable, Trade, Current Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Accounts payable, accrued expenses and other current liabilities Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities The net change during the reporting period in the aggregate amount of accounts payable accrued expenses and other liabilities incurred but not paid. Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Schedule of Amortization Expense Expected for Next Five Years Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Diluted (in shares) Weighted average number of common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Basic (in dollars per share) Earnings Per Share, Basic Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Entity File Number Entity File Number Debt Disclosure [Abstract] Debt Disclosure [Abstract] Recoveries of amounts previously written-off Accounts Receivable, Allowance for Credit Loss, Recovery Selling, general and administrative expenses Selling and Marketing Expense Non-cash interest Amortization of Debt Issuance Costs and Discounts Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Total deferred revenue Revenue, Remaining Performance Obligation, Amount Stock-based compensation expense Share-based Payment Arrangement, Expense Unrealized Gain on Available-for-sale Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Issuance of shares for employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Common stock, $.001 par value, 100,000,000 authorized; 65,871,736 and 62,685,492 issued and outstanding Common Stock, Value, Issued Long-term investments Long-term Investments Other assets Capitalized Contract Cost, Net, Noncurrent Drug Delivery Drug Delivery [Member] Drug Delivery [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Document Fiscal Year Focus Document Fiscal Year Focus 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Commercial paper Commercial Paper [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Summary of Contract Acquisition Costs Capitalized Contract Cost [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Subsequent Event [Table] Subsequent Event [Table] Purchases of investments Payments to Acquire Debt Securities, Available-for-sale Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Debt amortization period Debt Instrument, Amortization Period Debt Instrument, Amortization Period Equipment financing transaction one Equipment Financing Transaction One [Member] Equipment Financing Transaction One Convertible debt, net Total convertible debt, net Long-term Debt, Excluding Current Maturities Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total stockholders’ equity Beginning balance Ending balance Increase of accumulated deficit Stockholders' Equity Attributable to Parent Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities and stockholders’ equity Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Raw materials Inventory, Raw Materials, Gross Entity Address, City or Town Entity Address, City or Town Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Acquisition of intangible assets Payments to Acquire Intangible Assets Restricted stock units Unvested restricted stock units Restricted Stock Units (RSUs) [Member] Financial Instrument [Axis] Financial Instrument [Axis] Intellectual property Intellectual Property [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Equity Component [Domain] Equity Component [Domain] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Gross profit Gross Profit Property, plant and equipment, net Property, Plant and Equipment, Net 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three Entity Tax Identification Number Entity Tax Identification Number Net income Net income Net Income (Loss) Attributable to Parent Interest Expense Interest Income and Interest Expense Disclosure [Text Block] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Inventories Inventory Disclosure [Text Block] Work-in-process Inventory, Work in Process, Gross Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Operating expenses: Operating Expenses [Abstract] Earnings Per Share [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Reclassification of prior period amounts Prior Period Reclassification Adjustment Stockholders’ Equity Stockholders' Equity Attributable to Parent [Abstract] Accumulated Other Comprehensive Income [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Receipts from the maturity or sale of investments Proceeds from Sale of Short-term Investments Document Fiscal Period Focus Document Fiscal Period Focus Certificates of deposit Certificates of Deposit [Member] Other liabilities Contract with Customer, Liability, Noncurrent Issuance of employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Number of automated manufacturing lines Debt Instrument, Number Of Automated Manufacturing Lines Debt Instrument, Number Of Automated Manufacturing Lines Common Stock Common Stock [Member] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Prepaid expenses and other current assets Capitalized Contract Cost, Net, Current Convertible Debt Convertible Debt [Member] Associated gross intangible asset Other Finite-Lived Intangible Assets, Gross Other Commitments [Axis] Other Commitments [Axis] Other Commitments [Domain] Other Commitments [Domain] Secured Debt Secured Debt [Member] Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Gross Carrying Amount Finite-Lived Intangible Assets, Gross Sales Revenue Revenue Benchmark [Member] Debt, interest rate Debt Instrument, Interest Rate, Stated Percentage Issuance of shares for debt repayment (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Money market mutual funds Money Market Funds [Member] Provision for credit losses Provision for expected credit losses Accounts Receivable, Credit Loss Expense (Reversal) Product Warranty Liability [Table] Product Warranty Liability [Table] Supplemental noncash information: Noncash Investing and Financing Items [Abstract] Exercise of options to purchase common stock (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Repayment of convertible debt Repayments of Convertible Debt Stock options Stock options Share-based Payment Arrangement, Option [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Basic (in shares) Weighted average number of common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Subsequent Events [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Carrying Value Reported Value Measurement [Member] Revenue and Contract Acquisition Costs Revenue from Contract with Customer [Text Block] Lease liabilities arising from obtaining right-of-use assets Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Additional paid-in capital Additional Paid in Capital Stock-Based Compensation Shareholders' Equity and Share-based Payments [Text Block] 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Income tax expense Income Tax Expense (Benefit) Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current Diluted (in dollars per share) Earnings Per Share, Diluted Local Phone Number Local Phone Number Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Cash and Cash Equivalents Cash and Cash Equivalents Disclosure [Text Block] Principal amount of Senior Notes Long-term Debt, Gross Schedule of Outstanding Convertible Debt and Related Debt Issuance Costs Schedule of Long-term Debt Instruments [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Emerging Growth Company Entity Emerging Growth Company Exercise of options to purchase common stock Stock Issued During Period, Value, Stock Options Exercised Shipping and Handling costs Selling, General and Administrative Expenses, Policy [Policy Text Block] Prepaid expenses and other assets Prepaid Expenses and Other Current Assets [Member] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Amortization of debt issuance costs Amortization of Debt Issuance Costs Maximum Maximum [Member] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Accumulated Deficit Retained Earnings [Member] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Measurement Basis [Axis] Measurement Basis [Axis] Long-term investments Long Term Investments [Member] Long Term Investments [Member] Number of class actions filed (in legal matters) Loss Contingency, New Claims Filed, Number Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Restricted cash Restricted Cash [Member] Restricted Cash [Member] Reclassification [Table] Reclassification [Table] Trading Symbol Trading Symbol Accumulated Other Comprehensive Income [Table] Accumulated Other Comprehensive Income (Loss) [Table] Net Income Per Share Earnings Per Share [Text Block] Current Liabilities Liabilities, Current [Abstract] Entity Shell Company Entity Shell Company Product warranty term for PDMs Product Warranty Term Product Warranty Term Recurring fair value measurements Fair Value, Recurring [Member] Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 9 podd-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 podd-20200930_htm.xml IDEA: XBRL DOCUMENT 0001145197 2020-01-01 2020-09-30 0001145197 2020-10-28 0001145197 2020-09-30 0001145197 2019-12-31 0001145197 2020-07-01 2020-09-30 0001145197 2019-07-01 2019-09-30 0001145197 2019-01-01 2019-09-30 0001145197 us-gaap:CommonStockMember 2020-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001145197 us-gaap:RetainedEarningsMember 2020-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001145197 2020-06-30 0001145197 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001145197 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001145197 us-gaap:CommonStockMember 2020-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001145197 us-gaap:RetainedEarningsMember 2020-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001145197 us-gaap:CommonStockMember 2019-06-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001145197 us-gaap:RetainedEarningsMember 2019-06-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001145197 2019-06-30 0001145197 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2019-07-01 2019-09-30 0001145197 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001145197 us-gaap:CommonStockMember 2019-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001145197 us-gaap:RetainedEarningsMember 2019-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001145197 2019-09-30 0001145197 us-gaap:CommonStockMember 2019-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001145197 us-gaap:RetainedEarningsMember 2019-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001145197 2019-01-01 2019-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommonStockMember 2019-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001145197 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001145197 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001145197 us-gaap:CommonStockMember 2018-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001145197 us-gaap:RetainedEarningsMember 2018-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001145197 2018-12-31 0001145197 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001145197 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2019-01-01 2019-09-30 0001145197 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001145197 us-gaap:ShippingAndHandlingMember 2020-07-01 2020-09-30 0001145197 us-gaap:ShippingAndHandlingMember 2019-07-01 2019-09-30 0001145197 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-09-30 0001145197 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-09-30 0001145197 us-gaap:SellingAndMarketingExpenseMember 2019-07-01 2019-09-30 0001145197 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0001145197 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0001145197 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-09-30 0001145197 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-01-01 2019-09-30 0001145197 us-gaap:AccountsReceivableMember 2019-01-01 2019-09-30 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-06-30 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-06-30 0001145197 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0001145197 podd:U.S.OmnipodMember 2020-07-01 2020-09-30 0001145197 podd:U.S.OmnipodMember 2019-07-01 2019-09-30 0001145197 podd:U.S.OmnipodMember 2020-01-01 2020-09-30 0001145197 podd:U.S.OmnipodMember 2019-01-01 2019-09-30 0001145197 podd:InternationalOmnipodMember 2020-07-01 2020-09-30 0001145197 podd:InternationalOmnipodMember 2019-07-01 2019-09-30 0001145197 podd:InternationalOmnipodMember 2020-01-01 2020-09-30 0001145197 podd:InternationalOmnipodMember 2019-01-01 2019-09-30 0001145197 podd:ProductOmnipodMember 2020-07-01 2020-09-30 0001145197 podd:ProductOmnipodMember 2019-07-01 2019-09-30 0001145197 podd:ProductOmnipodMember 2020-01-01 2020-09-30 0001145197 podd:ProductOmnipodMember 2019-01-01 2019-09-30 0001145197 podd:DrugDeliveryMember 2020-07-01 2020-09-30 0001145197 podd:DrugDeliveryMember 2019-07-01 2019-09-30 0001145197 podd:DrugDeliveryMember 2020-01-01 2020-09-30 0001145197 podd:DrugDeliveryMember 2019-01-01 2019-09-30 0001145197 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001145197 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001145197 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001145197 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001145197 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001145197 us-gaap:CashMember 2020-09-30 0001145197 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001145197 us-gaap:CashMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0001145197 us-gaap:CashMember 2019-12-31 0001145197 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001145197 us-gaap:CashMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001145197 us-gaap:MoneyMarketFundsMember 2020-09-30 0001145197 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001145197 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0001145197 us-gaap:MoneyMarketFundsMember 2019-12-31 0001145197 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001145197 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001145197 us-gaap:CommercialPaperMember 2020-09-30 0001145197 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001145197 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0001145197 us-gaap:CommercialPaperMember 2019-12-31 0001145197 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001145197 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001145197 podd:RestrictedCashMember 2020-09-30 0001145197 podd:RestrictedCashMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0001145197 podd:RestrictedCashMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0001145197 podd:RestrictedCashMember 2019-12-31 0001145197 podd:RestrictedCashMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001145197 podd:RestrictedCashMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001145197 us-gaap:FairValueInputsLevel1Member 2020-09-30 0001145197 us-gaap:FairValueInputsLevel2Member 2020-09-30 0001145197 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001145197 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001145197 srt:MinimumMember 2020-01-01 2020-09-30 0001145197 srt:MaximumMember 2020-01-01 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-09-30 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:CommercialPaperMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001145197 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CertificatesOfDepositMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001145197 podd:LongTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001145197 us-gaap:CustomerRelationshipsMember 2020-09-30 0001145197 us-gaap:CustomerRelationshipsMember 2019-12-31 0001145197 podd:InternalUseSoftwareMember 2020-09-30 0001145197 podd:InternalUseSoftwareMember 2019-12-31 0001145197 us-gaap:IntellectualPropertyMember 2020-09-30 0001145197 us-gaap:IntellectualPropertyMember 2019-12-31 0001145197 country:US 2020-01-01 2020-09-30 0001145197 country:CA 2020-01-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2019-12-31 0001145197 podd:ConvertibleSeniorNotes1.375Member 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:ConvertibleDebtMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:ConvertibleDebtMember 2019-12-31 0001145197 podd:ConvertibleSeniorNotes375Member 2019-12-31 0001145197 podd:ConvertibleSeniorNotes375Member 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:ConvertibleDebtMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:ConvertibleDebtMember 2019-12-31 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001145197 podd:ConvertibleSeniorNotes1.375Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001145197 podd:ConvertibleSeniorNotes375Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001145197 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0001145197 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0001145197 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001145197 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001145197 2015-05-05 2015-06-16 0001145197 srt:MinimumMember podd:FeesToFormerEuropeanDistributorMember 2019-09-30 0001145197 srt:MaximumMember podd:FeesToFormerEuropeanDistributorMember 2019-09-30 0001145197 podd:FeesToFormerEuropeanDistributorMember 2019-12-31 0001145197 podd:FeesToFormerEuropeanDistributorMember 2020-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-01 2020-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-07-01 2019-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0001145197 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0001145197 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-09-30 0001145197 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001145197 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001145197 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001145197 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0001145197 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001145197 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001145197 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-09-30 0001145197 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001145197 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0001145197 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0001145197 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0001145197 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001145197 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001145197 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001145197 us-gaap:RestrictedStockUnitsRSUMember 2020-07-01 2020-09-30 0001145197 us-gaap:RestrictedStockUnitsRSUMember 2019-07-01 2019-09-30 0001145197 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001145197 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2020-07-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2020-01-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.25Member 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2020-07-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2020-01-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes1.375Member 2019-01-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2020-07-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2019-07-01 2019-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2020-01-01 2020-09-30 0001145197 podd:ConvertibleSeniorNotes375Member 2019-01-01 2019-09-30 0001145197 us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2020-10-31 0001145197 us-gaap:SecuredDebtMember us-gaap:SubsequentEventMember 2020-10-01 2020-10-31 0001145197 srt:ScenarioForecastMember us-gaap:SecuredDebtMember 2020-10-01 2020-12-31 0001145197 srt:ScenarioForecastMember us-gaap:SecuredDebtMember 2020-12-31 0001145197 srt:ScenarioForecastMember podd:EquipmentFinancingTransactionOneMember us-gaap:SecuredDebtMember 2020-12-31 0001145197 srt:ScenarioForecastMember podd:EquipmentFinancingTransactionOneMember us-gaap:SecuredDebtMember 2020-10-01 2020-12-31 0001145197 srt:ScenarioForecastMember podd:EquipmentFinancingTransactionTwoMember us-gaap:SecuredDebtMember 2020-12-31 0001145197 srt:ScenarioForecastMember podd:EquipmentFinancingTransactionTwoMember us-gaap:SecuredDebtMember 2020-10-01 2020-12-31 shares iso4217:USD iso4217:USD shares pure podd:lawsuit podd:numberOfTransaction podd:numberOfManufacturingLine false 2020 Q3 0001145197 --12-31 us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member P1Y 10-Q true 2020-09-30 false 001-33462 INSULET CORPORATION DE 04-3523891 100 Nagog Park Acton MA 01720 978 600-7000 Yes Yes Large Accelerated Filer false false false Common Stock, $0.001 Par Value Per Share PODD NASDAQ 65927871 838100000 213700000 58600000 162400000 3600000 3800000 85400000 69300000 124900000 101000000.0 53400000 44600000 1160400000 591000000.0 500000 58400000 449200000 399400000 10400000 13200000 39700000 39800000 50400000 41100000 1710600000 1142900000 57000000.0 54500000 118200000 103200000 175200000 157700000 921500000 887900000 18900000 21400000 1115600000 1067000000.0 0.001 0.001 5000000 5000000 0 0 0 0 0 0 0.001 0.001 100000000 100000000 65871736 65871736 62685492 62685492 100000 100000 1244700000 749000000.0 -649200000 -672000000.0 -600000 -1200000 595000000.0 75900000 1710600000 1142900000 234000000.0 192100000 658300000 528800000 82200000 69000000.0 237100000 182600000 151800000 123100000 421200000 346200000 38800000 31300000 108500000 96800000 89200000 74800000 253900000 217500000 23800000 17000000.0 58800000 31900000 -11400000 -7700000 -32600000 -18300000 0 -6400000 0 -6400000 1000000.0 -1800000 2000000.0 500000 13400000 1100000 28200000 7700000 1800000 300000 4300000 1100000 11600000 800000 23900000 23900000 6600000 6600000 0.18 0.01 0.37 0.11 0.17 0.01 0.36 0.11 65717820 60743211 64329181 59986163 66827692 62335679 65598197 61728018 11600000 800000 23900000 23900000 6600000 6600000 3300000 -1800000 500000 -3000000.0 -300000 0 100000 1300000 3000000.0 -1800000 600000 -1700000 14600000 -1000000.0 24500000 4900000 65604347 100000 1227600000 -660800000 -3600000 563300000 264456 10600000 10600000 6600000 6600000 2933 -100000 -100000 11600000 11600000 3000000.0 3000000.0 65871736 100000 1244700000 -649200000 -600000 595000000.0 60149926 100000 930300000 -677800000 -2800000 249800000 471356 17300000 17300000 6600000 6600000 8195 -300000 -300000 0.00375 207800000 207800000 0.0125 -438600000 -438600000 1157492 194400000 194400000 -85400000 -85400000 800000 800000 -1800000 -1800000 61786969 100000 832100000 -677000000.0 -4600000 150600000 62685492 100000 749000000.0 -672000000.0 -1200000 75900000 0 -1100000 -1100000 2369668 477500000 477500000 568830 21900000 21900000 18685 2900000 2900000 20300000 20300000 229061 -26900000 -26900000 23900000 23900000 600000 600000 65871736 100000 1244700000 -649200000 -600000 595000000.0 59188758 100000 898500000 -683600000 -2900000 212100000 1188043 40900000 40900000 27613 2000000.0 2000000.0 20700000 20700000 225063 -8200000 -8200000 0.00375 207800000 207800000 0.0125 -438600000 -438600000 1157492 194400000 194400000 -85400000 -85400000 6600000 6600000 -1700000 -1700000 61786969 100000 832100000 -677000000.0 -4600000 150600000 23900000 23900000 6600000 6600000 29700000 18800000 33600000 24300000 20300000 20700000 0 -6400000 3100000 2600000 300000 1900000 19900000 6800000 22900000 20000000.0 16800000 4000000.0 36100000 -1700000 -2400000 2700000 85000000.0 51500000 88500000 114600000 8300000 6400000 37900000 63900000 200000000.0 165300000 65300000 -19600000 477500000 0 0 780200000 0 453600000 0 85400000 24800000 42900000 26900000 8200000 475400000 275900000 -1300000 -1800000 624400000 306000000.0 213700000 113900000 838100000 419900000 4700000 10200000 2100000 5100000 Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements reflect the consolidated operations of Insulet Corporation and its subsidiaries (“Insulet” or the “Company”). The unaudited consolidated financial statements have been prepared in United States dollars, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. In management’s opinion, the unaudited consolidated financial statements contain all normal recurring adjustments necessary for a fair statement of the interim results reported. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or for any other subsequent interim period.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited consolidated financial statements do not include all of the annual disclosures required by GAAP; accordingly, they should be read in conjunction with the Company’s audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable consist of amounts due from third-party payors, customers and intermediaries and are presented at amortized cost. The allowance for credit losses reflects an estimate of losses inherent in the Company’s accounts receivable portfolio determined based on historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectable.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is measured on a collective (pool) basis when similar risk characteristics exist. The Company has identified the following portfolio segments and measures the allowance for credit losses using the following methods:</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Customer Receivables</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company measures expected credit losses on direct customer receivables using an aging methodology. The risk of loss for direct customer receivables is higher than other portfolios. The Company relies on third-party payors to accept and timely process claims and on direct consumers to have the ability to pay. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributor Receivables</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company measures expected credit losses on distributor receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers payment history as well as credit ratings of the distributors, in addition to current conditions and supportable forecasts. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">National Healthcare System Receivables</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company measures expected credit losses on national healthcare system receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are included in selling, general and administrative expenses and were $3.2 million and $2.2 million for the three months ended September 30, 2020 and 2019, respectively, and were $7.0 million and $7.1 million for the nine months ended September 30, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. To measure fair value of assets and liabilities, the Company uses the following fair value hierarchy based on three levels of inputs: </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—observable inputs, such as quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:5pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—significant other observable inputs that are observable either directly or indirectly; and</span></div><div style="margin-top:5pt;padding-left:76.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—significant unobservable inputs for which there are little or no market data, which require the Company to develop its own assumptions.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity. See Notes 3 and 8 for financial assets and liabilities held at carrying amount on the consolidated balance sheet and Note 4 for investments measured at fair value on a recurring basis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses advertising costs as they are incurred. Advertising expenses were $10.0 million and $3.4 million for the three months ended September 30, 2020 and 2019, respectively and $15.6 million and $8.6 million for the nine months ended September 30, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification of Prior Period Amounts</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. A portion of facility costs and certain information technology costs have been allocated from selling, general and administrative to research and development expenses based on square foot and system usage, respectively. In addition, certain quality assurance costs were reclassified from research and development expenses to selling, general and administrative expenses. The net impact of these adjustments wa</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s a $0.6 million and $1.9 million increase to research and development expenses and a corresponding decrease to selling, general and administrative expenses for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September 30, 2019, respectively</span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change to previously reported operating or net income. </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Company reclassified the $0.9 million chang</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e in unbilled receivables from the change in accounts and unbilled receivables to the change in prepaid expenses and other assets in the prior year statement of cash flows. This reclassification had no effect on previously reported net cash provided by operating activities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost, such as the Company’s trade receivables and contract assets, to be presented net of expected credit losses, which may be estimated based on relevant information such as historical experience, current conditions and future expectation for each pool of similar financial assets. The new guidance also requires enhanced disclosures related to trade receivables and associated credit losses. The Company adopted ASU 2016-13 using the modified retrospective method, whereby the guidance is applied prospectively as of the date of adoption and prior periods are not restated. The cumulative effect of adopting <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiMWY5ZWFmNWIzZDRjMzM5MzQyZGY1MWExOGNkZjczL3NlYzo0YjFmOWVhZjViM2Q0YzMzOTM0MmRmNTFhMThjZGY3M18zNC9mcmFnOmI5OTgzNDNlNjA3MDRmY2ZiYzk0NDFmNTVkODZmOWUzL3RleHRyZWdpb246Yjk5ODM0M2U2MDcwNGZjZmJjOTQ0MWY1NWQ4NmY5ZTNfNzk0NA_aeb17281-e47d-476a-96f8-af2472cd387e">ASU 2016-13</span> resulted in a $1.1 million increase to the opening balance of accumulated deficit upon adoption related to an increase in the allowance for credit losses on accounts receivable. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of adoption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period after adoption</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recoveries of amounts previously written-off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit losses at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2020, the Company adopted ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2017-04”). ASU 2017-04 requires an entity to measure the impairment of goodwill assigned to a reporting unit as the amount by which the carrying value of the assets and liabilities of the reporting unit, including goodwill, exceeds the reporting units’ fair value. The adoption of this guidance had no impact on the consolidated financial statements.</span></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements reflect the consolidated operations of Insulet Corporation and its subsidiaries (“Insulet” or the “Company”). The unaudited consolidated financial statements have been prepared in United States dollars, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. In management’s opinion, the unaudited consolidated financial statements contain all normal recurring adjustments necessary for a fair statement of the interim results reported. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or for any other subsequent interim period.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited consolidated financial statements do not include all of the annual disclosures required by GAAP; accordingly, they should be read in conjunction with the Company’s audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.</span></div> <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable consist of amounts due from third-party payors, customers and intermediaries and are presented at amortized cost. The allowance for credit losses reflects an estimate of losses inherent in the Company’s accounts receivable portfolio determined based on historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectable.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is measured on a collective (pool) basis when similar risk characteristics exist. The Company has identified the following portfolio segments and measures the allowance for credit losses using the following methods:</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Direct Customer Receivables</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company measures expected credit losses on direct customer receivables using an aging methodology. The risk of loss for direct customer receivables is higher than other portfolios. The Company relies on third-party payors to accept and timely process claims and on direct consumers to have the ability to pay. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts. </span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributor Receivables</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The Company measures expected credit losses on distributor receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers payment history as well as credit ratings of the distributors, in addition to current conditions and supportable forecasts. </span></div>National Healthcare System Receivables—The Company measures expected credit losses on national healthcare system receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts. <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are included in selling, general and administrative expenses and were $3.2 million and $2.2 million for the three months ended September 30, 2020 and 2019, respectively, and were $7.0 million and $7.1 million for the nine months ended September 30, 2020 and 2019, respectively.</span></div> 3200000 2200000 7000000.0 7100000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. To measure fair value of assets and liabilities, the Company uses the following fair value hierarchy based on three levels of inputs: </span></div><div style="margin-top:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—observable inputs, such as quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-top:5pt;padding-left:85.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—significant other observable inputs that are observable either directly or indirectly; and</span></div><div style="margin-top:5pt;padding-left:76.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—significant unobservable inputs for which there are little or no market data, which require the Company to develop its own assumptions.</span></div>Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity. Advertising CostsThe Company expenses advertising costs as they are incurred. 10000000.0 3400000 15600000 8600000 Reclassification of Prior Period AmountsCertain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. A portion of facility costs and certain information technology costs have been allocated from selling, general and administrative to research and development expenses based on square foot and system usage, respectively. In addition, certain quality assurance costs were reclassified from research and development expenses to selling, general and administrative expenses. 600000 600000 1900000 1900000 900000 900000 <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost, such as the Company’s trade receivables and contract assets, to be presented net of expected credit losses, which may be estimated based on relevant information such as historical experience, current conditions and future expectation for each pool of similar financial assets. The new guidance also requires enhanced disclosures related to trade receivables and associated credit losses. The Company adopted ASU 2016-13 using the modified retrospective method, whereby the guidance is applied prospectively as of the date of adoption and prior periods are not restated. The cumulative effect of adopting <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiMWY5ZWFmNWIzZDRjMzM5MzQyZGY1MWExOGNkZjczL3NlYzo0YjFmOWVhZjViM2Q0YzMzOTM0MmRmNTFhMThjZGY3M18zNC9mcmFnOmI5OTgzNDNlNjA3MDRmY2ZiYzk0NDFmNTVkODZmOWUzL3RleHRyZWdpb246Yjk5ODM0M2U2MDcwNGZjZmJjOTQ0MWY1NWQ4NmY5ZTNfNzk0NA_aeb17281-e47d-476a-96f8-af2472cd387e">ASU 2016-13</span> resulted in a $1.1 million increase to the opening balance of accumulated deficit upon adoption related to an increase in the allowance for credit losses on accounts receivable. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of adoption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period after adoption</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recoveries of amounts previously written-off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit losses at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2020, the Company adopted ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2017-04”). ASU 2017-04 requires an entity to measure the impairment of goodwill assigned to a reporting unit as the amount by which the carrying value of the assets and liabilities of the reporting unit, including goodwill, exceeds the reporting units’ fair value. The adoption of this guidance had no impact on the consolidated financial statements.</span></div> -1100000 <div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of adoption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit losses at the beginning of the period after adoption</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-offs charged against allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recoveries of amounts previously written-off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit losses at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4600000 3800000 0 1100000 4600000 4900000 500000 3100000 1600000 4700000 100000 300000 3600000 3600000 Revenue and Contract Acquisition Costs<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s disaggregated revenues:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:43.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Omnipod</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">132.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">377.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Omnipod</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">79.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Omnipod</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">212.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drug Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">54.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">234.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">658.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2020, the Company had one customer that represented 11% and two customers that in aggregate represented 21% of total revenue, respectively. During both the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended September 30, 2019,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company had one customer that represented 11% of total reve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nue. At September 30, 2020, the company had one customer that accounted for 12% of consolidated net accounts receivable. No customer accounted for more than 10% of consolidated net accounts receivable balance at December 31, 2019.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During both the three months ended September 30, 2020 and 2019, the Company recognized insignificant revenue included in deferred revenue at the beginning of 2020 and 2019, respectively. During the nine months ended September 30, 2020 and 2019, the Company recognized $1.7 million and $1.1 million of revenue included in deferred revenue at the beginning of 2020 and 2019, respectively.</span></div><div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total capitalized contract acquisition costs, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $2.7 million and $2.3 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2020 and 2019, respectively. The Company recognized $7.8 million and $6.4 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2020 and 2019, respectively.</span></div>The Company had unbilled receivables of $15.2 million and $13.5 million at September 30, 2020 and December 31, 2019, respectively. <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s disaggregated revenues:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:43.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Omnipod</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">132.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">377.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Omnipod</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">79.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">226.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Omnipod</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">212.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drug Delivery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">54.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">234.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">658.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 132300000 109400000 377700000 293600000 79800000 67800000 226100000 187400000 212100000 177200000 603800000 481000000.0 21900000 14900000 54500000 47800000 234000000.0 192100000 658300000 528800000 0.11 0.21 0.11 0.11 0.12 <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total deferred revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4300000 3200000 900000 1000000.0 5200000 4200000 1700000 1100000 <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total capitalized contract acquisition costs, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10400000 9500000 20700000 19900000 31100000 29400000 2700000 2300000 7800000 6400000 15200000 13500000 Cash and Cash Equivalents<div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> <div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> <div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">535.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">838.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> 298400000 298400000 0 85300000 85300000 0 535900000 535900000 0 115500000 115500000 0 0 0 0 10000000.0 0 10000000.0 3800000 3800000 0 2900000 2900000 0 838100000 838100000 0 213700000 203700000 10000000.0 Investments<div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s short-term and long-term investments in debt securities had maturity dates that range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjRiMWY5ZWFmNWIzZDRjMzM5MzQyZGY1MWExOGNkZjczL3NlYzo0YjFmOWVhZjViM2Q0YzMzOTM0MmRmNTFhMThjZGY3M180My9mcmFnOjlhNzk0M2FhMThkNDQ1ZWZiNDUzYjgxN2JiM2Y4OWQ1L3RleHRyZWdpb246OWE3OTQzYWExOGQ0NDVlZmI0NTNiODE3YmIzZjg5ZDVfODc5NjA5MzAyMjc4OQ_56c94b85-9789-49df-aabf-e128c5fff769">one</span> to two years at September 30, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Realized gains or losses for both the three and nine months ended September 30, 2020 and 2019 were insignificant.</span></div><div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides amortized costs, gross unrealized gains and losses, fair values and the level in the fair value hierarchy for the Company’s investments at September 30, 2020 and December 31, 2019: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:28.171%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.109%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total long-term investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial Paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total long-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> P2Y <div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides amortized costs, gross unrealized gains and losses, fair values and the level in the fair value hierarchy for the Company’s investments at September 30, 2020 and December 31, 2019: </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:28.171%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.500%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.109%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">52.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">58.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">53.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total long-term investments</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial Paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. government and agency bonds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total long-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> 52700000 400000 0 53100000 53100000 0 2800000 0 0 2800000 0 2800000 2700000 0 0 2700000 0 2700000 58200000 400000 0 58600000 53100000 5500000 500000 0 0 500000 0 500000 500000 0 0 500000 0 500000 94700000 300000 0 95000000.0 85000000.0 10000000.0 51000000.0 100000 0 51100000 0 51100000 6300000 0 0 6300000 0 6300000 10000000.0 0 0 10000000.0 0 10000000.0 162000000.0 400000 0 162400000 85000000.0 77400000 52900000 100000 100000 52900000 42900000 10000000.0 2800000 0 0 2800000 0 2800000 2700000 0 0 2700000 0 2700000 58400000 100000 100000 58400000 42900000 15500000 Inventories<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each period, inventories were comprised of the following:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">    Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">124.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each period, inventories were comprised of the following:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">57.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">    Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">124.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 27300000 23300000 57200000 40300000 40400000 37400000 124900000 101000000.0 Goodwill and Other Intangible Assets, Net<div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the nine months ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Goodwill at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes customer relationships acquired from the Company’s former European distributor. See Note 9.</span></div><div style="margin-bottom:9pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $0.7 million for both the three months ended September 30, 2020 and 2019. Amortization expense for intangible assets was $2.2 million and $1.9 million for the nine months ended September 30, 2020, and 2019, respectively. Amortization expense associated with intangible assets included on the Company’s consolidated balance sheet as of September 30, 2020 is expected to be as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.095%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 (remaining)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">     Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the nine months ended September 30, 2020 was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Goodwill at September 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 39800000 -100000 39700000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:28.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Book <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes customer relationships acquired from the Company’s former European distributor. See Note 9.</span></div> 9800000 3400000 6400000 9900000 2800000 7100000 11300000 8200000 3100000 12000000.0 6800000 5200000 1000000.0 100000 900000 1000000.0 100000 900000 22100000 11700000 10400000 22900000 9700000 13200000 700000 700000 2200000 1900000 Amortization expense associated with intangible assets included on the Company’s consolidated balance sheet as of September 30, 2020 is expected to be as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.095%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31, </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020 (remaining)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">     Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 700000 2200000 1700000 1200000 1100000 3500000 10400000 Accrued Expenses and Other Current Liabilities<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accrued expenses and other current liabilities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee compensation and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value added taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">37.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">118.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Warranty Costs</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">four-year warranty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Personal Diabetes Managers (“PDMs”) sold in the United States and Europe and a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five-year warranty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty at the time the product is shipped based on historical experience and the estimated cost to service the claims. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of operations. Cost to service the claims reflects the current product cost. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to the Company’s product warranty liability:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product warranty liability at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty claims settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product warranty liability at the end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accrued expenses and other current liabilities were as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee compensation and related costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">45.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value added taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">37.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">118.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 45900000 45800000 9800000 7500000 5400000 2400000 4900000 1800000 4300000 3200000 4600000 3600000 3200000 4700000 2300000 1700000 37800000 32500000 118200000 103200000 Product Warranty Costs<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">four-year warranty </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on Personal Diabetes Managers (“PDMs”) sold in the United States and Europe and a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five-year warranty </span>on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty at the time the product is shipped based on historical experience and the estimated cost to service the claims. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of operations. Cost to service the claims reflects the current product cost. P4Y P5Y <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to the Company’s product warranty liability:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.690%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product warranty liability at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warranty claims settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product warranty liability at the end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8100000 6600000 8500000 6400000 3100000 3300000 8300000 8600000 4200000 3100000 9800000 8200000 7000000.0 6800000 7000000.0 6800000 Convertible Debt, Net<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of outstanding convertible debt consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes, due November 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">402.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes, due September 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">800.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(263.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total convertible debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">921.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and the estimated fair value of the Company’s convertible debt, which is based on the Level 2 quoted market prices, were as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes, due November 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">319.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">512.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes, due September 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">602.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,022.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">840.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">  Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">921.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,535.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,352.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of outstanding convertible debt consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes, due November 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">402.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes, due September 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">800.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(263.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(294.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total convertible debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">921.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.01375 0.01375 402500000 402500000 0.00375 0.00375 800000000.0 800000000.0 263400000 294800000 17600000 19800000 921500000 887900000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount and the estimated fair value of the Company’s convertible debt, which is based on the Level 2 quoted market prices, were as follows: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes, due November 2024</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">319.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">512.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">512.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes, due September 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">602.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,022.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">840.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">  Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">921.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,535.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">887.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,352.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fair value was determined using market prices obtained from third-party pricing sources.</span></div> 0.01375 0.01375 319500000 512800000 306900000 512800000 0.00375 0.00375 602000000.0 1022800000 581000000.0 840000000.0 921500000 1535600000 887900000 1352800000 Commitments and Contingencies<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between May 5, 2015 and June 16, 2015, three class action lawsuits were filed by shareholders in the U.S. District Court, for the District of Massachusetts, against the Company and certain then current and former executives of the Company. Two suits subsequently were voluntarily dismissed. Arkansas Teacher Retirement System v. Insulet, et al., 1:15-cv-12345, (“ATRS”) alleged that the Company (and certain then current and former executives) committed violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making allegedly false and misleading statements about the Company’s business, operations and prospects. On February 8, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment was made into an escrow account for the plaintiffs and the class they purport to represent. On August 6, 2018, the Court issued an order approving the settlement, but took the plaintiffs’ motion for fees and expenses under advisement, which motion remains pending. The Company had previously accrued fees and expenses in connection with this matter for the amount of the final settlement liability that was not covered by insurance, the amount of which was not material to the Company’s consolidated financial statements. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on April 26, 2017, a derivative action (Walker v. DeSisto, et al., 1:17-cv-10738) (“Walker”) was filed, and on October 13, 2017, a second derivative action (Carnazza v. DeSisto, et al., 1:17-cv-11977) (“Carnazza”) was filed, both on behalf of the Company, each by a shareholder in the U.S. District Court for the District of Massachusetts against the Company (as a nominal defendant) and certain individual then current and former officers and directors of the Company. The allegations in the actions are substantially similar to those alleged in the securities class action. The actions seek, among other things, damages, disgorgement of certain types of compensation or profits, and attorneys’ fees and costs. On July 11, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment of attorneys’ fees and reimbursement of expenses will be paid to plaintiffs’ counsel, subject to the Court’s approval. On July 13, 2018, the plaintiffs filed a motion for preliminary approval of the settlement, which is pending. The Company expects that such fees and expenses payable to plaintiff’s counsel will be covered by the Company’s insurance. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, Roche Diabetes Care, Inc. (“Roche”) filed a patent infringement lawsuit against the Company in the United States District Court for the District of Delaware alleging that the Company’s manufacture and sale of its Omnipod Insulin Management System, Omnipod Starter Kit and Omnipod 10 Pod Pack in the United States infringed Roche’s now-expired U.S. Patent 7,931,613. Roche is seeking monetary damages in the form of a reasonable royalty and attorneys’ fees and costs. Since the patent expired in 2019, Roche is not seeking injunctive relief and the lawsuit will have no impact on ongoing sales of the Company’s products. The Company believes that it has meritorious defenses to Roche’s claims and intends to vigorously defend against them. The court has set a trial date of July 25, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses, which could be material.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company filed a patent infringement claim against Roche Diabetes Care Limited (“Roche Ltd.”) in the United Kingdom alleging that Roche Ltd.’s manufacture and sale of the Accu-Chek® Solo insulin pump and its consumable components infringes European Patent No. 1 335 764 in the United Kingdom. The Company is seeking an injunction to last until expiry of the patent and monetary damages. Roche Ltd. has responded to the complaint and argues that the patent is invalid and not infringed.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is, from time to time, involved in the normal course of business in various legal proceedings, including intellectual property, contract, employment and product liability suits. Other than as described above, the Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its results of operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fees to Former European Distributor </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the expiration of an agreement with a former European distributor on June 30, 2018, the Company was required to pay a quarterly per-unit fee for Omnipod sales to certain customers of the former European distributor for a one-year period through June 30, 2019. The Company recognized a liability and an associated intangible asset for this fee as qualifying sales occurred. The methodology applicable for determining the total fee under the distribution agreement is subject to an active arbitration proceeding in Switzerland. The final amount of the fee could vary significantly depending on the number of customers who count for purposes of calculating the fee under the terms of the agreement. The Company estimates that the final aggregate fee is in the range of $5 million to $55 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of both September 30, 2020 and December 31, 2019, the Company had $2.7 million accrued related to this matter. The associated gross intangible asset was $7.8 million at both September 30, 2020 and December 31, 2019.</span></div> 3 2 5000000 55000000 2700000 2700000 7800000 7800000 Accumulated Other Comprehensive Loss<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of accumulated other comprehensive loss, net of tax, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at the end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.435%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at the end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the components of accumulated other comprehensive loss, net of tax, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at the end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.435%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Available-for-sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at the end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -4400000 800000 -3600000 -1600000 400000 -1200000 3300000 -300000 3000000.0 500000 100000 600000 -1100000 500000 -600000 -1100000 500000 -600000 -3400000 600000 -2800000 -2200000 -700000 -2900000 -1800000 0 -1800000 -3000000.0 1300000 -1700000 -5200000 600000 -4600000 -5200000 600000 -4600000 Interest Expense<div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual coupon interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">     Interest expense, net of portion capitalized</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contractual coupon interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accretion of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">     Interest expense, net of portion capitalized</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">35.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2100000 2600000 6400000 7500000 10600000 8200000 31500000 22200000 700000 700000 2100000 2100000 1500000 2100000 4700000 8100000 11900000 9400000 35300000 23700000 500000 1700000 2700000 5400000 -11400000 -7700000 -32600000 -18300000 Stock-Based Compensation <div style="margin-bottom:9pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to stock-based awards was recorded as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:9pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense related to stock-based awards was recorded as follows:</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.177%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.098%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 100000 300000 300000 900000 2300000 2200000 7300000 6400000 4200000 4100000 12700000 13400000 6600000 6600000 20300000 20700000 Income TaxesThe Company’s effective tax rate for the three and nine months ended September 30, 2020 was 13.3% and 15.3%, compared with 24.7% and 14.1% for the three and nine months ended September 30, 2019. Income tax benefits have not been recorded for losses in jurisdictions where valuation allowances exist against net deferred tax assets, primarily in the United States. As of September 30, 2020 and December 31, 2019, the Company maintained a full valuation allowance against its U.S. net deferred tax assets based on the determination that it is not more likely than not that these future benefits will be realized. The Company had no uncertain tax positions at both September 30, 2020 and December 31, 2019. In April 2020, new interpretations of a German tax law related to intellectual property and withholding tax were released. Based on t 0.133 0.153 0.247 0.141 Net Income Per Share<div style="margin-bottom:6pt;margin-top:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted net income per share is computed using the weighted average number of common shares outstanding and, when dilutive, common share equivalents from outstanding stock options and restricted stock units (using the treasury-stock method), and potential common shares from the Company’s convertible notes (using the if-converted method). The weighted-average number of common shares used in the computation of basic and diluted net income per share were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,717,820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,743,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">64,329,181</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,986,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">978,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,370,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,082,247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,514,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">131,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">186,769</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,610 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66,827,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,335,679 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,598,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,728,018 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4.5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common share equivalents excluded from the computation of diluted net income per share because either the effect would have been anti-dilutive, or the performance criteria related to the units had not yet been met, were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,319,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319,429 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,319,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319,429 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,528,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,528,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">272,992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">272,877</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,331</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">56,522</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,186,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,367,349 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,177,228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,495,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> The weighted-average number of common shares used in the computation of basic and diluted net income per share were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, basic</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,717,820</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,743,211 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">64,329,181</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,986,163 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">978,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,370,792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,082,247</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,514,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">131,215</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">186,769</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,610 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66,827,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,335,679 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,598,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,728,018 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 65717820 60743211 64329181 59986163 978657 1370792 1082247 1514245 131215 221676 186769 227610 66827692 62335679 65598197 61728018 <div style="margin-bottom:4.5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common share equivalents excluded from the computation of diluted net income per share because either the effect would have been anti-dilutive, or the performance criteria related to the units had not yet been met, were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.25% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,055,786 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.375% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,319,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319,429 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,319,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,319,429 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.375% Convertible Senior Notes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,528,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,528,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,528,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">272,992</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">272,877</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">455,824 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,331</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">56,522</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136,342 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,186,152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,367,349 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,177,228</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,495,781 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0125 0.0125 0 2055786 0 2055786 0.01375 0.01375 4319429 4319429 4319429 4319429 0.00375 0.00375 3528400 3528400 3528400 3528400 272992 455876 272877 455824 65331 7858 56522 136342 8186152 10367349 8177228 10495781 Subsequent Events<div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company entered into a $70 million loan secured by a mortgage of its facility located in Acton, Massachusetts. The loan has a five-year term and an interest rate of approximately 5.2%. The monthly payment is based on a 20-year amortization period with the final payment of the outstanding principal due in 2025.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, the Company entered into two equipment financing transactions secured by machinery and equipment associated with two of its highly automated manufacturing lines located in Acton, Massachusetts. The first transaction was in the amount of approximately $37 million with a term of 60 months and an interest rate of approximately 4.5%. The second transaction was in the amount of $23 million with a term of 42 months and an interest rate of approximately 5.4%.</span></div> 70000000 P5Y 0.052 P20Y 2 2 37000000 P60M 0.045 23000000 P42M 0.054 XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover - shares
 9 Months Ended
Sep. 30, 2020
Oct. 28, 2020
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2020  
Document Transition Report false  
Entity File Number 001-33462  
Entity Registrant Name INSULET CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 04-3523891  
Entity Address, Address Line One 100 Nagog Park  
Entity Address, City or Town Acton  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01720  
City Area Code 978  
Local Phone Number 600-7000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Title of 12(b) Security Common Stock, $0.001 Par Value Per Share  
Trading Symbol PODD  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding (in shares)   65,927,871
Amendment Flag false  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001145197  
Current Fiscal Year End Date --12-31  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 838.1 $ 213.7
Short-term investments 58.6 162.4
Accounts receivable trade, less allowance for credit losses of $3.6 and $3.8 85.4 69.3
Inventories 124.9 101.0
Prepaid expenses and other current assets 53.4 44.6
Total current assets 1,160.4 591.0
Long-term investments 0.5 58.4
Property, plant and equipment, net 449.2 399.4
Other intangible assets, net 10.4 13.2
Goodwill 39.7 39.8
Other assets 50.4 41.1
Total assets 1,710.6 1,142.9
Current Liabilities    
Accounts payable 57.0 54.5
Accrued expenses and other current liabilities 118.2 103.2
Total current liabilities 175.2 157.7
Convertible debt, net 921.5 887.9
Other liabilities 18.9 21.4
Total liabilities 1,115.6 1,067.0
Commitments and contingencies (Note 9)
Stockholders’ Equity    
Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding 0.0 0.0
Common stock, $.001 par value, 100,000,000 authorized; 65,871,736 and 62,685,492 issued and outstanding 0.1 0.1
Additional paid-in capital 1,244.7 749.0
Accumulated deficit (649.2) (672.0)
Accumulated other comprehensive loss (0.6) (1.2)
Total stockholders’ equity 595.0 75.9
Total liabilities and stockholders’ equity $ 1,710.6 $ 1,142.9
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 3.6 $ 3.8
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, authorized (in shares) 5,000,000 5,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 65,871,736 62,685,492
Common stock, outstanding (in shares) 65,871,736 62,685,492
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 234.0 $ 192.1 $ 658.3 $ 528.8
Cost of revenue 82.2 69.0 237.1 182.6
Gross profit 151.8 123.1 421.2 346.2
Operating expenses:        
Research and development expenses 38.8 31.3 108.5 96.8
Selling, general and administrative expenses 89.2 74.8 253.9 217.5
Operating income 23.8 17.0 58.8 31.9
Interest expense, net (11.4) (7.7) (32.6) (18.3)
Loss on extinguishment of debt 0.0 (6.4) 0.0 (6.4)
Other income (expense), net 1.0 (1.8) 2.0 0.5
Income before income taxes 13.4 1.1 28.2 7.7
Income tax expense (1.8) (0.3) (4.3) (1.1)
Net income $ 11.6 $ 0.8 $ 23.9 $ 6.6
Net income per share:        
Basic (in dollars per share) $ 0.18 $ 0.01 $ 0.37 $ 0.11
Diluted (in dollars per share) $ 0.17 $ 0.01 $ 0.36 $ 0.11
Weighted-average number of common shares outstanding:        
Basic (in shares) 65,717,820 60,743,211 64,329,181 59,986,163
Diluted (in shares) 66,827,692 62,335,679 65,598,197 61,728,018
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statement of Comprehensive Income [Abstract]        
Net income $ 11.6 $ 0.8 $ 23.9 $ 6.6
Other comprehensive income (loss), net of tax:        
Currency translation adjustment 3.3 (1.8) 0.5 (3.0)
Unrealized (loss) gain on available-for-sale debt securities (0.3) 0.0 0.1 1.3
Total other comprehensive income (loss), net of tax 3.0 (1.8) 0.6 (1.7)
Comprehensive income (loss) $ 14.6 $ (1.0) $ 24.5 $ 4.9
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
0.375% Convertible Senior Notes
1.25% Convertible Senior Notes
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
0.375% Convertible Senior Notes
Additional Paid-in Capital
1.25% Convertible Senior Notes
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018         59,188,758              
Beginning balance at Dec. 31, 2018 $ 212.1       $ 0.1   $ 898.5     $ (683.6)   $ (2.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of options to purchase common stock (in shares)         1,188,043              
Exercise of options to purchase common stock 40.9           40.9          
Issuance of employee stock purchase plan (in shares)         27,613              
Issuance of shares for employee stock purchase plan 2.0           2.0          
Stock-based compensation 20.7           20.7          
Restricted stock units vested, net of shares withheld for taxes (in shares)         225,063              
Restricted stock units vested, net of shares withheld for taxes (8.2)           (8.2)          
Conversion feature, net of issuance costs     $ 207.8 $ (438.6)       $ 207.8 $ (438.6)      
Issuance of shares for debt repayment (in shares)         1,157,492              
Issuance of shares for debt repayment 194.4           194.4          
Purchase of capped call options (85.4)           (85.4)          
Net income 6.6                 6.6    
Other comprehensive income (loss) (1.7)                     (1.7)
Ending balance (in shares) at Sep. 30, 2019         61,786,969              
Ending balance at Sep. 30, 2019 150.6       $ 0.1   832.1     (677.0)   (4.6)
Beginning balance (in shares) at Dec. 31, 2018         59,188,758              
Beginning balance at Dec. 31, 2018 $ 212.1       $ 0.1   898.5     (683.6)   (2.9)
Ending balance (in shares) at Dec. 31, 2019 62,685,492       62,685,492 0            
Ending balance at Dec. 31, 2019 $ 75.9 $ (1.1)     $ 0.1   749.0     (672.0) $ (1.1) (1.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                      
Beginning balance (in shares) at Jun. 30, 2019         60,149,926              
Beginning balance at Jun. 30, 2019 $ 249.8       $ 0.1   930.3     (677.8)   (2.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of options to purchase common stock (in shares)         471,356              
Exercise of options to purchase common stock 17.3           17.3          
Stock-based compensation 6.6           6.6          
Restricted stock units vested, net of shares withheld for taxes (in shares)         8,195              
Restricted stock units vested, net of shares withheld for taxes (0.3)           (0.3)          
Conversion feature, net of issuance costs     $ 207.8 $ (438.6)       $ 207.8 $ (438.6)      
Issuance of shares for debt repayment (in shares)         1,157,492              
Issuance of shares for debt repayment 194.4           194.4          
Purchase of capped call options (85.4)           (85.4)          
Net income 0.8                 0.8    
Other comprehensive income (loss) (1.8)                     (1.8)
Ending balance (in shares) at Sep. 30, 2019         61,786,969              
Ending balance at Sep. 30, 2019 $ 150.6       $ 0.1   832.1     (677.0)   (4.6)
Beginning balance (in shares) at Dec. 31, 2019 62,685,492       62,685,492 0            
Beginning balance at Dec. 31, 2019 $ 75.9 $ (1.1)     $ 0.1   749.0     (672.0) $ (1.1) (1.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock (in shares)         2,369,668              
Issuance of common stock 477.5           477.5          
Exercise of options to purchase common stock (in shares)         568,830              
Exercise of options to purchase common stock 21.9           21.9          
Issuance of employee stock purchase plan (in shares)         18,685              
Issuance of shares for employee stock purchase plan 2.9           2.9          
Stock-based compensation 20.3           20.3          
Restricted stock units vested, net of shares withheld for taxes (in shares)         229,061              
Restricted stock units vested, net of shares withheld for taxes (26.9)           (26.9)          
Net income 23.9                 23.9    
Other comprehensive income (loss) $ 0.6                     0.6
Ending balance (in shares) at Sep. 30, 2020 65,871,736       65,871,736              
Ending balance at Sep. 30, 2020 $ 595.0       $ 0.1   1,244.7     (649.2)   (0.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                      
Beginning balance (in shares) at Jun. 30, 2020         65,604,347              
Beginning balance at Jun. 30, 2020 $ 563.3       $ 0.1   1,227.6     (660.8)   (3.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Exercise of options to purchase common stock (in shares)         264,456              
Exercise of options to purchase common stock 10.6           10.6          
Stock-based compensation 6.6           6.6          
Restricted stock units vested, net of shares withheld for taxes (in shares)         2,933              
Restricted stock units vested, net of shares withheld for taxes (0.1)           (0.1)          
Net income 11.6                 11.6    
Other comprehensive income (loss) $ 3.0                     3.0
Ending balance (in shares) at Sep. 30, 2020 65,871,736       65,871,736              
Ending balance at Sep. 30, 2020 $ 595.0       $ 0.1   $ 1,244.7     $ (649.2)   $ (0.6)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) (Parenthetical)
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
0.375% Convertible Senior Notes      
Debt, interest rate 0.375% 0.375% 0.375%
1.25% Convertible Senior Notes      
Debt, interest rate 1.25%   1.25%
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net income $ 23.9 $ 6.6
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 29.7 18.8
Non-cash interest 33.6 24.3
Stock-based compensation 20.3 20.7
Loss on extinguishment of debt 0.0 6.4
Provision for credit losses 3.1 2.6
Other 0.3 1.9
Changes in operating assets and liabilities:    
Accounts receivable (19.9) (6.8)
Inventories (22.9) (20.0)
Prepaid expenses and other assets (16.8) (4.0)
Accounts payable, accrued expenses and other current liabilities 36.1 (1.7)
Other liabilities (2.4) 2.7
Net cash provided by operating activities 85.0 51.5
Cash flows from investing activities    
Capital expenditures (88.5) (114.6)
Acquisition of intangible assets (8.3) (6.4)
Purchases of investments (37.9) (63.9)
Receipts from the maturity or sale of investments 200.0 165.3
Net cash provided by (used in) investing activities 65.3 (19.6)
Cash flows from financing activities    
Proceeds from issuance of common stock, net of issuance costs 477.5 0.0
Proceeds from issuance of convertible notes, net of issuance costs 0.0 780.2
Repayment of convertible debt 0.0 (453.6)
Purchase of capped call options 0.0 (85.4)
Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan 24.8 42.9
Payment of withholding taxes in connection with vesting of restricted stock units (26.9) (8.2)
Net cash provided by financing activities 475.4 275.9
Effect of exchange rate changes on cash (1.3) (1.8)
Net increase in cash, cash equivalents and restricted cash 624.4 306.0
Cash, cash equivalents and restricted cash at beginning of period 213.7 113.9
Cash, cash equivalents and restricted cash at end of period 838.1 419.9
Supplemental noncash information:    
Purchases of property and equipment included in accounts payable and accrued expenses 4.7 10.2
Lease liabilities arising from obtaining right-of-use assets $ 2.1 $ 5.1
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying financial statements reflect the consolidated operations of Insulet Corporation and its subsidiaries (“Insulet” or the “Company”). The unaudited consolidated financial statements have been prepared in United States dollars, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. In management’s opinion, the unaudited consolidated financial statements contain all normal recurring adjustments necessary for a fair statement of the interim results reported. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or for any other subsequent interim period.
The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited consolidated financial statements do not include all of the annual disclosures required by GAAP; accordingly, they should be read in conjunction with the Company’s audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Accounts Receivable and Allowance for Credit Losses
Trade accounts receivable consist of amounts due from third-party payors, customers and intermediaries and are presented at amortized cost. The allowance for credit losses reflects an estimate of losses inherent in the Company’s accounts receivable portfolio determined based on historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectable.
The allowance for credit losses is measured on a collective (pool) basis when similar risk characteristics exist. The Company has identified the following portfolio segments and measures the allowance for credit losses using the following methods:
Direct Customer Receivables—The Company measures expected credit losses on direct customer receivables using an aging methodology. The risk of loss for direct customer receivables is higher than other portfolios. The Company relies on third-party payors to accept and timely process claims and on direct consumers to have the ability to pay. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Distributor Receivables—The Company measures expected credit losses on distributor receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers payment history as well as credit ratings of the distributors, in addition to current conditions and supportable forecasts.
National Healthcare System Receivables—The Company measures expected credit losses on national healthcare system receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Shipping and Handling Costs
Shipping and handling costs are included in selling, general and administrative expenses and were $3.2 million and $2.2 million for the three months ended September 30, 2020 and 2019, respectively, and were $7.0 million and $7.1 million for the nine months ended September 30, 2020 and 2019, respectively.
Fair Value Measurements
Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. To measure fair value of assets and liabilities, the Company uses the following fair value hierarchy based on three levels of inputs:
Level 1—observable inputs, such as quoted prices in active markets for identical assets or liabilities;
Level 2—significant other observable inputs that are observable either directly or indirectly; and
Level 3—significant unobservable inputs for which there are little or no market data, which require the Company to develop its own assumptions.
Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity. See Notes 3 and 8 for financial assets and liabilities held at carrying amount on the consolidated balance sheet and Note 4 for investments measured at fair value on a recurring basis.
Advertising Costs
The Company expenses advertising costs as they are incurred. Advertising expenses were $10.0 million and $3.4 million for the three months ended September 30, 2020 and 2019, respectively and $15.6 million and $8.6 million for the nine months ended September 30, 2020 and 2019, respectively.
Reclassification of Prior Period Amounts
Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. A portion of facility costs and certain information technology costs have been allocated from selling, general and administrative to research and development expenses based on square foot and system usage, respectively. In addition, certain quality assurance costs were reclassified from research and development expenses to selling, general and administrative expenses. The net impact of these adjustments was a $0.6 million and $1.9 million increase to research and development expenses and a corresponding decrease to selling, general and administrative expenses for the three and nine months ended September 30, 2019, respectively. There was no change to previously reported operating or net income. Further, the Company reclassified the $0.9 million change in unbilled receivables from the change in accounts and unbilled receivables to the change in prepaid expenses and other assets in the prior year statement of cash flows. This reclassification had no effect on previously reported net cash provided by operating activities.
Recently Adopted Accounting Standards
Effective January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2016-13, Credit Losses (Topic 326) (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost, such as the Company’s trade receivables and contract assets, to be presented net of expected credit losses, which may be estimated based on relevant information such as historical experience, current conditions and future expectation for each pool of similar financial assets. The new guidance also requires enhanced disclosures related to trade receivables and associated credit losses. The Company adopted ASU 2016-13 using the modified retrospective method, whereby the guidance is applied prospectively as of the date of adoption and prior periods are not restated. The cumulative effect of adopting ASU 2016-13 resulted in a $1.1 million increase to the opening balance of accumulated deficit upon adoption related to an increase in the allowance for credit losses on accounts receivable.
The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.
(in millions)Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
Credit losses at the beginning of the period$4.6 $3.8 
Effect of adoption— 1.1 
Credit losses at the beginning of the period after adoption4.6 4.9 
Provision for expected credit losses0.5 3.1 
Write-offs charged against allowance(1.6)(4.7)
Recoveries of amounts previously written-off0.1 0.3 
Credit losses at the end of the period$3.6 $3.6 
Effective January 1, 2020, the Company adopted ASU 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 requires an entity to measure the impairment of goodwill assigned to a reporting unit as the amount by which the carrying value of the assets and liabilities of the reporting unit, including goodwill, exceeds the reporting units’ fair value. The adoption of this guidance had no impact on the consolidated financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs
 9 Months Ended
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]  
Revenue and Contract Acquisition Costs Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenues:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
U.S. Omnipod$132.3 $109.4 $377.7 $293.6 
International Omnipod79.8 67.8 226.1 187.4 
Total Omnipod212.1 177.2 603.8 481.0 
Drug Delivery21.9 14.9 54.5 47.8 
Total$234.0 $192.1 $658.3 $528.8 
During the three and nine months ended September 30, 2020, the Company had one customer that represented 11% and two customers that in aggregate represented 21% of total revenue, respectively. During both the three and nine months ended September 30, 2019, the Company had one customer that represented 11% of total revenue. At September 30, 2020, the company had one customer that accounted for 12% of consolidated net accounts receivable. No customer accounted for more than 10% of consolidated net accounts receivable balance at December 31, 2019.
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2020December 31, 2019
Accrued expenses and other current liabilities$4.3 $3.2 
Other liabilities0.9 1.0 
Total deferred revenue$5.2 $4.2 
During both the three months ended September 30, 2020 and 2019, the Company recognized insignificant revenue included in deferred revenue at the beginning of 2020 and 2019, respectively. During the nine months ended September 30, 2020 and 2019, the Company recognized $1.7 million and $1.1 million of revenue included in deferred revenue at the beginning of 2020 and 2019, respectively.
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2020December 31, 2019
Prepaid expenses and other current assets$10.4 $9.5 
Other assets20.7 19.9 
Total capitalized contract acquisition costs, net$31.1 $29.4 
The Company recognized $2.7 million and $2.3 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2020 and 2019, respectively. The Company recognized $7.8 million and $6.4 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2020 and 2019, respectively.
The Company had unbilled receivables of $15.2 million and $13.5 million at September 30, 2020 and December 31, 2019, respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Cash and Cash Equivalents
 9 Months Ended
Sep. 30, 2020
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents Cash and Cash Equivalents
The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:
September 30, 2020December 31, 2019
(in millions)TotalLevel 1Level 2TotalLevel 1
Level 2 (1)
Cash$298.4 $298.4 $— $85.3 $85.3 $— 
Money market mutual funds535.9 535.9 — 115.5 115.5 — 
Commercial paper— — — 10.0 — 10.0 
Restricted cash3.8 3.8 — 2.9 2.9 — 
Total cash and cash equivalents$838.1 $838.1 $— $213.7 $203.7 $10.0 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Investments
 9 Months Ended
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
The Company’s short-term and long-term investments in debt securities had maturity dates that range from one to two years at September 30, 2020. Realized gains or losses for both the three and nine months ended September 30, 2020 and 2019 were insignificant.
The following table provides amortized costs, gross unrealized gains and losses, fair values and the level in the fair value hierarchy for the Company’s investments at September 30, 2020 and December 31, 2019:
(in millions)Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueLevel 1
Level 2 (1)
September 30, 2020
U.S. government and agency bonds$52.7 $0.4 $— $53.1 $53.1 $— 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total short-term investments$58.2 $0.4 $— $58.6 $53.1 $5.5 
Certificates of deposit$0.5 $— $— $0.5 $— $0.5 
Total long-term investments$0.5 $— $— $0.5 $— $0.5 
December 31, 2019
U.S. government and agency bonds$94.7 $0.3 $— $95.0 $85.0 $10.0 
Corporate bonds51.0 0.1 — 51.1 — 51.1 
Certificates of deposit6.3 — — 6.3 — 6.3 
Commercial Paper10.0 — — 10.0 — 10.0 
Total short-term investments$162.0 $0.4 $— $162.4 $85.0 $77.4 
U.S. government and agency bonds$52.9 $0.1 $(0.1)$52.9 $42.9 $10.0 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total long-term investments$58.4 $0.1 $(0.1)$58.4 $42.9 $15.5 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Inventories Inventories
At the end of each period, inventories were comprised of the following:
(in millions)September 30, 2020December 31, 2019
Raw materials$27.3 $23.3 
Work-in-process57.2 40.3 
Finished goods40.4 37.4 
    Total inventories$124.9 $101.0 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets, Net Goodwill and Other Intangible Assets, Net
The change in the carrying amount of goodwill for the nine months ended September 30, 2020 was as follows:
(in millions)
Goodwill at December 31, 2019$39.8 
Foreign currency translation(0.1)
Goodwill at September 30, 2020$39.7 
The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:
September 30, 2020December 31, 2019
(in millions)
Gross Carrying AmountAccumulated AmortizationNet Book
Value		Gross Carrying AmountAccumulated AmortizationNet Book
Value
Customer relationships (1)
$9.8 $(3.4)$6.4 $9.9 $(2.8)$7.1 
Internal-use software11.3 (8.2)3.1 12.0 (6.8)5.2 
Intellectual property1.0 (0.1)0.9 1.0 (0.1)0.9 
Total$22.1 $(11.7)$10.4 $22.9 $(9.7)$13.2 
(1) Includes customer relationships acquired from the Company’s former European distributor. See Note 9.
Amortization expense for intangible assets was $0.7 million for both the three months ended September 30, 2020 and 2019. Amortization expense for intangible assets was $2.2 million and $1.9 million for the nine months ended September 30, 2020, and 2019, respectively. Amortization expense associated with intangible assets included on the Company’s consolidated balance sheet as of September 30, 2020 is expected to be as follows:
Years Ending December 31,
(in millions)
2020 (remaining)$0.7 
20212.2 
20221.7 
20231.2 
20241.1 
Thereafter3.5 
     Total$10.4 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses and Other Current Liabilities
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
The components of accrued expenses and other current liabilities were as follows:
(in millions)September 30, 2020December 31, 2019
Employee compensation and related costs$45.9 $45.8 
Accrued rebates9.8 7.5 
Supplier purchases5.4 2.4 
Value added taxes payable4.9 1.8 
Deferred revenue4.3 3.2 
Short-term lease liability4.6 3.6 
Warranty liability3.2 4.7 
Accrued interest2.3 1.7 
Other37.8 32.5 
Accrued expenses and other current liabilities$118.2 $103.2 
Product Warranty Costs
The Company provides a four-year warranty on Personal Diabetes Managers (“PDMs”) sold in the United States and Europe and a five-year warranty on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty at the time the product is shipped based on historical experience and the estimated cost to service the claims. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of operations. Cost to service the claims reflects the current product cost.
The following table is a summary of the activity related to the Company’s product warranty liability: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Product warranty liability at beginning of period$8.1 $6.6 $8.5 $6.4 
Warranty expense3.1 3.3 8.3 8.6 
Warranty claims settled(4.2)(3.1)(9.8)(8.2)
Product warranty liability at the end of period$7.0 $6.8 $7.0 $6.8 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Debt, Net
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Convertible Debt, Net Convertible Debt, Net
The components of outstanding convertible debt consisted of the following:
(in millions)
September 30, 2020December 31, 2019
1.375% Convertible Senior Notes, due November 2024
$402.5 $402.5 
0.375% Convertible Senior Notes, due September 2026
800.0 800.0 
Unamortized debt discount(263.4)(294.8)
Debt issuance costs(17.6)(19.8)
Total convertible debt, net$921.5 $887.9 
The carrying amount and the estimated fair value of the Company’s convertible debt, which is based on the Level 2 quoted market prices, were as follows:
September 30, 2020December 31, 2019
(in millions)
Carrying Value
Estimated Fair Value (1)
Carrying Value
Estimated Fair Value (1)
1.375% Convertible Senior Notes, due November 2024
$319.5 $512.8 $306.9 $512.8 
0.375% Convertible Senior Notes, due September 2026
602.0 1,022.8 581.0 840.0 
  Total$921.5 $1,535.6 $887.9 $1,352.8 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Proceedings
Between May 5, 2015 and June 16, 2015, three class action lawsuits were filed by shareholders in the U.S. District Court, for the District of Massachusetts, against the Company and certain then current and former executives of the Company. Two suits subsequently were voluntarily dismissed. Arkansas Teacher Retirement System v. Insulet, et al., 1:15-cv-12345, (“ATRS”) alleged that the Company (and certain then current and former executives) committed violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by making allegedly false and misleading statements about the Company’s business, operations and prospects. On February 8, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment was made into an escrow account for the plaintiffs and the class they purport to represent. On August 6, 2018, the Court issued an order approving the settlement, but took the plaintiffs’ motion for fees and expenses under advisement, which motion remains pending. The Company had previously accrued fees and expenses in connection with this matter for the amount of the final settlement liability that was not covered by insurance, the amount of which was not material to the Company’s consolidated financial statements.
In addition, on April 26, 2017, a derivative action (Walker v. DeSisto, et al., 1:17-cv-10738) (“Walker”) was filed, and on October 13, 2017, a second derivative action (Carnazza v. DeSisto, et al., 1:17-cv-11977) (“Carnazza”) was filed, both on behalf of the Company, each by a shareholder in the U.S. District Court for the District of Massachusetts against the Company (as a nominal defendant) and certain individual then current and former officers and directors of the Company. The allegations in the actions are substantially similar to those alleged in the securities class action. The actions seek, among other things, damages, disgorgement of certain types of compensation or profits, and attorneys’ fees and costs. On July 11, 2018, the parties executed a binding stipulation of settlement, under which all claims were released, and a payment of attorneys’ fees and reimbursement of expenses will be paid to plaintiffs’ counsel, subject to the Court’s approval. On July 13, 2018, the plaintiffs filed a motion for preliminary approval of the settlement, which is pending. The Company expects that such fees and expenses payable to plaintiff’s counsel will be covered by the Company’s insurance.
In June 2020, Roche Diabetes Care, Inc. (“Roche”) filed a patent infringement lawsuit against the Company in the United States District Court for the District of Delaware alleging that the Company’s manufacture and sale of its Omnipod Insulin Management System, Omnipod Starter Kit and Omnipod 10 Pod Pack in the United States infringed Roche’s now-expired U.S. Patent 7,931,613. Roche is seeking monetary damages in the form of a reasonable royalty and attorneys’ fees and costs. Since the patent expired in 2019, Roche is not seeking injunctive relief and the lawsuit will have no impact on ongoing sales of the Company’s products. The Company believes that it has meritorious defenses to Roche’s claims and intends to vigorously defend against them. The court has set a trial date of July 25, 2022. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses, which could be material.
In July 2020, the Company filed a patent infringement claim against Roche Diabetes Care Limited (“Roche Ltd.”) in the United Kingdom alleging that Roche Ltd.’s manufacture and sale of the Accu-Chek® Solo insulin pump and its consumable components infringes European Patent No. 1 335 764 in the United Kingdom. The Company is seeking an injunction to last until expiry of the patent and monetary damages. Roche Ltd. has responded to the complaint and argues that the patent is invalid and not infringed.
The Company is, from time to time, involved in the normal course of business in various legal proceedings, including intellectual property, contract, employment and product liability suits. Other than as described above, the Company does not expect the outcome of these proceedings, either individually or in the aggregate, to have a material adverse effect on its results of operations.
Fees to Former European Distributor
Following the expiration of an agreement with a former European distributor on June 30, 2018, the Company was required to pay a quarterly per-unit fee for Omnipod sales to certain customers of the former European distributor for a one-year period through June 30, 2019. The Company recognized a liability and an associated intangible asset for this fee as qualifying sales occurred. The methodology applicable for determining the total fee under the distribution agreement is subject to an active arbitration proceeding in Switzerland. The final amount of the fee could vary significantly depending on the number of customers who count for purposes of calculating the fee under the terms of the agreement. The Company estimates that the final aggregate fee is in the range of $5 million to $55 million. As of both September 30, 2020 and December 31, 2019, the Company had $2.7 million accrued related to this matter. The associated gross intangible asset was $7.8 million at both September 30, 2020 and December 31, 2019.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Loss
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
Changes in the components of accumulated other comprehensive loss, net of tax, were as follows:
Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(4.4)$0.8 $(3.6)$(1.6)$0.4 $(1.2)
Other comprehensive income (loss)3.3 (0.3)3.0 0.5 0.1 0.6 
Balance at the end of period$(1.1)$0.5 $(0.6)$(1.1)$0.5 $(0.6)

Three Months Ended September 30, 2019Nine Months Ended September 30, 2019
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized (Loss) Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(3.4)$0.6 $(2.8)$(2.2)$(0.7)$(2.9)
Other comprehensive (loss) income(1.8)— (1.8)(3.0)1.3 (1.7)
Balance at the end of period$(5.2)$0.6 $(4.6)$(5.2)$0.6 $(4.6)
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Interest Expense
 9 Months Ended
Sep. 30, 2020
Other Income and Expenses [Abstract]  
Interest Expense Interest Expense
Interest expense, net was as follows: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Contractual coupon interest$2.1 $2.6 $6.4 $7.5 
Accretion of debt discount10.6 8.2 31.5 22.2 
Amortization of debt issuance costs0.7 0.7 2.1 2.1 
Capitalized interest(1.5)(2.1)(4.7)(8.1)
     Interest expense, net of portion capitalized11.9 9.4 35.3 23.7 
Interest income(0.5)(1.7)(2.7)(5.4)
Interest expense, net$11.4 $7.7 $32.6 $18.3 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Compensation expense related to stock-based awards was recorded as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Cost of revenue$0.1 $0.3 $0.3 $0.9 
Research and development expenses2.3 2.2 7.3 6.4 
Selling, general and administrative expenses4.2 4.1 12.7 13.4 
Total$6.6 $6.6 $20.3 $20.7 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
 9 Months Ended
Sep. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income TaxesThe Company’s effective tax rate for the three and nine months ended September 30, 2020 was 13.3% and 15.3%, compared with 24.7% and 14.1% for the three and nine months ended September 30, 2019. Income tax benefits have not been recorded for losses in jurisdictions where valuation allowances exist against net deferred tax assets, primarily in the United States. As of September 30, 2020 and December 31, 2019, the Company maintained a full valuation allowance against its U.S. net deferred tax assets based on the determination that it is not more likely than not that these future benefits will be realized. The Company had no uncertain tax positions at both September 30, 2020 and December 31, 2019. In April 2020, new interpretations of a German tax law related to intellectual property and withholding tax were released. Based on t
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Share
 9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted net income per share is computed using the weighted average number of common shares outstanding and, when dilutive, common share equivalents from outstanding stock options and restricted stock units (using the treasury-stock method), and potential common shares from the Company’s convertible notes (using the if-converted method). The weighted-average number of common shares used in the computation of basic and diluted net income per share were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Weighted average number of common shares outstanding, basic65,717,820 60,743,211 64,329,181 59,986,163 
Stock options978,657 1,370,792 1,082,247 1,514,245 
Restricted stock units131,215 221,676 186,769 227,610 
Weighted average number of common shares outstanding, diluted66,827,692 62,335,679 65,598,197 61,728,018 
The number of common share equivalents excluded from the computation of diluted net income per share because either the effect would have been anti-dilutive, or the performance criteria related to the units had not yet been met, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
1.25% Convertible Senior Notes
— 2,055,786 — 2,055,786 
1.375% Convertible Senior Notes
4,319,429 4,319,429 4,319,429 4,319,429 
0.375% Convertible Senior Notes
3,528,400 3,528,400 3,528,400 3,528,400 
Unvested restricted stock units272,992 455,876 272,877 455,824 
Stock options65,331 7,858 56,522 136,342 
Total8,186,152 10,367,349 8,177,228 10,495,781 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
 9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
In October 2020, the Company entered into a $70 million loan secured by a mortgage of its facility located in Acton, Massachusetts. The loan has a five-year term and an interest rate of approximately 5.2%. The monthly payment is based on a 20-year amortization period with the final payment of the outstanding principal due in 2025.
In the fourth quarter of 2020, the Company entered into two equipment financing transactions secured by machinery and equipment associated with two of its highly automated manufacturing lines located in Acton, Massachusetts. The first transaction was in the amount of approximately $37 million with a term of 60 months and an interest rate of approximately 4.5%. The second transaction was in the amount of $23 million with a term of 42 months and an interest rate of approximately 5.4%.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying financial statements reflect the consolidated operations of Insulet Corporation and its subsidiaries (“Insulet” or the “Company”). The unaudited consolidated financial statements have been prepared in United States dollars, in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results may differ from those estimates. In management’s opinion, the unaudited consolidated financial statements contain all normal recurring adjustments necessary for a fair statement of the interim results reported. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020, or for any other subsequent interim period.
The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited consolidated financial statements do not include all of the annual disclosures required by GAAP; accordingly, they should be read in conjunction with the Company’s audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Accounts Receivable and Allowance for Credit Losses
Accounts Receivable and Allowance for Credit Losses
Trade accounts receivable consist of amounts due from third-party payors, customers and intermediaries and are presented at amortized cost. The allowance for credit losses reflects an estimate of losses inherent in the Company’s accounts receivable portfolio determined based on historical experience, specific allowances for known troubled accounts and other available evidence. Accounts receivable are written off when management determines they are uncollectable.
The allowance for credit losses is measured on a collective (pool) basis when similar risk characteristics exist. The Company has identified the following portfolio segments and measures the allowance for credit losses using the following methods:
Direct Customer Receivables—The Company measures expected credit losses on direct customer receivables using an aging methodology. The risk of loss for direct customer receivables is higher than other portfolios. The Company relies on third-party payors to accept and timely process claims and on direct consumers to have the ability to pay. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Distributor Receivables—The Company measures expected credit losses on distributor receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers payment history as well as credit ratings of the distributors, in addition to current conditions and supportable forecasts.
National Healthcare System Receivables—The Company measures expected credit losses on national healthcare system receivables using an individual reserve methodology. The risk of loss in this portfolio is low based on the Company’s historical experience. The estimate of expected credit losses considers historical credit loss information that is adjusted for current conditions and supportable forecasts.
Shipping and Handling costs
Shipping and Handling Costs
Shipping and handling costs are included in selling, general and administrative expenses and were $3.2 million and $2.2 million for the three months ended September 30, 2020 and 2019, respectively, and were $7.0 million and $7.1 million for the nine months ended September 30, 2020 and 2019, respectively.
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. To measure fair value of assets and liabilities, the Company uses the following fair value hierarchy based on three levels of inputs:
Level 1—observable inputs, such as quoted prices in active markets for identical assets or liabilities;
Level 2—significant other observable inputs that are observable either directly or indirectly; and
Level 3—significant unobservable inputs for which there are little or no market data, which require the Company to develop its own assumptions.
Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity.
Advertising Costs Advertising CostsThe Company expenses advertising costs as they are incurred.
Reclassification of Prior Period Amounts Reclassification of Prior Period AmountsCertain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. A portion of facility costs and certain information technology costs have been allocated from selling, general and administrative to research and development expenses based on square foot and system usage, respectively. In addition, certain quality assurance costs were reclassified from research and development expenses to selling, general and administrative expenses.
Recently Adopted Accounting Standards
Recently Adopted Accounting Standards
Effective January 1, 2020, the Company adopted Accounting Standards Update (“ASU”) 2016-13, Credit Losses (Topic 326) (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost, such as the Company’s trade receivables and contract assets, to be presented net of expected credit losses, which may be estimated based on relevant information such as historical experience, current conditions and future expectation for each pool of similar financial assets. The new guidance also requires enhanced disclosures related to trade receivables and associated credit losses. The Company adopted ASU 2016-13 using the modified retrospective method, whereby the guidance is applied prospectively as of the date of adoption and prior periods are not restated. The cumulative effect of adopting ASU 2016-13 resulted in a $1.1 million increase to the opening balance of accumulated deficit upon adoption related to an increase in the allowance for credit losses on accounts receivable.
The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.
(in millions)Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
Credit losses at the beginning of the period$4.6 $3.8 
Effect of adoption— 1.1 
Credit losses at the beginning of the period after adoption4.6 4.9 
Provision for expected credit losses0.5 3.1 
Write-offs charged against allowance(1.6)(4.7)
Recoveries of amounts previously written-off0.1 0.3 
Credit losses at the end of the period$3.6 $3.6 
Effective January 1, 2020, the Company adopted ASU 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). ASU 2017-04 requires an entity to measure the impairment of goodwill assigned to a reporting unit as the amount by which the carrying value of the assets and liabilities of the reporting unit, including goodwill, exceeds the reporting units’ fair value. The adoption of this guidance had no impact on the consolidated financial statements.
Product Warranty Costs Product Warranty CostsThe Company provides a four-year warranty on Personal Diabetes Managers (“PDMs”) sold in the United States and Europe and a five-year warranty on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty at the time the product is shipped based on historical experience and the estimated cost to service the claims. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of operations. Cost to service the claims reflects the current product cost.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Allowance for Credit Loss
The following table presents the activity in the allowance for credit losses for the three and nine months ended September 30, 2020, comprised primarily of our direct consumer receivable portfolio. The allowance for credit losses of other portfolios is insignificant.
(in millions)Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
Credit losses at the beginning of the period$4.6 $3.8 
Effect of adoption— 1.1 
Credit losses at the beginning of the period after adoption4.6 4.9 
Provision for expected credit losses0.5 3.1 
Write-offs charged against allowance(1.6)(4.7)
Recoveries of amounts previously written-off0.1 0.3 
Credit losses at the end of the period$3.6 $3.6 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs (Tables)
 9 Months Ended
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]  
Summary of Revenue from Contracts with Customers
The following table summarizes the Company’s disaggregated revenues:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
U.S. Omnipod$132.3 $109.4 $377.7 $293.6 
International Omnipod79.8 67.8 226.1 187.4 
Total Omnipod212.1 177.2 603.8 481.0 
Drug Delivery21.9 14.9 54.5 47.8 
Total$234.0 $192.1 $658.3 $528.8 
Summary of Deferred Revenue
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2020December 31, 2019
Accrued expenses and other current liabilities$4.3 $3.2 
Other liabilities0.9 1.0 
Total deferred revenue$5.2 $4.2 
Summary of Contract Acquisition Costs
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2020December 31, 2019
Prepaid expenses and other current assets$10.4 $9.5 
Other assets20.7 19.9 
Total capitalized contract acquisition costs, net$31.1 $29.4 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Cash and Cash Equivalents (Tables)
 9 Months Ended
Sep. 30, 2020
Cash and Cash Equivalents [Abstract]  
Summary of Cash and Cash Equivalents
The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:
September 30, 2020December 31, 2019
(in millions)TotalLevel 1Level 2TotalLevel 1
Level 2 (1)
Cash$298.4 $298.4 $— $85.3 $85.3 $— 
Money market mutual funds535.9 535.9 — 115.5 115.5 — 
Commercial paper— — — 10.0 — 10.0 
Restricted cash3.8 3.8 — 2.9 2.9 — 
Total cash and cash equivalents$838.1 $838.1 $— $213.7 $203.7 $10.0 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
Summary of Restricted Cash and Cash Equivalents
The following table provides a summary of cash and cash equivalents and the level in the fair value hierarchy in which those measurements fall:
September 30, 2020December 31, 2019
(in millions)TotalLevel 1Level 2TotalLevel 1
Level 2 (1)
Cash$298.4 $298.4 $— $85.3 $85.3 $— 
Money market mutual funds535.9 535.9 — 115.5 115.5 — 
Commercial paper— — — 10.0 — 10.0 
Restricted cash3.8 3.8 — 2.9 2.9 — 
Total cash and cash equivalents$838.1 $838.1 $— $213.7 $203.7 $10.0 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Investments (Tables)
 9 Months Ended
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments
The following table provides amortized costs, gross unrealized gains and losses, fair values and the level in the fair value hierarchy for the Company’s investments at September 30, 2020 and December 31, 2019:
(in millions)Amortized CostGross Unrealized GainsGross Unrealized LossesFair ValueLevel 1
Level 2 (1)
September 30, 2020
U.S. government and agency bonds$52.7 $0.4 $— $53.1 $53.1 $— 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total short-term investments$58.2 $0.4 $— $58.6 $53.1 $5.5 
Certificates of deposit$0.5 $— $— $0.5 $— $0.5 
Total long-term investments$0.5 $— $— $0.5 $— $0.5 
December 31, 2019
U.S. government and agency bonds$94.7 $0.3 $— $95.0 $85.0 $10.0 
Corporate bonds51.0 0.1 — 51.1 — 51.1 
Certificates of deposit6.3 — — 6.3 — 6.3 
Commercial Paper10.0 — — 10.0 — 10.0 
Total short-term investments$162.0 $0.4 $— $162.4 $85.0 $77.4 
U.S. government and agency bonds$52.9 $0.1 $(0.1)$52.9 $42.9 $10.0 
Corporate bonds2.8 — — 2.8 — 2.8 
Certificates of deposit2.7 — — 2.7 — 2.7 
Total long-term investments$58.4 $0.1 $(0.1)$58.4 $42.9 $15.5 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories (Tables)
 9 Months Ended
Sep. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Components of Inventories
At the end of each period, inventories were comprised of the following:
(in millions)September 30, 2020December 31, 2019
Raw materials$27.3 $23.3 
Work-in-process57.2 40.3 
Finished goods40.4 37.4 
    Total inventories$124.9 $101.0 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net (Tables)
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Changes in Carrying Amounts of Goodwill
The change in the carrying amount of goodwill for the nine months ended September 30, 2020 was as follows:
(in millions)
Goodwill at December 31, 2019$39.8 
Foreign currency translation(0.1)
Goodwill at September 30, 2020$39.7 
Schedule of Components of Other Intangible Assets
The gross carrying amount, accumulated amortization and net book value of intangible assets at the end of each period were as follows:
September 30, 2020December 31, 2019
(in millions)
Gross Carrying AmountAccumulated AmortizationNet Book
Value		Gross Carrying AmountAccumulated AmortizationNet Book
Value
Customer relationships (1)
$9.8 $(3.4)$6.4 $9.9 $(2.8)$7.1 
Internal-use software11.3 (8.2)3.1 12.0 (6.8)5.2 
Intellectual property1.0 (0.1)0.9 1.0 (0.1)0.9 
Total$22.1 $(11.7)$10.4 $22.9 $(9.7)$13.2 
(1) Includes customer relationships acquired from the Company’s former European distributor. See Note 9.
Schedule of Amortization Expense Expected for Next Five Years Amortization expense associated with intangible assets included on the Company’s consolidated balance sheet as of September 30, 2020 is expected to be as follows:
Years Ending December 31,
(in millions)
2020 (remaining)$0.7 
20212.2 
20221.7 
20231.2 
20241.1 
Thereafter3.5 
     Total$10.4 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses and Other Current Liabilities (Tables)
 9 Months Ended
Sep. 30, 2020
Payables and Accruals [Abstract]  
Schedule of Components of Accrued Expenses and Other Current Liabilities
The components of accrued expenses and other current liabilities were as follows:
(in millions)September 30, 2020December 31, 2019
Employee compensation and related costs$45.9 $45.8 
Accrued rebates9.8 7.5 
Supplier purchases5.4 2.4 
Value added taxes payable4.9 1.8 
Deferred revenue4.3 3.2 
Short-term lease liability4.6 3.6 
Warranty liability3.2 4.7 
Accrued interest2.3 1.7 
Other37.8 32.5 
Accrued expenses and other current liabilities$118.2 $103.2 
Schedule of Reconciliation of Changes in Product Warranty Liability
The following table is a summary of the activity related to the Company’s product warranty liability: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Product warranty liability at beginning of period$8.1 $6.6 $8.5 $6.4 
Warranty expense3.1 3.3 8.3 8.6 
Warranty claims settled(4.2)(3.1)(9.8)(8.2)
Product warranty liability at the end of period$7.0 $6.8 $7.0 $6.8 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Debt, Net (Tables)
 9 Months Ended
Sep. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Outstanding Convertible Debt and Related Debt Issuance Costs
The components of outstanding convertible debt consisted of the following:
(in millions)
September 30, 2020December 31, 2019
1.375% Convertible Senior Notes, due November 2024
$402.5 $402.5 
0.375% Convertible Senior Notes, due September 2026
800.0 800.0 
Unamortized debt discount(263.4)(294.8)
Debt issuance costs(17.6)(19.8)
Total convertible debt, net$921.5 $887.9 
Summary of Carrying Amount and Estimated Fair Value of Convertible Debt
The carrying amount and the estimated fair value of the Company’s convertible debt, which is based on the Level 2 quoted market prices, were as follows:
September 30, 2020December 31, 2019
(in millions)
Carrying Value
Estimated Fair Value (1)
Carrying Value
Estimated Fair Value (1)
1.375% Convertible Senior Notes, due November 2024
$319.5 $512.8 $306.9 $512.8 
0.375% Convertible Senior Notes, due September 2026
602.0 1,022.8 581.0 840.0 
  Total$921.5 $1,535.6 $887.9 $1,352.8 
(1) Fair value was determined using market prices obtained from third-party pricing sources.
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Loss (Tables)
 9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income
Changes in the components of accumulated other comprehensive loss, net of tax, were as follows:
Three Months Ended September 30, 2020Nine Months Ended September 30, 2020
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(4.4)$0.8 $(3.6)$(1.6)$0.4 $(1.2)
Other comprehensive income (loss)3.3 (0.3)3.0 0.5 0.1 0.6 
Balance at the end of period$(1.1)$0.5 $(0.6)$(1.1)$0.5 $(0.6)

Three Months Ended September 30, 2019Nine Months Ended September 30, 2019
(in millions)Foreign Currency Translation AdjustmentUnrealized Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive LossForeign Currency Translation AdjustmentUnrealized (Loss) Gain on Available-for-sale SecuritiesAccumulated Other Comprehensive Loss
Balance at beginning of period$(3.4)$0.6 $(2.8)$(2.2)$(0.7)$(2.9)
Other comprehensive (loss) income(1.8)— (1.8)(3.0)1.3 (1.7)
Balance at the end of period$(5.2)$0.6 $(4.6)$(5.2)$0.6 $(4.6)
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Interest Expense (Tables)
 9 Months Ended
Sep. 30, 2020
Other Income and Expenses [Abstract]  
Summary of Interest and Other Expense
Interest expense, net was as follows: 
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Contractual coupon interest$2.1 $2.6 $6.4 $7.5 
Accretion of debt discount10.6 8.2 31.5 22.2 
Amortization of debt issuance costs0.7 0.7 2.1 2.1 
Capitalized interest(1.5)(2.1)(4.7)(8.1)
     Interest expense, net of portion capitalized11.9 9.4 35.3 23.7 
Interest income(0.5)(1.7)(2.7)(5.4)
Interest expense, net$11.4 $7.7 $32.6 $18.3 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense
Compensation expense related to stock-based awards was recorded as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Cost of revenue$0.1 $0.3 $0.3 $0.9 
Research and development expenses2.3 2.2 7.3 6.4 
Selling, general and administrative expenses4.2 4.1 12.7 13.4 
Total$6.6 $6.6 $20.3 $20.7 
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Share (Tables)
 9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income (Loss) per Share The weighted-average number of common shares used in the computation of basic and diluted net income per share were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2020201920202019
Weighted average number of common shares outstanding, basic65,717,820 60,743,211 64,329,181 59,986,163 
Stock options978,657 1,370,792 1,082,247 1,514,245 
Restricted stock units131,215 221,676 186,769 227,610 
Weighted average number of common shares outstanding, diluted66,827,692 62,335,679 65,598,197 61,728,018 
Schedule of Potential Common Share Equivalents Excluded from Computation of Diluted Net Income (Loss) per Share
The number of common share equivalents excluded from the computation of diluted net income per share because either the effect would have been anti-dilutive, or the performance criteria related to the units had not yet been met, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
 2020201920202019
1.25% Convertible Senior Notes
— 2,055,786 — 2,055,786 
1.375% Convertible Senior Notes
4,319,429 4,319,429 4,319,429 4,319,429 
0.375% Convertible Senior Notes
3,528,400 3,528,400 3,528,400 3,528,400 
Unvested restricted stock units272,992 455,876 272,877 455,824 
Stock options65,331 7,858 56,522 136,342 
Total8,186,152 10,367,349 8,177,228 10,495,781 
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2018
Reclassification [Line Items]                
Cost of revenue $ 82.2 $ 69.0 $ 237.1 $ 182.6        
Advertising expense 10.0 3.4 $ 15.6 8.6        
Accounts, Notes, Loans and Financing Receivable [Line Items]                
Accounting Standards Update [Extensible List]     us-gaap:AccountingStandardsUpdate201613Member   us-gaap:AccountingStandardsUpdate201613Member      
Increase of accumulated deficit (595.0) (150.6) $ (595.0) (150.6) $ (75.9) $ (563.3) $ (249.8) $ (212.1)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]                
Beginning balance 4.6   3.8          
Provision for expected credit losses 0.5   3.1 2.6        
Write-offs charged against allowance (1.6)   (4.7)          
Recoveries of amounts previously written-off 0.1   0.3          
Ending balance 3.6   3.6   3.8      
Accounts and unbilled receivables                
Reclassification [Line Items]                
Reclassification of prior period amounts       0.9        
Prepaid expenses and other assets                
Reclassification [Line Items]                
Reclassification of prior period amounts       0.9        
Selling, general and administrative expenses                
Reclassification [Line Items]                
Reclassification of prior period amounts   0.6   1.9        
Research and development expenses                
Reclassification [Line Items]                
Reclassification of prior period amounts   0.6   1.9        
Cumulative Effect, Period of Adoption, Adjusted Balance                
Accounts Receivable, Allowance for Credit Loss [Roll Forward]                
Beginning balance 4.6   4.9          
Ending balance         4.9      
Cumulative Effect, Period of Adoption, Adjustment                
Accounts, Notes, Loans and Financing Receivable [Line Items]                
Increase of accumulated deficit         1.1      
Accounts Receivable, Allowance for Credit Loss [Roll Forward]                
Beginning balance 0.0   1.1          
Ending balance         1.1      
Shipping and Handling                
Reclassification [Line Items]                
Cost of revenue 3.2 2.2 7.0 7.1        
Accumulated Deficit                
Accounts, Notes, Loans and Financing Receivable [Line Items]                
Increase of accumulated deficit $ 649.2 $ 677.0 $ 649.2 $ 677.0 672.0 $ 660.8 $ 677.8 $ 683.6
Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment                
Accounts, Notes, Loans and Financing Receivable [Line Items]                
Increase of accumulated deficit         $ 1.1      
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Disaggregation of Revenue [Line Items]        
Revenue $ 234.0 $ 192.1 $ 658.3 $ 528.8
U.S. Omnipod        
Disaggregation of Revenue [Line Items]        
Revenue 132.3 109.4 377.7 293.6
International Omnipod        
Disaggregation of Revenue [Line Items]        
Revenue 79.8 67.8 226.1 187.4
Total Omnipod        
Disaggregation of Revenue [Line Items]        
Revenue 212.1 177.2 603.8 481.0
Drug Delivery        
Disaggregation of Revenue [Line Items]        
Revenue $ 21.9 $ 14.9 $ 54.5 $ 47.8
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Accrued expenses and other current liabilities $ 4.3 $ 3.2
Other liabilities 0.9 1.0
Total deferred revenue $ 5.2 $ 4.2
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Disaggregation of Revenue [Line Items]          
Revenue recognized     $ 1.7 $ 1.1  
Amortization of capitalized commission costs $ 2.7 $ 2.3 7.8 $ 6.4  
Unbilled receivable $ 15.2   $ 15.2   $ 13.5
Sales Revenue | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage 11.00% 11.00% 21.00% 11.00%  
Accounts Receivable | Customer Concentration Risk          
Disaggregation of Revenue [Line Items]          
Concentration risk, percentage     12.00%    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Prepaid expenses and other current assets $ 10.4 $ 9.5
Other assets 20.7 19.9
Total capitalized contract acquisition costs, net $ 31.1 $ 29.4
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Cash and Cash Equivalents (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents $ 838.1 $ 213.7
Cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 298.4 85.3
Money market mutual funds    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 535.9 115.5
Commercial paper    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 10.0
Restricted cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 3.8 2.9
Level 1    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 838.1 203.7
Level 1 | Cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 298.4 85.3
Level 1 | Money market mutual funds    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 535.9 115.5
Level 1 | Commercial paper    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 0.0
Level 1 | Restricted cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 3.8 2.9
Level 2    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 10.0
Level 2 | Cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 0.0
Level 2 | Money market mutual funds    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 0.0
Level 2 | Commercial paper    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents 0.0 10.0
Level 2 | Restricted cash    
Cash and Cash Equivalents [Line Items]    
Total cash and cash equivalents $ 0.0 $ 0.0
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Investments - Narrative (Details)
 9 Months Ended
Sep. 30, 2020
Minimum  
Debt Securities, Available-for-sale [Line Items]  
Derivative maturity date range 1 year
Maximum  
Debt Securities, Available-for-sale [Line Items]  
Derivative maturity date range 2 years
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost $ 58.2 $ 162.0
Gross Unrealized Gains 0.4 0.4
Gross Unrealized Losses 0.0 0.0
Fair Value 58.6 162.4
Short-term investments | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 53.1 85.0
Short-term investments | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 5.5 77.4
Short-term investments | U.S. government and agency bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost 52.7 94.7
Gross Unrealized Gains 0.4 0.3
Gross Unrealized Losses 0.0 0.0
Fair Value 53.1 95.0
Short-term investments | U.S. government and agency bonds | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 53.1 85.0
Short-term investments | U.S. government and agency bonds | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.0 10.0
Short-term investments | Corporate bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost 2.8 51.0
Gross Unrealized Gains 0.0 0.1
Gross Unrealized Losses 0.0 0.0
Fair Value 2.8 51.1
Short-term investments | Corporate bonds | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.0 0.0
Short-term investments | Corporate bonds | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 2.8 51.1
Short-term investments | Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost 2.7 6.3
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 2.7 6.3
Short-term investments | Certificates of deposit | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.0 0.0
Short-term investments | Certificates of deposit | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 2.7 6.3
Short-term investments | Commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost   10.0
Gross Unrealized Gains   0.0
Gross Unrealized Losses   0.0
Fair Value   10.0
Short-term investments | Commercial paper | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   0.0
Short-term investments | Commercial paper | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   10.0
Long-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost 0.5 58.4
Gross Unrealized Gains 0.0 0.1
Gross Unrealized Losses 0.0 (0.1)
Fair Value 0.5 58.4
Long-term investments | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.0 42.9
Long-term investments | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.5 15.5
Long-term investments | U.S. government and agency bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost   52.9
Gross Unrealized Gains   0.1
Gross Unrealized Losses   (0.1)
Fair Value   52.9
Long-term investments | U.S. government and agency bonds | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   42.9
Long-term investments | U.S. government and agency bonds | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   10.0
Long-term investments | Corporate bonds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost   2.8
Gross Unrealized Gains   0.0
Gross Unrealized Losses   0.0
Fair Value   2.8
Long-term investments | Corporate bonds | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   0.0
Long-term investments | Corporate bonds | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value   2.8
Long-term investments | Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Amortized Cost 0.5 2.7
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 0.5 2.7
Long-term investments | Certificates of deposit | Level 1 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 0.0 0.0
Long-term investments | Certificates of deposit | Level 2 | Recurring fair value measurements    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value $ 0.5 $ 2.7
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories - Components of Inventories (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Raw materials $ 27.3 $ 23.3
Work-in-process 57.2 40.3
Finished goods 40.4 37.4
Total inventories $ 124.9 $ 101.0
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2020
USD ($)
Goodwill [Roll Forward]  
Goodwill at December 31, 2019 $ 39.8
Foreign currency translation (0.1)
Goodwill at September 30, 2020 $ 39.7
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 22.1 $ 22.9
Accumulated Amortization (11.7) (9.7)
Net Book Value 10.4 13.2
Customer relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 9.8 9.9
Accumulated Amortization (3.4) (2.8)
Net Book Value 6.4 7.1
Internal-use software    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 11.3 12.0
Accumulated Amortization (8.2) (6.8)
Net Book Value 3.1 5.2
Intellectual property    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1.0 1.0
Accumulated Amortization (0.1) (0.1)
Net Book Value $ 0.9 $ 0.9
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization of other intangible assets $ 0.7 $ 0.7 $ 2.2 $ 1.9
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]    
2020 (remaining) $ 0.7  
2021 2.2  
2022 1.7  
2023 1.2  
2024 1.1  
Thereafter 3.5  
Net Book Value $ 10.4 $ 13.2
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Payables and Accruals [Abstract]    
Employee compensation and related costs $ 45.9 $ 45.8
Accrued rebates 9.8 7.5
Supplier purchases 5.4 2.4
Value added taxes payable 4.9 1.8
Deferred revenue 4.3 3.2
Short-term lease liability 4.6 3.6
Warranty liability 3.2 4.7
Accrued interest 2.3 1.7
Other 37.8 32.5
Accrued expenses and other current liabilities $ 118.2 $ 103.2
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses and Other Current Liabilities - Narrative (Details)
 9 Months Ended
Sep. 30, 2020
United States  
Product Warranty Liability [Line Items]  
Product warranty term for PDMs 4 years
CANADA  
Product Warranty Liability [Line Items]  
Product warranty term for PDMs 5 years
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]        
Product warranty liability at beginning of period $ 8.1 $ 6.6 $ 8.5 $ 6.4
Warranty expense 3.1 3.3 8.3 8.6
Warranty claims settled (4.2) (3.1) (9.8) (8.2)
Product warranty liability at the end of period $ 7.0 $ 6.8 $ 7.0 $ 6.8
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
Debt Instrument [Line Items]      
Unamortized debt discount $ (263.4) $ (294.8)  
Debt issuance costs (17.6) (19.8)  
Total convertible debt, net $ 921.5 $ 887.9  
1.375% Convertible Senior Notes      
Debt Instrument [Line Items]      
Debt, interest rate 1.375% 1.375% 1.375%
0.375% Convertible Senior Notes      
Debt Instrument [Line Items]      
Debt, interest rate 0.375% 0.375% 0.375%
Convertible Debt | 1.375% Convertible Senior Notes      
Debt Instrument [Line Items]      
Principal amount of Senior Notes $ 402.5 $ 402.5  
Convertible Debt | 0.375% Convertible Senior Notes      
Debt Instrument [Line Items]      
Principal amount of Senior Notes $ 800.0 $ 800.0  
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Sep. 30, 2019
1.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt, interest rate 1.375% 1.375% 1.375%
0.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Debt, interest rate 0.375% 0.375% 0.375%
Level 2 | Carrying Value      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value $ 921.5 $ 887.9  
Level 2 | Carrying Value | 1.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value 319.5 306.9  
Level 2 | Carrying Value | 0.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value 602.0 581.0  
Level 2 | Estimated Fair Value      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value 1,535.6 1,352.8  
Level 2 | Estimated Fair Value | 1.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value 512.8 512.8  
Level 2 | Estimated Fair Value | 0.375% Convertible Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Financial instrument value $ 1,022.8 $ 840.0  
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Narrative (Details)
 1 Months Ended
Jun. 16, 2015
lawsuit
Sep. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Loss Contingencies [Line Items]        
Number of class actions filed (in legal matters) | lawsuit 3      
Number of class actions dismissed (in legal matters) | lawsuit 2      
Fees To Former European Distributor        
Loss Contingencies [Line Items]        
Accrued liabilities   $ 2,700,000 $ 2,700,000  
Associated gross intangible asset   $ 7,800,000 $ 7,800,000  
Fees To Former European Distributor | Minimum        
Loss Contingencies [Line Items]        
Commitment due in next twelve months       $ 5,000,000
Fees To Former European Distributor | Maximum        
Loss Contingencies [Line Items]        
Commitment due in next twelve months       $ 55,000,000
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Accumulated Other Comprehensive Income [Line Items]        
Beginning balance $ 563.3 $ 249.8 $ 75.9 $ 212.1
Other comprehensive income (loss) 3.0 (1.8) 0.6 (1.7)
Ending balance 595.0 150.6 595.0 150.6
Foreign Currency Translation Adjustment        
Accumulated Other Comprehensive Income [Line Items]        
Beginning balance (4.4) (3.4) (1.6) (2.2)
Other comprehensive income (loss) 3.3 (1.8) 0.5 (3.0)
Ending balance (1.1) (5.2) (1.1) (5.2)
Unrealized Gain on Available-for-sale Securities        
Accumulated Other Comprehensive Income [Line Items]        
Beginning balance 0.8 0.6 0.4 (0.7)
Other comprehensive income (loss) (0.3) 0.0 0.1 1.3
Ending balance 0.5 0.6 0.5 0.6
Accumulated Other Comprehensive Loss        
Accumulated Other Comprehensive Income [Line Items]        
Beginning balance (3.6) (2.8) (1.2) (2.9)
Other comprehensive income (loss) 3.0 (1.8) 0.6 (1.7)
Ending balance $ (0.6) $ (4.6) $ (0.6) $ (4.6)
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Interest Expense - Interest Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Debt Disclosure [Abstract]        
Contractual coupon interest $ 2.1 $ 2.6 $ 6.4 $ 7.5
Accretion of debt discount 10.6 8.2 31.5 22.2
Amortization of debt issuance costs 0.7 0.7 2.1 2.1
Capitalized interest (1.5) (2.1) (4.7) (8.1)
Interest expense, net of portion capitalized 11.9 9.4 35.3 23.7
Interest income (0.5) (1.7) (2.7) (5.4)
Interest expense, net $ 11.4 $ 7.7 $ 32.6 $ 18.3
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 6.6 $ 6.6 $ 20.3 $ 20.7
Cost of revenue        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 0.1 0.3 0.3 0.9
Research and development expenses        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense 2.3 2.2 7.3 6.4
Selling, general and administrative expenses        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expense $ 4.2 $ 4.1 $ 12.7 $ 13.4
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes - Narrative (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Tax Disclosure [Abstract]        
Effective tax rate 13.30% 24.70% 15.30% 14.10%
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Weighted average number of common shares outstanding, basic (in shares) 65,717,820 60,743,211 64,329,181 59,986,163
Weighted average number of common shares outstanding, diluted (in shares) 66,827,692 62,335,679 65,598,197 61,728,018
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of dilutive securities (in shares) 978,657 1,370,792 1,082,247 1,514,245
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of dilutive securities (in shares) 131,215 221,676 186,769 227,610
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.20.2
Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 8,186,152 10,367,349 8,177,228 10,495,781  
1.25% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 0 2,055,786 0 2,055,786  
1.375% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 4,319,429 4,319,429 4,319,429 4,319,429  
0.375% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 3,528,400 3,528,400 3,528,400 3,528,400  
Unvested restricted stock units          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 272,992 455,876 272,877 455,824  
Stock options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share (in shares) 65,331 7,858 56,522 136,342  
1.25% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Debt, interest rate 1.25% 1.25% 1.25% 1.25%  
1.375% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Debt, interest rate 1.375% 1.375% 1.375% 1.375% 1.375%
0.375% Convertible Senior Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Debt, interest rate 0.375% 0.375% 0.375% 0.375% 0.375%
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - Secured Debt
 1 Months Ended 3 Months Ended
Oct. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
numberOfTransaction
numberOfManufacturingLine
Forecast    
Subsequent Event [Line Items]    
Number of equipment financing transactions | numberOfTransaction   2
Number of automated manufacturing lines | numberOfManufacturingLine   2
Equipment financing transaction one | Forecast    
Subsequent Event [Line Items]    
Debt instrument, face amount   $ 37,000,000
Debt instrument, term   60 months
Debt, interest rate   4.50%
Equipment financing transaction two | Forecast    
Subsequent Event [Line Items]    
Debt instrument, face amount   $ 23,000,000
Debt instrument, term   42 months
Debt, interest rate   5.40%
Subsequent event    
Subsequent Event [Line Items]    
Debt instrument, face amount $ 70,000,000  
Debt instrument, term 5 years  
Debt, interest rate 5.20%  
Debt amortization period 20 years  
EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 74 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 267 305 1 false 59 0 false 7 false false R1.htm 0001001 - Document - Cover Sheet http://www.myomnipod.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED) Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED) (Parenthetical) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED) (Parenthetical) Statements 7 false false R8.htm 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 8 false false R9.htm 2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 2105102 - Disclosure - Revenue and Contract Acquisition Costs Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCosts Revenue and Contract Acquisition Costs Notes 10 false false R11.htm 2111103 - Disclosure - Cash and Cash Equivalents Sheet http://www.myomnipod.com/role/CashandCashEquivalents Cash and Cash Equivalents Notes 11 false false R12.htm 2114104 - Disclosure - Investments Sheet http://www.myomnipod.com/role/Investments Investments Notes 12 false false R13.htm 2118105 - Disclosure - Inventories Sheet http://www.myomnipod.com/role/Inventories Inventories Notes 13 false false R14.htm 2121106 - Disclosure - Goodwill and Other Intangible Assets, Net Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNet Goodwill and Other Intangible Assets, Net Notes 14 false false R15.htm 2127107 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 2132108 - Disclosure - Convertible Debt, Net Sheet http://www.myomnipod.com/role/ConvertibleDebtNet Convertible Debt, Net Notes 16 false false R17.htm 2136109 - Disclosure - Commitments and Contingencies Sheet http://www.myomnipod.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 2138110 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 18 false false R19.htm 2141111 - Disclosure - Interest Expense Sheet http://www.myomnipod.com/role/InterestExpense Interest Expense Notes 19 false false R20.htm 2144112 - Disclosure - Stock-Based Compensation Sheet http://www.myomnipod.com/role/StockBasedCompensation Stock-Based Compensation Notes 20 false false R21.htm 2147113 - Disclosure - Income Taxes Sheet http://www.myomnipod.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 2149114 - Disclosure - Net Income Per Share Sheet http://www.myomnipod.com/role/NetIncomePerShare Net Income Per Share Notes 22 false false R23.htm 2153115 - Disclosure - Subsequent Events Sheet http://www.myomnipod.com/role/SubsequentEvents Subsequent Events Notes 23 false false R24.htm 2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 24 false false R25.htm 2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 25 false false R26.htm 2306302 - Disclosure - Revenue and Contract Acquisition Costs (Tables) Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsTables Revenue and Contract Acquisition Costs (Tables) Tables http://www.myomnipod.com/role/RevenueandContractAcquisitionCosts 26 false false R27.htm 2312303 - Disclosure - Cash and Cash Equivalents (Tables) Sheet http://www.myomnipod.com/role/CashandCashEquivalentsTables Cash and Cash Equivalents (Tables) Tables http://www.myomnipod.com/role/CashandCashEquivalents 27 false false R28.htm 2315304 - Disclosure - Investments (Tables) Sheet http://www.myomnipod.com/role/InvestmentsTables Investments (Tables) Tables http://www.myomnipod.com/role/Investments 28 false false R29.htm 2319305 - Disclosure - Inventories (Tables) Sheet http://www.myomnipod.com/role/InventoriesTables Inventories (Tables) Tables http://www.myomnipod.com/role/Inventories 29 false false R30.htm 2322306 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables) Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetTables Goodwill and Other Intangible Assets, Net (Tables) Tables http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNet 30 false false R31.htm 2328307 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilities 31 false false R32.htm 2333308 - Disclosure - Convertible Debt, Net (Tables) Sheet http://www.myomnipod.com/role/ConvertibleDebtNetTables Convertible Debt, Net (Tables) Tables http://www.myomnipod.com/role/ConvertibleDebtNet 32 false false R33.htm 2339309 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLoss 33 false false R34.htm 2342310 - Disclosure - Interest Expense (Tables) Sheet http://www.myomnipod.com/role/InterestExpenseTables Interest Expense (Tables) Tables http://www.myomnipod.com/role/InterestExpense 34 false false R35.htm 2345311 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.myomnipod.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.myomnipod.com/role/StockBasedCompensation 35 false false R36.htm 2350312 - Disclosure - Net Income Per Share (Tables) Sheet http://www.myomnipod.com/role/NetIncomePerShareTables Net Income Per Share (Tables) Tables http://www.myomnipod.com/role/NetIncomePerShare 36 false false R37.htm 2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables 37 false false R38.htm 2407402 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details) Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details) Details 38 false false R39.htm 2408403 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details) Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details) Details 39 false false R40.htm 2409404 - Disclosure - Revenue and Contract Acquisition Costs - Narrative (Details) Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails Revenue and Contract Acquisition Costs - Narrative (Details) Details 40 false false R41.htm 2410405 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details) Sheet http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details) Details 41 false false R42.htm 2413406 - Disclosure - Cash and Cash Equivalents (Details) Sheet http://www.myomnipod.com/role/CashandCashEquivalentsDetails Cash and Cash Equivalents (Details) Details http://www.myomnipod.com/role/CashandCashEquivalentsTables 42 false false R43.htm 2416407 - Disclosure - Investments - Narrative (Details) Sheet http://www.myomnipod.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 43 false false R44.htm 2417408 - Disclosure - Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details) Sheet http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details) Details 44 false false R45.htm 2420409 - Disclosure - Inventories - Components of Inventories (Details) Sheet http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails Inventories - Components of Inventories (Details) Details 45 false false R46.htm 2423410 - Disclosure - Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details) Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetSummaryofChangesinCarryingAmountsofGoodwillDetails Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details) Details 46 false false R47.htm 2424411 - Disclosure - Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details) Details 47 false false R48.htm 2425412 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details) Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails Goodwill and Other Intangible Assets, Net - Narrative (Details) Details 48 false false R49.htm 2426413 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details) Sheet http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details) Details 49 false false R50.htm 2429414 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Details 50 false false R51.htm 2430415 - Disclosure - Accrued Expenses and Other Current Liabilities - Narrative (Details) Sheet http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails Accrued Expenses and Other Current Liabilities - Narrative (Details) Details 51 false false R52.htm 2431416 - Disclosure - Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details) Sheet http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details) Details 52 false false R53.htm 2434417 - Disclosure - Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details) Sheet http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details) Details 53 false false R54.htm 2435418 - Disclosure - Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details) Sheet http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details) Details 54 false false R55.htm 2437419 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 55 false false R56.htm 2440420 - Disclosure - Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details) Sheet http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details) Details 56 false false R57.htm 2443421 - Disclosure - Interest Expense - Interest Expense (Details) Sheet http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails Interest Expense - Interest Expense (Details) Details 57 false false R58.htm 2446422 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details) Sheet http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details) Details 58 false false R59.htm 2448423 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.myomnipod.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 59 false false R60.htm 2451424 - Disclosure - Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details) Sheet http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details) Details 60 false false R61.htm 2452425 - Disclosure - Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details) Sheet http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details) Details 61 false false R62.htm 2454426 - Disclosure - Subsequent Events (Details) Sheet http://www.myomnipod.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.myomnipod.com/role/SubsequentEvents 62 false false All Reports Book All Reports podd-20200930.htm podd-20200930.xsd podd-20200930_cal.xml podd-20200930_def.xml podd-20200930_lab.xml podd-20200930_pre.xml podd-exx311x2020x09x30.htm podd-exx312x2020x09x30x.htm podd-exx321x2020x09x30.htm http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 79 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "podd-20200930.htm": { "axisCustom": 0, "axisStandard": 21, "contextCount": 267, "dts": { "calculationLink": { "local": [ "podd-20200930_cal.xml" ] }, "definitionLink": { "local": [ "podd-20200930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "podd-20200930.htm" ] }, "labelLink": { "local": [ "podd-20200930_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "podd-20200930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "podd-20200930.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 407, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 3, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 8 }, "keyCustom": 10, "keyStandard": 295, "memberCustom": 13, "memberStandard": 41, "nsprefix": "podd", "nsuri": "http://www.myomnipod.com/20200930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.myomnipod.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105102 - Disclosure - Revenue and Contract Acquisition Costs", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCosts", "shortName": "Revenue and Contract Acquisition Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111103 - Disclosure - Cash and Cash Equivalents", "role": "http://www.myomnipod.com/role/CashandCashEquivalents", "shortName": "Cash and Cash Equivalents", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114104 - Disclosure - Investments", "role": "http://www.myomnipod.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118105 - Disclosure - Inventories", "role": "http://www.myomnipod.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2121106 - Disclosure - Goodwill and Other Intangible Assets, Net", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNet", "shortName": "Goodwill and Other Intangible Assets, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127107 - Disclosure - Accrued Expenses and Other Current Liabilities", "role": "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2132108 - Disclosure - Convertible Debt, Net", "role": "http://www.myomnipod.com/role/ConvertibleDebtNet", "shortName": "Convertible Debt, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2136109 - Disclosure - Commitments and Contingencies", "role": "http://www.myomnipod.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2138110 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141111 - Disclosure - Interest Expense", "role": "http://www.myomnipod.com/role/InterestExpense", "shortName": "Interest Expense", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2144112 - Disclosure - Stock-Based Compensation", "role": "http://www.myomnipod.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147113 - Disclosure - Income Taxes", "role": "http://www.myomnipod.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149114 - Disclosure - Net Income Per Share", "role": "http://www.myomnipod.com/role/NetIncomePerShare", "shortName": "Net Income Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2153115 - Disclosure - Subsequent Events", "role": "http://www.myomnipod.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "role": "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "role": "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306302 - Disclosure - Revenue and Contract Acquisition Costs (Tables)", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsTables", "shortName": "Revenue and Contract Acquisition Costs (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312303 - Disclosure - Cash and Cash Equivalents (Tables)", "role": "http://www.myomnipod.com/role/CashandCashEquivalentsTables", "shortName": "Cash and Cash Equivalents (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315304 - Disclosure - Investments (Tables)", "role": "http://www.myomnipod.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319305 - Disclosure - Inventories (Tables)", "role": "http://www.myomnipod.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2322306 - Disclosure - Goodwill and Other Intangible Assets, Net (Tables)", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetTables", "shortName": "Goodwill and Other Intangible Assets, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328307 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "role": "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2333308 - Disclosure - Convertible Debt, Net (Tables)", "role": "http://www.myomnipod.com/role/ConvertibleDebtNetTables", "shortName": "Convertible Debt, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2339309 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "podd:ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2342310 - Disclosure - Interest Expense (Tables)", "role": "http://www.myomnipod.com/role/InterestExpenseTables", "shortName": "Interest Expense (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "podd:ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2345311 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.myomnipod.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350312 - Disclosure - Net Income Per Share (Tables)", "role": "http://www.myomnipod.com/role/NetIncomePerShareTables", "shortName": "Net Income Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)", "role": "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details)", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails", "shortName": "Revenue and Contract Acquisition Costs - Summary of Revenue from Contracts with Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "id48073f06c454c23a6ae34902aa6adb9_D20200701-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details)", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails", "shortName": "Revenue and Contract Acquisition Costs - Summary of Deferred Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - Revenue and Contract Acquisition Costs - Narrative (Details)", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails", "shortName": "Revenue and Contract Acquisition Costs - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:CapitalizedContractCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CapitalizedContractCostNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410405 - Disclosure - Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details)", "role": "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails", "shortName": "Revenue and Contract Acquisition Costs - Summary of Contract Acquisition Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:CapitalizedContractCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CapitalizedContractCostNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413406 - Disclosure - Cash and Cash Equivalents (Details)", "role": "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "shortName": "Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ic2b6f1632c0e431fa5d7f46cf0cfcfa9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAverageRemainingMaturity1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416407 - Disclosure - Investments - Narrative (Details)", "role": "http://www.myomnipod.com/role/InvestmentsNarrativeDetails", "shortName": "Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ic2b6f1632c0e431fa5d7f46cf0cfcfa9_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAverageRemainingMaturity1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ice2eaf835f784e09a4508312d6fa7596_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417408 - Disclosure - Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details)", "role": "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails", "shortName": "Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ice2eaf835f784e09a4508312d6fa7596_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420409 - Disclosure - Inventories - Components of Inventories (Details)", "role": "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails", "shortName": "Inventories - Components of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ia2d62aec4c444517897c5eedf0c916d1_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423410 - Disclosure - Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details)", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetSummaryofChangesinCarryingAmountsofGoodwillDetails", "shortName": "Goodwill and Other Intangible Assets, Net - Summary of Changes in Carrying Amounts of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424411 - Disclosure - Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details)", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets, Net - Components of Other Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "us-gaap:AmortizationOfIntangibleAssets", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425412 - Disclosure - Goodwill and Other Intangible Assets, Net - Narrative (Details)", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails", "shortName": "Goodwill and Other Intangible Assets, Net - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AmortizationOfIntangibleAssets", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426413 - Disclosure - Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details)", "role": "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails", "shortName": "Goodwill and Other Intangible Assets, Net - Amortization Expense Expected for Next Five Years (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429414 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)", "role": "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails", "shortName": "Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie7e95099b4e447a29d3c7ddbe068aebc_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "podd:ProductWarrantyTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430415 - Disclosure - Accrued Expenses and Other Current Liabilities - Narrative (Details)", "role": "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails", "shortName": "Accrued Expenses and Other Current Liabilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie7e95099b4e447a29d3c7ddbe068aebc_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "podd:ProductWarrantyTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i4100783d2f774f7d89ba8c3bf40afed0_I20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431416 - Disclosure - Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details)", "role": "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails", "shortName": "Accrued Expenses and Other Current Liabilities - Product Warranty Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i4100783d2f774f7d89ba8c3bf40afed0_I20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434417 - Disclosure - Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details)", "role": "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "shortName": "Convertible Debt, Net - Outstanding Convertible Debt and Related Debt Issuance Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie008211dcdb4461ca5b57f97d260ed03_I20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentInterestRateStatedPercentage", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i9494e09bcf2d45b7ab9f61018e395c0c_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435418 - Disclosure - Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details)", "role": "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "shortName": "Convertible Debt, Net - Summary of Carrying Amount and Estimated Fair Value of Convertible Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i9152fa1d6ff84790bf40b71d696bfae1_I20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "iebf8d646c88247b1b2e0386c3b085e12_D20150505-20150616", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyNewClaimsFiledNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437419 - Disclosure - Commitments and Contingencies - Narrative (Details)", "role": "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "iebf8d646c88247b1b2e0386c3b085e12_D20150505-20150616", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyNewClaimsFiledNumber", "reportCount": 1, "unique": true, "unitRef": "lawsuit", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i4100783d2f774f7d89ba8c3bf40afed0_I20200630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440420 - Disclosure - Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details)", "role": "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "shortName": "Accumulated Other Comprehensive Income - Components of Accumulated Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i554c419f10004675b83490b538633e38_I20200630", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "podd:ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443421 - Disclosure - Interest Expense - Interest Expense (Details)", "role": "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails", "shortName": "Interest Expense - Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "podd:ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446422 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details)", "role": "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails", "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense Related to Share-Based Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448423 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.myomnipod.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "ie7fd869837754f0e97d4ac468f6ae869_I20181231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "idf1fbae425c1475580ab63474c45b188_D20190101-20190930", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451424 - Disclosure - Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details)", "role": "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "shortName": "Net Income Per Share - Computation of Basic and Diluted Net Income per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i76b30494fe0e4b59806104ab0c214b83_D20200701-20200930", "decimals": "0", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452425 - Disclosure - Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details)", "role": "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails", "shortName": "Net Income Per Share - Potential Common Share Equivalents Excluded from Computation of Diluted Net Income per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i821a4cd4260b45a5a300ce37f1cea878_D20200701-20200930", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i5a3a2190031b4b05a3ca82ca24326023_D20201001-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "podd:DebtInstrumentNumberOfEquipmentFinancingTransactions", "reportCount": 1, "unique": true, "unitRef": "numberoftransaction", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454426 - Disclosure - Subsequent Events (Details)", "role": "http://www.myomnipod.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i5a3a2190031b4b05a3ca82ca24326023_D20201001-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "podd:DebtInstrumentNumberOfEquipmentFinancingTransactions", "reportCount": 1, "unique": true, "unitRef": "numberoftransaction", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "us-gaap:DebtInstrumentInterestRateStatedPercentage", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i7e903f1bc96f464fa10aada5b1a357ba_I20200930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED) (Parenthetical)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R8": { "firstAnchor": { "ancestors": [ "us-gaap:NetIncomeLoss", "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "role": "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "podd-20200930.htm", "contextRef": "i8902640a979041cd80db034a04e9385b_D20200101-20200930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 59, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CANADA", "terseLabel": "CANADA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r496" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r498" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r493" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r494" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "podd_AdjustmentsToAdditionalPaidInCapitalCappedCallOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Adjustments To Additional Paid in Capital Capped Call Options", "label": "Adjustments To Additional Paid in Capital Capped Call Options", "terseLabel": "Purchase of capped call options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalCappedCallOptions", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "podd_ConvertibleSeniorNotes1.25Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes, 1.25% [Member]", "label": "Convertible Senior Notes, 1.25% [Member]", "terseLabel": "1.25% Convertible Senior Notes", "verboseLabel": "1.25% Convertible Senior Notes" } } }, "localname": "ConvertibleSeniorNotes1.25Member", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "podd_ConvertibleSeniorNotes1.375Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes, 1.375% [Member]", "label": "Convertible Senior Notes, 1.375% [Member]", "terseLabel": "1.375% Convertible Senior Notes", "verboseLabel": "1.375% Convertible Senior Notes" } } }, "localname": "ConvertibleSeniorNotes1.375Member", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "podd_ConvertibleSeniorNotes375Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Senior Notes .375% [Member]", "label": "Convertible Senior Notes .375% [Member]", "terseLabel": "0.375% Convertible Senior Notes", "verboseLabel": "0.375% Convertible Senior Notes" } } }, "localname": "ConvertibleSeniorNotes375Member", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "podd_DebtInstrumentAmortizationPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Amortization Period", "label": "Debt Instrument, Amortization Period", "terseLabel": "Debt amortization period" } } }, "localname": "DebtInstrumentAmortizationPeriod", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "podd_DebtInstrumentNumberOfAutomatedManufacturingLines": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Number Of Automated Manufacturing Lines", "label": "Debt Instrument, Number Of Automated Manufacturing Lines", "terseLabel": "Number of automated manufacturing lines" } } }, "localname": "DebtInstrumentNumberOfAutomatedManufacturingLines", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "podd_DebtInstrumentNumberOfEquipmentFinancingTransactions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument, Number Of Equipment Financing Transactions", "label": "Debt instrument, Number Of Equipment Financing Transactions", "terseLabel": "Number of equipment financing transactions" } } }, "localname": "DebtInstrumentNumberOfEquipmentFinancingTransactions", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "podd_DrugDeliveryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Drug Delivery [Member]", "label": "Drug Delivery [Member]", "terseLabel": "Drug Delivery" } } }, "localname": "DrugDeliveryMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "domainItemType" }, "podd_EquipmentFinancingTransactionOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment Financing Transaction One", "label": "Equipment Financing Transaction One [Member]", "terseLabel": "Equipment financing transaction one" } } }, "localname": "EquipmentFinancingTransactionOneMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "podd_EquipmentFinancingTransactionTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment Financing Transaction Two", "label": "Equipment Financing Transaction Two [Member]", "terseLabel": "Equipment financing transaction two" } } }, "localname": "EquipmentFinancingTransactionTwoMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "podd_FeesToFormerEuropeanDistributorMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fees To Former European Distributor [Member]", "label": "Fees To Former European Distributor [Member]", "terseLabel": "Fees To Former European Distributor" } } }, "localname": "FeesToFormerEuropeanDistributorMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "podd_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "podd_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The net change during the reporting period in the aggregate amount of accounts payable accrued expenses and other liabilities incurred but not paid.", "label": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "podd_IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) In Accounts Receivable And Unbilled Revenue", "label": "Increase (Decrease) In Accounts Receivable And Unbilled Revenue", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "podd_InternalUseSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Internal Use Software [Member]", "label": "Internal Use Software [Member]", "terseLabel": "Internal-use software" } } }, "localname": "InternalUseSoftwareMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "podd_InternationalOmnipodMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "International Omnipod [Member]", "label": "International Omnipod [Member]", "terseLabel": "International Omnipod" } } }, "localname": "InternationalOmnipodMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "domainItemType" }, "podd_LongTermInvestmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long Term Investments [Member]", "label": "Long Term Investments [Member]", "terseLabel": "Long-term investments" } } }, "localname": "LongTermInvestmentsMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "podd_ProductOmnipodMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product, Omnipod [Member]", "label": "Product, Omnipod [Member]", "terseLabel": "Total Omnipod" } } }, "localname": "ProductOmnipodMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "domainItemType" }, "podd_ProductWarrantyTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product Warranty Term", "label": "Product Warranty Term", "terseLabel": "Product warranty term for PDMs" } } }, "localname": "ProductWarrantyTerm", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "podd_RestrictedCashMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Cash [Member]", "label": "Restricted Cash [Member]", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "podd_ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Interest Expense on Debt", "label": "Schedule Of Interest And Other Expense On Debt [Table Text Block]", "terseLabel": "Summary of Interest and Other Expense" } } }, "localname": "ScheduleOfInterestAndOtherExpenseOnDebtTableTextBlock", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseTables" ], "xbrltype": "textBlockItemType" }, "podd_U.S.OmnipodMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "U.S. Omnipod [Member]", "label": "U.S. Omnipod [Member]", "terseLabel": "U.S. Omnipod" } } }, "localname": "U.S.OmnipodMember", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "domainItemType" }, "podd_ValueAddedTaxesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value Added Taxes Payable, Current", "label": "Value Added Taxes Payable, Current", "terseLabel": "Value added taxes payable" } } }, "localname": "ValueAddedTaxesPayableCurrent", "nsuri": "http://www.myomnipod.com/20200930", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r111", "r118", "r189", "r310", "r311", "r312", "r327", "r328" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjusted Balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r111", "r118", "r189", "r310", "r311", "r312", "r327", "r328" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r111", "r118", "r189", "r310", "r311", "r312", "r327", "r328" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r111", "r118", "r189", "r310", "r311", "r312", "r327", "r328" ], "lang": { "en-US": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r293", "r295", "r392", "r393", "r394", "r395", "r396", "r397", "r416", "r459", "r462" ], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r293", "r295", "r392", "r393", "r394", "r395", "r396", "r397", "r416", "r459", "r462" ], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r160", "r272", "r276", "r417", "r458", "r460" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r160", "r272", "r276", "r417", "r458", "r460" ], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r284", "r293", "r295", "r392", "r393", "r394", "r395", "r396", "r397", "r416", "r459", "r462" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r284", "r293", "r295", "r392", "r393", "r394", "r395", "r396", "r397", "r416", "r459", "r462" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails", "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r161", "r162", "r272", "r277", "r461", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490" ], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r161", "r162", "r272", "r277", "r461", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r230", "r294", "r384" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r112", "r113", "r114", "r115", "r186", "r187", "r188", "r189", "r190", "r191", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r327", "r328", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474" ], "lang": { "en-US": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible List]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses and Other Current Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r8", "r36" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Supplier purchases" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r197" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts and unbilled receivables", "verboseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r19", "r164", "r165" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable trade, less allowance for credit losses of $3.6 and $3.8" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedExchangeFeeRebateCurrentAndNoncurrent": { "auth_ref": [ "r428", "r452" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates of an exchange fee some mutual funds impose on shareholders if they exchange (transfer) to another fund within the same fund group.", "label": "Accrued Exchange Fee Rebate", "terseLabel": "Accrued rebates" } } }, "localname": "AccruedExchangeFeeRebateCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r428", "r452" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r7", "r8", "r39" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Salaries, Current", "terseLabel": "Employee compensation and related costs" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r54", "r55", "r56", "r60", "r61" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized Gain on Available-for-sale Securities" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r22", "r58", "r59", "r60", "r447", "r470", "r474" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r366", "r367", "r368", "r369", "r370", "r372" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r57", "r60", "r61", "r108", "r109", "r110", "r344", "r465", "r466" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r53", "r60", "r61", "r344", "r367", "r368", "r369", "r370", "r372" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustment" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r313" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r108", "r109", "r110", "r310", "r311", "r312" ], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r253", "r258", "r326" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature", "terseLabel": "Conversion feature, net of issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r296", "r297", "r315", "r316" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r319" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r297", "r304", "r314" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r26", "r166", "r192" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "auth_ref": [ "r196" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "terseLabel": "Recoveries of amounts previously written-off" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r195" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Write-offs charged against allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r78", "r95", "r375" ], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Accretion of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r75", "r95", "r377" ], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r95", "r377" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Non-cash interest" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r95", "r215", "r220" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of other intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r103", "r149", "r152", "r158", "r185", "r341", "r345", "r364", "r423", "r445" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r52", "r103", "r185", "r341", "r345", "r364" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r174" ], "calculation": { "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r175" ], "calculation": { "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedTerseLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r172", "r201" ], "calculation": { "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r169", "r173", "r201", "r427" ], "calculation": { "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r171", "r201" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Debt Securities, Available-for-sale, Current", "terseLabel": "Short-term investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r347", "r348" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r98", "r99", "r100" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment included in accounts payable and accrued expenses" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortization": { "auth_ref": [ "r208" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Amortization", "terseLabel": "Amortization of capitalized commission costs" } } }, "localname": "CapitalizedContractCostAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r207" ], "calculation": { "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net", "totalLabel": "Total capitalized contract acquisition costs, net" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNetCurrent": { "auth_ref": [ "r207" ], "calculation": { "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails": { "order": 1.0, "parentTag": "us-gaap_CapitalizedContractCostNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.", "label": "Capitalized Contract Cost, Net, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "CapitalizedContractCostNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNetNoncurrent": { "auth_ref": [ "r207" ], "calculation": { "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails": { "order": 2.0, "parentTag": "us-gaap_CapitalizedContractCostNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.", "label": "Capitalized Contract Cost, Net, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "CapitalizedContractCostNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofContractAcquisitionCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostTableTextBlock": { "auth_ref": [ "r209" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.", "label": "Capitalized Contract Cost [Table Text Block]", "terseLabel": "Summary of Contract Acquisition Costs" } } }, "localname": "CapitalizedContractCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r360", "r361" ], "lang": { "en-US": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash and Cash Equivalents [Abstract]", "terseLabel": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r33", "r97" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "Cash and Cash Equivalents Disclosure [Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Total cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Cash and Cash Equivalents [Line Items]", "terseLabel": "Cash and Cash Equivalents [Line Items]" } } }, "localname": "CashAndCashEquivalentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r92", "r97", "r101" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r92", "r365" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]", "terseLabel": "Cash" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r442" ], "lang": { "en-US": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r229", "r429", "r451" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r226", "r227", "r228", "r237" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r108", "r109" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r18", "r253" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r18" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 100,000,000 authorized; 65,871,736 and 62,685,492 issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r64", "r66", "r67", "r71", "r432", "r455" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r70", "r81", "r431", "r454" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r142", "r143", "r163", "r362", "r363" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r142", "r143", "r163", "r362", "r363", "r476" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r142", "r143", "r163", "r362", "r363", "r476" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r142", "r143", "r163", "r362", "r363" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "verboseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r142", "r143", "r163", "r362", "r363" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Summary of Deferred Revenue" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r260", "r261", "r273" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 }, "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails": { "order": 1.0, "parentTag": "us-gaap_RevenueRemainingPerformanceObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r260", "r261", "r273" ], "calculation": { "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails": { "order": 2.0, "parentTag": "us-gaap_RevenueRemainingPerformanceObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r274" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r248" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]", "terseLabel": "Corporate bonds" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r77", "r417" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r141", "r163" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r252" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Convertible Debt, Net" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r424", "r425", "r444" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r16", "r249", "r425", "r444" ], "calculation": { "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Principal amount of Senior Notes" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r376", "r378" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "verboseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r359" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Financial instrument value" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r42" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical", "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r105", "r254", "r255", "r256", "r257", "r375", "r376", "r378", "r443" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r375", "r378" ], "calculation": { "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred cost assets and assets classified as other.", "label": "Deferred Costs and Other Assets", "terseLabel": "Other assets" } } }, "localname": "DeferredCostsAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r35", "r377" ], "calculation": { "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r95", "r147" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAverageRemainingMaturity1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average remaining period until maturity of the derivative contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Average Remaining Maturity", "terseLabel": "Derivative maturity date range" } } }, "localname": "DerivativeAverageRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r272", "r276", "r277", "r278", "r279", "r280", "r281", "r282" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Summary of Revenue from Contracts with Customers" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r72", "r116", "r117", "r118", "r119", "r120", "r124", "r126", "r131", "r132", "r133", "r137", "r138", "r433", "r456" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net income per share:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r72", "r116", "r117", "r118", "r119", "r120", "r126", "r131", "r132", "r133", "r137", "r138", "r433", "r456" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r134", "r135", "r136", "r139" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r365" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r322", "r331" ], "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r302" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options", "verboseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r108", "r109", "r110", "r113", "r121", "r123", "r140", "r189", "r253", "r258", "r310", "r311", "r312", "r327", "r328", "r366", "r367", "r368", "r369", "r370", "r372", "r465", "r466", "r467" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r359" ], "lang": { "en-US": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimated Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r349", "r350", "r351", "r355" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r350", "r389", "r390", "r391" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r349", "r356" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r349", "r350", "r352", "r353", "r357" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r285", "r286", "r291", "r292", "r350", "r389" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r285", "r286", "r291", "r292", "r350", "r390" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r349", "r350" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.", "label": "Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]", "terseLabel": "Summary of Carrying Amount and Estimated Fair Value of Convertible Debt" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r389", "r390", "r391" ], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails", "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails", "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r354", "r357" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "verboseLabel": "Recurring fair value measurements" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r178", "r179", "r193", "r197", "r198", "r199", "r200", "r202", "r203", "r204", "r205", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r219" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r221" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "2020 (remaining)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r221" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r221" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r221" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r216", "r217", "r219", "r222", "r418", "r419" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r219", "r419" ], "calculation": { "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r216", "r218" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r219", "r418" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Book Value", "verboseLabel": "Other intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetAmortizationExpenseExpectedforNextFiveYearsDetails", "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r95", "r250", "r251" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of debt", "terseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r210", "r211", "r422" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill at September 30, 2020", "periodStartLabel": "Goodwill at December 31, 2019", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetSummaryofChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r212" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetSummaryofChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetSummaryofChangesinCarryingAmountsofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r76", "r103", "r149", "r151", "r154", "r157", "r159", "r185", "r364" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r106", "r149", "r151", "r154", "r157", "r159" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r225" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r323", "r324", "r325", "r329", "r332", "r334", "r335", "r336" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r104", "r122", "r123", "r148", "r321", "r330", "r333", "r457" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r94" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r94" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r94" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r127", "r128", "r129", "r133" ], "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Effect of dilutive securities (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Other Intangible Assets, Net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r338" ], "lang": { "en-US": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Intellectual property" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestAndDividendIncomeOperating": { "auth_ref": [ "r435" ], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.", "label": "Interest and Dividend Income, Operating", "negatedTerseLabel": "Interest income" } } }, "localname": "InterestAndDividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalizedAdjustment": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_InterestExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest costs capitalized disclosed as an adjusting item to interest costs incurred.", "label": "Interest Costs Capitalized Adjustment", "negatedTerseLabel": "Capitalized interest" } } }, "localname": "InterestCostsCapitalizedAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r68", "r146", "r374", "r377", "r437" ], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "totalLabel": "Interest expense, net of portion capitalized" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r80" ], "calculation": { "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual coupon interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock": { "auth_ref": [ "r434" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities.", "label": "Interest Income and Interest Expense Disclosure [Text Block]", "terseLabel": "Interest Expense" } } }, "localname": "InterestIncomeAndInterestExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InterestExpense" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r436" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 }, "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedTotalLabel": "Interest expense, net", "terseLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.myomnipod.com/role/InterestExpenseInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r428", "r452" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r206" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r48" ], "calculation": { "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r51" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r50" ], "calculation": { "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r49" ], "calculation": { "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InventoriesComponentsofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r184", "r420", "r441", "r481" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r103", "r153", "r185", "r342", "r345", "r346", "r364" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r25", "r103", "r185", "r364", "r426", "r449" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r103", "r185", "r342", "r345", "r346", "r364" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Convertible debt, net", "totalLabel": "Total convertible debt, net" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r34" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Long-term investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r247" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetOutstandingConvertibleDebtandRelatedDebtIssuanceCostsDetails", "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r229", "r230", "r231", "r233", "r234", "r235", "r236", "r238", "r239" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsDismissedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of claims dismissed.", "label": "Loss Contingency, Claims Dismissed, Number", "terseLabel": "Number of class actions dismissed (in legal matters)" } } }, "localname": "LossContingencyClaimsDismissedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Number of class actions filed (in legal matters)" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r285" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market mutual funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r92" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r92" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r92", "r93", "r96" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r62", "r65", "r69", "r96", "r103", "r112", "r116", "r117", "r118", "r119", "r122", "r123", "r130", "r149", "r151", "r154", "r157", "r159", "r185", "r364", "r430", "r453" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Supplemental noncash information:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r149", "r151", "r154", "r157", "r159" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r379" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Short-term lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r9", "r39" ], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year One", "terseLabel": "Commitment due in next twelve months" } } }, "localname": "OtherCommitmentDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r339", "r340", "r343" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r63", "r66", "r339", "r340", "r343" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r54", "r58" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "terseLabel": "Unrealized (loss) gain on available-for-sale debt securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherFiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.", "label": "Other Finite-Lived Intangible Assets, Gross", "terseLabel": "Associated gross intangible asset" } } }, "localname": "OtherFiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Income and Expenses [Abstract]", "terseLabel": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r79" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": { "auth_ref": [ "r90", "r91" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.", "label": "Payments for Derivative Instrument, Financing Activities", "negatedTerseLabel": "Purchase of capped call options" } } }, "localname": "PaymentsForDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r88" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Payment of withholding taxes in connection with vesting of restricted stock units" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r82", "r84", "r170" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-sale", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r85" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Acquisition of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r85" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r358" ], "lang": { "en-US": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetSummaryofCarryingAmountandEstimatedFairValueofConvertibleDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r17" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r31", "r32" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PriorPeriodReclassificationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.", "label": "Prior Period Reclassification Adjustment", "terseLabel": "Reclassification of prior period amounts" } } }, "localname": "PriorPeriodReclassificationAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassification of Prior Period Amounts" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r87" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible notes, net of issuance costs" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r86" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "auth_ref": [ "r83" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Proceeds from Sale of Short-term Investments", "terseLabel": "Receipts from the maturity or sale of investments" } } }, "localname": "ProceedsFromSaleOfShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r86", "r305" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r243", "r244", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Product warranty liability at the end of period", "periodStartLabel": "Product warranty liability at beginning of period" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedLabel": "Warranty claims settled" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r241" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Warranty expense" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyLiabilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Warranty Liability [Line Items]", "terseLabel": "Product Warranty Liability [Line Items]" } } }, "localname": "ProductWarrantyLiabilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.", "label": "Product Warranty Liability [Table]", "terseLabel": "Product Warranty Liability [Table]" } } }, "localname": "ProductWarrantyLiabilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r224", "r450" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r74", "r194" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for credit losses", "verboseLabel": "Provision for expected credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r27", "r102", "r167" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Credit Losses" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification [Line Items]", "terseLabel": "Reclassification [Line Items]" } } }, "localname": "ReclassificationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationTable": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification [Table]", "terseLabel": "Reclassification [Table]" } } }, "localname": "ReclassificationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r89" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedTerseLabel": "Repayment of convertible debt" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r320", "r492" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Restricted stock units vested, net of shares withheld for taxes (in shares)" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Unvested restricted stock units", "verboseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Restricted stock units vested, net of shares withheld for taxes" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r258", "r313", "r448", "r469", "r474" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r108", "r109", "r110", "r113", "r121", "r123", "r189", "r310", "r311", "r312", "r327", "r328", "r465", "r467" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r144", "r145", "r150", "r155", "r156", "r160", "r161", "r163", "r271", "r272", "r417" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofRevenuefromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r270", "r275", "r283" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue and Contract Acquisition Costs" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r268" ], "calculation": { "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "totalLabel": "Total deferred revenue" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsSummaryofDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r380", "r381" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Lease liabilities arising from obtaining right-of-use assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r142", "r163" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r47" ], "lang": { "en-US": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Components of Accrued Expenses and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r60", "r371", "r372" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r216" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetComponentsofOtherIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails", "http://www.myomnipod.com/role/NetIncomePerSharePotentialCommonShareEquivalentsExcludedfromComputationofDilutedNetIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Potential Common Share Equivalents Excluded from Computation of Diluted Net Income (Loss) per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.", "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]", "terseLabel": "Summary of Amortized Cost, Gross Unrealized Gains and Losses, Fair Value and Level in Fair Value Hierarchy for Investments" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r176", "r177", "r180", "r181", "r182", "r183", "r439", "r440" ], "lang": { "en-US": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-sale Securities [Table]", "terseLabel": "Schedule of Available-for-sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.", "label": "Schedule of Cash and Cash Equivalents [Table]", "terseLabel": "Schedule of Cash and Cash Equivalents [Table]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Summary of Cash and Cash Equivalents" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r42", "r105", "r254", "r255", "r256", "r257", "r375", "r376", "r378", "r443" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Outstanding Convertible Debt and Related Debt Issuance Costs" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/ConvertibleDebtNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Computation of Basic and Diluted Net Income (Loss) per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/NetIncomePerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r297", "r303", "r314" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r216", "r218" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Components of Other Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r213", "r214" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Summary of Changes in Carrying Amounts of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r10", "r28", "r29", "r30" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Components of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Changes in Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r11", "r101", "r421", "r446" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Summary of Restricted Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CashandCashEquivalentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r298", "r300", "r301" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Share-Based Compensation Expense" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Amortization Expense Expected for Next Five Years" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/GoodwillandOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r73" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseRelatedtoShareBasedAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r102", "r318" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Shipping and Handling costs" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r94" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r259", "r317" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r276" ], "lang": { "en-US": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Short-term Investments [Abstract]", "terseLabel": "Short-term Investments [Abstract]" } } }, "localname": "ShortTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r477", "r478", "r479", "r480" ], "lang": { "en-US": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short-term Investments [Member]", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyAccrualCurrent": { "auth_ref": [], "calculation": { "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual, Current", "terseLabel": "Warranty liability" } } }, "localname": "StandardProductWarrantyAccrualCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r102", "r242" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranty Costs" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r46", "r108", "r109", "r110", "r113", "r121", "r123", "r140", "r189", "r253", "r258", "r310", "r311", "r312", "r327", "r328", "r366", "r367", "r368", "r369", "r370", "r372", "r465", "r466", "r467" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r108", "r109", "r110", "r140", "r417" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITEDParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r45", "r253", "r254", "r258" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Issuance of shares for debt repayment (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r17", "r18", "r253", "r258" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r17", "r18", "r253", "r258" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r17", "r18", "r253", "r258", "r299" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Exercise of options to purchase common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r46", "r253", "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of shares for debt repayment" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r17", "r18", "r253", "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of shares for employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r17", "r18", "r253", "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r46", "r253", "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of options to purchase common stock" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r18", "r23", "r24", "r103", "r168", "r185", "r364" ], "calculation": { "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedLabel": "Increase of accumulated deficit", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/AccumulatedOtherComprehensiveIncomeComponentsofAccumulatedOtherComprehensiveLossDetails", "http://www.myomnipod.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED", "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r373", "r383" ], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r373", "r383" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r373", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r373", "r383" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r382", "r385" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r178", "r179", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r285", "r438", "r475" ], "lang": { "en-US": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. government and agency bonds" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/InvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesFairValueandLevelinFairValueHierarchyforInvestmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnbilledReceivablesCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.", "label": "Unbilled Receivables, Current", "terseLabel": "Unbilled receivable" } } }, "localname": "UnbilledReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/RevenueandContractAcquisitionCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r125", "r133" ], "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average number of common shares outstanding, diluted (in shares)", "verboseLabel": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average number of common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r124", "r133" ], "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of common shares outstanding, basic (in shares)", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.myomnipod.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED", "http://www.myomnipod.com/role/NetIncomePerShareComputationofBasicandDilutedNetIncomeperShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r259": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r336": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5558-128473" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r385": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-12)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.1-5)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803" }, "r441": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010" }, "r481": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r493": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r494": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r495": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r496": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r497": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r498": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3505-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" } }, "version": "2.1" } ZIP 80 0001145197-20-000037-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001145197-20-000037-xbrl.zip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�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